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SUMMARY
Neurons, astrocytes and oligodendrocytes of the central nervous system (CNS) arise
from a common pool of multipotent neuroepithelial progenitor cells, lining the walls of the
neural tube. Within the thickness of the neural tube, progenitor cells extend between the
ventricular surface and the basal lamina. They are coupled by adherence and tight junctions
and exhibit the apical-basal polarity with the distinct apical and basolateral plasma
membrane domains.
Initially, neuroepithelial cells undergo symmetric proliferative divisions, thereby
expanding the progenitor pool and determining the size of brain compartments. At the
onset of neurogenesis, a subset of progenitors divides asymmetrically, which is accompanied
by transformation of neuroepithelial cells into radial glia. Radial glia cells display certain
astrocytic characteristics, such as expression of the brain lipid binding protein (BLBP) and
astrocyte-specific glutamate transporter (GLAST). Neuroepithelial/radial progenitors in the
telencephalon give rise to the third progenitor type, the basal progenitor, which as an
intermediate precursor undergoes terminal neurogenic divisions at the basal aspect of the
neuroepithelium. As the diversity of cell types in the mammalian CNS arises in the
stereotyped temporal sequence, it is necessary to maintain progenitor cells via asymmetric
and/or symmetric proliferative divisions throughout development.
Prior to the neural tube closure, neuroepithelial cells initiate expression of Hes genes
from the bHLH family of translational repressors, which inhibit neuronal differentiation.
Upon the switch from proliferation to neurogenesis, expression of Hes genes, and thus
maintenance of progenitor cells, becomes dependent on Notch signalling, which is then
downregulated when cells are selected, through the process called lateral inhibition, to
undergo symmetric terminal divisions and enter the differentiation program.
The mechanisms responsible for the maintenance of progenitor cells proliferation are far
from being fully understood. The family of Y-box proteins is involved in control of
proliferation and transformation in various normal and pathological cellular systems, and
therefore was considered as a candidate to exert such a function. Y-box proteins have a
capacity to bind DNA and RNA, thereby controlling gene expression from transcription to
translation. Particularly, the canine and human Y-box protein 3 (ZONAB/dbpA) were
shown to increase proliferation and cell density in mature monolayers of MDCK and
MCF-10A epithelial cell lines, respectively. This function is linked with the subcellular
localisation: in cells at a low density, ZONAB/dbpA is localised in the nucleus and acts as a
transcription factor for genes encoding growth related proteins. With increasing cell density
and formation of functional tight junctions, ZONAB/dbpA translocates form the nucleus
to the cytoplasm, where it binds to the peripheral junctional protein zonula occludens-1
(ZO-1). Importantly, the pro-proliferative effects of ZONAB/dbpA are counteracted by
ZO-1, which is believed to sequester the protein from the nucleus at junctions. Because
ZO-1 expression increases upon closure of the neural tube and prior to the onset of
neurogenesis, the mouse Y-box protein 3  (MSY3) in the neuroepithelium could be involved
in the control of progenitor maintenance in a manner opposite to ZO-1. This study aimed
to examine the expression of MSY3 in the developing murine nervous system and elucidate
its putative role in regulation of proliferation of progenitor cells.
As presented in this thesis, the MSY3 protein in the developing CNS is expressed solely
in progenitor cells and not neurons. Moreover, as shown by two independent approaches:
morphologically, i.e. using immunofluorescence and confocal microscopy, and
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biochemically, MSY3 expression is downregulated concomitantly with the spatiotemporal
progression of neurogenesis,: i) from caudal to rostral along the anteroposterior axis of the
brain; ii) from ventral do dorsal; iii) in the telencephalon from rostrolateral to caudomedial;
iv) in the cortical hem prior to other regions. In addition, MSY3 was absent from specialised
regions of the neural tube, which are largely composed from post-mitotic cells: the floor
plate, the roof plate, and the choroid plexus epithelium. The time of downregulation of
MSY3 coincides with the lengthening of the cell cycle of progenitor cells.
Furthermore, it was shown here that the downregulation of MSY3 parallels the
developmental progression of GLAST induction, and also the onset of active Notch
signalling as visualised using the Hes5-GFP transgenic mouse, in which expression of GFP
from the Hes5 promoter is entirely dependent on the active Notch. Since the expression of
GLAST and activation of Notch characterise the transition from neuroepithelial cells to
radial glia, MSY3 appears to be downregulated in radial glia, which undergo mostly
asymmetric divisions.
After the onset of neurogenesis, MSY3 expression declines but is still expressed by
progenitor cells at variable levels. Nonetheless, the presence of the MSY3 protein did not
seem to correlate with a particular division mode of neuroepithelial cells. First, in the
Tis21-GFP heterozygous knock-in embryos, in which expression of GFP marks all
neurogenic, but not proliferating cells, expression of MSY3 was not selectively
downregulated in many GFP-positive cells. Second, in the Hes5-GFP embryos MSY3 was
present randomly in GFP positive and GFP negative cells, the latter presumably being
progenitors selected for differentiation.
Given that MSY3 correlates with initial proliferation of neuroepithelial cells and is
reduced with the appearance of restricted neurogenic progenitors, it was tempting to
speculate that MSY3 positively regulates proliferation, or/and its downregulation is
necessary for differentiation. To test this hypothesis, the levels of the MSY3 protein in the
progenitors were acutely downregulated or elevated by electroporation of RNAi or MSY3
expression plasmids, respectively. Neither premature reduction of MSY3 in the
neuroepithelium (E9.5-E11.5) nor prolonged expression at the developmental time when
this protein is endogenously downregulated (E10.5-14.5) did affect proliferation versus the
cell cycle exit of progenitors. Knockdown of MSY3 also did not induce prematurely radial
glial markers or increase of the abundance of basal progenitors. Moreover, in
Notch1-deficient progenitors in the cerebellar anlage, which exhibit precocious
differentiation, MSY3 was not prematurely downregulated, suggesting that MSY3 also is not
an early marker of differentiation.
Interestingly, in preliminary results it was shown that MSY3 is expressed in Dcx-positive
transient amplifying precursors in germinal zones of the adult brain, and in EGF-dependent
neurospheres.
In attempt to understand the function of MSY3 in neuroepithelial cells, its subcellular
localisation was investigated by light and electron microscopy, as well as by differential
centrifugation. In the neuroepithelium, the MSY3 protein was distributed throughout the
cytoplasm and, unlike ZONAB/dbpA in epithelial cell lines, was not found in the nucleus
or at junctions, suggesting that it acts through a distinct mechanism than regulation of
transcription. Indeed, differential centrifugation, immunoprecipitation and polysomal
analysis performed in this study revealed that the MSY3 protein in the developing embryo,
as well as in Neuro-2A cells, is associated with RNA. On a sucrose density gradient MSY3
co-fractionates with ribosomes and actively translating polysomes, suggesting that it might
have a role in regulation of translation. However, downregulation or overexpression of
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MSY3 in the Neuro-2A cell line did not affect global translation rates. Other researchers
suggested that the MSY3 protein has the redundant function with Y-box protein 1 (YB-1).
Accordingly, in our system the MSY3 protein could be co-immunoprecipitated with YB-1.
Importantly, developmentally regulated expression of MSY3 is not a hallmark of general
translation apparatus, as several other proteins involved in translation, namely eukaryotic
initiation factor 4E (eIF4E), fragile X mental retardation protein (FMRP) and YB-1, did not
show similar downregulation.
To conclude, this work showed that the MSY3 protein is a marker of proliferation of
progenitor cells in the embryonic and adult brain, being absent from neurons, but also from
slowly dividing stem and progenitor cells. Discovery of the molecular mechanism by which
MSY3 exerts its role in the cell could provide the link between the translational machinery
and proliferation.
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1 INTRODUCTION
The mammalian telencephalon, which gives rise to the cerebral cortex and basal ganglia,
is a venue of motor coordination, emotions, memory, higher cognition and consciousness.
The final shape, size and organisation of the brain is tightly linked with the birth and
assembly of different cell types in high-order systems during embryonic development and
the early postnatal period. Initially, to generate the cellular diversity and pattern,
proliferation and differentiation of progenitors must be strictly controlled, which is achieved
by integrating environmental and intrinsic cues. Here, I focused on the intrinsic mechanisms
regulating proliferation and the cell cycle exit of progenitor cells. In the second part of the
Introduction, I reviewed current background on the Y-box family of nucleic acid binding
proteins, which are implicated in the control of proliferation in various cellular systems.
1.1 Neurogenesis in the central nervous system
1.1.1 Origin and organisation of the neural tube
Neurons, astrocytes and oligodendrocytes of the central nervous system arise from a
common pool of multipotent progenitor cells, which originally derive from an unspecified
cellular sheet of the ectoderm. Subsequent tissue movements result in bending of the neural
plate and closure of the neural groove, thereby forming the neural tube (Colas and
Schoenwolf, 2001). The neural tissue is patterned along the anteroposterior axis into distinct
compartments (Figure I) (reviewed in: Rallu et al., 2002; Wilson and Houart, 2004). The
anterior neural tube expands into prominent vesicles, which represent anlage of the
forebrain (prosencephalon), the midbrain (mesencephalon) and the hindbrain
(rhombencephalon). The neural tube caudally to the hindbrain gives rise to the spinal cord.
The forebrain subdivides further into the dorsally positioned telencephalon and eyes, the
ventrally positioned hypothalamus and the more caudally located diencephalon.
Specification, maintenance and pattering of the CNS divisions rely on the interplay between
various signalling pathways and differential cellular response to the same signal over time
(Ciani and Salinas, 2005; Liu and Niswander, 2005; Rallu et al., 2002; Rao and Jacobson,
2005; Wilson and Houart, 2004). In the brain, each structure undergoes additional pattering
and morphogenesis, which in the dorsal telencephalon leads to emergence of the cortex,
and ventrally three distinct eminences: the medial and lateral ganglionic eminences (MGE
and LGE) anteriorly, and the caudal ganglionic eminence (CGE) posteriorly (Fuccillo et al.,
2006; Rallu et al., 2002).
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Figure I. Regionalisation of the neural tube. (A) Schematic representation of the neural plate of the mouse embryo at
around embryonic day 8 (E8). The neural plate subdivides anteriorly into forebrain and midbrain, and caudally into
hindbrain and spinal cord. (B ) Side view of the brain of mouse embryo at E10. Forebrain undergoes further
specification into the rostral telencephalon and caudally positioned diencephalon. Modified from Rallu et al., 2002.
1.1.2 Division modes of progenitor cells: how to generate cellular diversity
Stem cells can undergo three types of divisions in terms of the fate of daughter cells: i) a
symmetric proliferative division, which generates two daughter stem cells; ii) a symmetric
terminal division, which generates two postmitotic cells; and iii) an asymmetric,
self-renewing division, which produces one postmitotic cell, whereas the other daughter
continues to proliferate (Morrison and Kimble, 2006). Prior to the onset of neurogenesis,
neuroepithelial cells undergo proliferative symmetric divisions, thereby establishing the
original pool of progenitors available to generate neurons at the onset of neurogenesis
(Bayer and Altman, 1991). This type of divisions is believed to determine the size of brain
compartments, particularly of the cortex (Caviness et al., 1995; Rakic, 1995). Subsequently, a
subset of neuroepithelial cells switch to asymmetric and terminal neurogenic divisions. All
three types of divisions coexist in the neural tube throughout the entire period of
neurogenesis, with increase of neurogenic terminal divisions as neurogenesis proceeds (Cai
et al., 2002; Kornack and Rakic, 1998; Mione et al., 1997; Reznikov et al., 1997; Takahashi et
al., 1996). Notably, most of neurons in the rodent telencephalon is produced by symmetric
terminal divisions (Haubensak et al., 2004).
In addition to spatial specification of progenitors, the variety of cell types in the
mammalian brain arises in the stereotyped temporal sequence. Therefore, the maintenance
of progenitors throughout development, through symmetric proliferative or asymmetric
divisions, is essential for generation of full diversity of neuronal and glial cells. Neurons
emerge primarily during the embryonic period, while most glia are produced after birth
(Bayer and Altman, 1991). Among glial lineages, generation of astrocytes precedes
oligodendrogenesis (Parnavelas, 1999). Particularly in the cortex, the time of birth of
projection (pyramidal) neurons is linked with specification of laminar fate. The earliest born
neurons are designed for the subplate and deep layer VI, whereas the later born neurons
Introduction
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intercalate between these two layers and occupy progressively more superficial layers V-II
(Berry and Rogers, 1965). Moreover, spatial, but also temporal, origin of interneurons
predicts their physiological profile, subtype, and layer positioning in the mature cortex (Butt
et al., 2005; Wonders and Anderson, 2006).
The pattern of generation of distinct neuronal and glial cells can be recapitulated in
cultures of isolated cortical cells (Qian et al., 2000; Shen et al., 2006). Importantly, these
studies provided an insight into the division modes and potential of individual progenitors.
The multipotent stem cells, which produce large clones containing neuronal and glial
progeny, constitute around 10% of progenitor cells isolated from cortices at the onset of
neurogenesis (Davis and Temple, 1994; Qian et al., 1998; Qian et al., 2000). These stem cells
give rise to more restricted progenitors, which undergo stereotyped modes of divisions to
generate neurons or glia. Glioblasts are generated after the majority of neuroblasts and
undergo a series of proliferative divisions before differentiation (Qian et al., 2000).
1.1.3 Progenitor cell types during the neurogenic period
Neuroepithelial  cells
Initially, the neuroepithelial tissue is a one-cell-thick layer of collumnar cells. As the
neural tube closes, elongation and proliferation of the neuroepithelial cells result in
thickening of the walls of the neural tube and pseudostratified organisation of the
neuroepithelium. The neuroepithelial cells inherit the apical-basal polarity of the ectoderm,
extending from the ventricular, apical surface of the neural tube towards the basal lamina.
Within the thickness of the neural tube, the nuclei of neuroepithelial cells undergo a
to-and-fro movement, which is synchronised with the cell cycle, accordingly called
interkinetic nuclear migration (Sauer, 1935) (Figure II). Neuroepithelial cells during mitosis
round up at the apical side of the neural tube, and during G1 phase the nuclei of daughter
cells migrate basally to undergo S phase. During G2 the nuclei migrate back to the apical
surface.
Radial gl ia
During the neurogenic interval, three distinct, yet related, types of progenitors can be
distinguished (reviewed in: Campbell, 2005; Gotz and Huttner, 2005; Guillemot, 2005;
Huttner and Kosodo, 2005) (Figure II). The early neuroepithelial cells give rise to the
earliest-born neurons. As neurons migrate basally and accumulate forming neuronal layers,
the progenitor cell bodies become separated from the pia. This process is accompanied by
transformation of neuroepithelial cells into radial glia, which differ from neuroepithelial cells
ultrastructurally as containing glycogen granules, and express a set of markers characteristic
to differentiated astrocytes, such as the astrocyte-specific glutamate transporter (GLAST),
brain lipid binding protein (BLBP), and Tenascin C (Anthony et al., 2004; Campbell and
Gotz, 2002; Gotz and Barde, 2005; Hartfuss et al., 2001; Malatesta et al., 2003). Primate
radial glia express also the glia-fibrillary acidic protein (GFAP). Radial glia maintain the
connection to the pial surface (Misson et al., 1988; Wilson, 1983). In the dorsal
telencephalon, radial glia, directly and indirectly, are the major source of projection neurons,
whilst in the basal telencephalon, the extent to which they contribute to neuronal
production remains controversial (Anthony et al., 2004; Gotz and Barde, 2005; Gotz and
Huttner, 2005; Malatesta et al., 2003; Noctor et al., 2002). Time-lapse studies revealed that
the majority of radial glia cells divide asymmetrically at the apical surface of the
neuroepithelium (Chenn and McConnell, 1995; Miyata et al., 2001; Miyata et al., 2004;
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Noctor et al., 2001; Noctor et al., 2004; Tamamaki et al., 2001). Several studies indicated
that all cells in the ventricular zone, except basal progenitors (see below), are radial glia, i.e.
after the onset of neurogenesis all neuroepithelial cells acquire radial glia fate (Anthony et
al., 2004; Hartfuss et al., 2001; Noctor et al., 2002). However, other studies showed that
during the neurogenic interval, two populations of radial progenitors coexist in the
ventricular zone: i) radial glia cells that span the entire neocortical wall and maintain
contacts with the ventricular and pial surfaces; and ii) short neural precursors, equivalent to
neuroepithelial cells, which possess a basal process of variable length that do not contact the
pia (Gadisseaux et al., 1992; Gal et al., 2006; Koch, 2000). These two cell populations show
differential activity of reporter promoters, indicating distinct molecular characteristics (Gal
et al., 2006). Radial glia, except being neuronal progenitors, have also a scaffolding function
and guide neuronal migration (Bentivoglio and Mazzarello, 1999; Gadisseux et al., 1990;
Haubst et al., 2006; Noctor et al., 2001; Rakic, 1972). After the period of neurogenesis they
transform into astrocytes (Misson et al., 1988; Voigt, 1989).
Basal progenitors
Neuroepithelial/radial glial cells give rise to the third progenitor type, the basal
progenitor, which as an intermediate precursor undergoes symmetric neurogenic divisions
distantly from the ventricular surface, i.e. at the basal side of the ventricular zone
(Haubensak et al., 2004; Miyata et al., 2004; Noctor et al., 2004). In rare cases (10%) these
cells expand for one additional division (Noctor et al., 2004). Basal progenitors are present
already at the onset of neurogenesis (Haubensak et al., 2004), and in the mid-neurogenesis
form the subventricular zone (SVZ) (Bayer and Altman, 1991), contributing to a large
fraction of cortical neurons (Haubensak et al., 2004; Miyata et al., 2004). Whereas radial glia
and neuroepithelial cells are ubiquitous progenitors throughout the developing CNS, the
SVZ is confined to the telencephalon, conceivably to answer a demand for large neuronal
production (Haubensak et al., 2004; Smart et al., 2002). Moreover, basal progenitors lose the
ventricular process (Miyata et al., 2004), and exhibit different molecular markers, such as
downregulation of nestin and Pax6 and expression of transcription factors Tbr2 (Englund et
al., 2005), Cux1 and Cux2 (Nieto et al., 2004; Zimmer et al., 2004) and non-coding RNA
Svet1 (Tarabykin et al., 2001).
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Figure II. Several types of progenitors generate neurons in the mammalian CNS. Before and at the beginning of
neurogenesis, neuroepithelial cells (yellow, left), which extend from the ventricular, apical, surface (towards bottom) and
basal lamina (up), form the ventricular zone (VZ). With accumulation of neurons in the neuronal layer (NL), a subset
of neuroepithelial cells transforms into radial glia (green, middle) exhibiting characteristics of neuroepithelial and glial
cells. Neuroepithelial and radial glial progenitors undergo interkinetic nuclear migration, and divide at the apical surface
either symmetrically in a proliferative manner, or asymmetrically to generate a progenitor cell which remains in the
ventricular zone, and a cell destined to the neuronal lineage: a neuron (red), which migrates basally to the neuronal layer,
or a basal progenitor (light blue, right), which moves to the subventricular zone (SVZ) and divides symmetrically giving
rise to two neurons. Modified from Gotz and Huttner, 2005; Guillemot, 2005.
1.1.4 Cell cycle dynamics: proliferation versus differentiation
Histogenesis of the developing CNS is tightly linked with the division mode and cell
cycle parameters (reviewed in: Caviness et al., 2003; Caviness et al., 1995; Cremisi et al.,
2003; Ohnuma and Harris, 2003). The fraction of progenitors that exit the cell cycle
increases as neurogenesis proceeds (Takahashi et al., 1996). Moreover, in temporal and
spatial correlation with neurogenesis, the average cell cycle length of progenitor cells
constantly increases from approximately 8 h at the onset of neurogenesis to about 18 h at
the end of the neurogenic period (Takahashi et al., 1995). This difference is primarily
accounted for by the lengthening of G1 phase, which in the course of neurogenesis
increases fourfold (Takahashi et al., 1995). Although early reports suggested that the cell
cycle length is homogenous in the ventricular zone at the time when neurogenesis is peaking
and neurogenic and proliferative divisions coexist (Cai et al., 1997a), other studies indicated
a variability of cell cycle parameters among progenitors (Calegari et al., 2005b; Hartfuss et
al., 2001; Reznikov et al., 1997). Notably, progenitors which undergo neurogenic divisions
exhibit a significantly longer cell cycle than the proliferative population (Calegari et al.,
2005b).
At the molecular level, progenitors which generate neurons, in asymmetric or symmetric
divisions, express the anti-proliferative gene Tis21/BTG2/PC3 (Haubensak et al., 2004;
Iacopetti et al., 1994; Iacopetti et al., 1999), here for convenience referred to as Tis21. The
Tis21 mRNA is expressed only during G1 phase, prior to the cell division, and the protein is
inherited by daughter cells. In vitro, Tis21 induces cell cycle arrest in G1 by inhibiting the
transcription of cyclin D1 and delaying the expression of cyclin E and cyclin dependent
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kinase 4 (Cdk4) (Guardavaccaro et al., 2000; Lim et al., 1998). Tis21 also inhibits
degradation of cyclin A and B1, and binds to Cdc2/Cdk1 (cell division cycle 2), which may
lead to the failure of mitotic exit (Lim, 2006; Ryu et al., 2004). Overexpression of
Tis21/PC3 in a transgenic mouse model leads to prematurely increased neurogenesis at the
expense of progenitor proliferation (Canzoniere et al., 2004).
The cyclin dependent kinase inhibitor p27Kip1 is a critical part of the internal regulatory
mechanism controlling proliferation and differentiation of progenitor cells. Its expression in
the ventricular zone is regulated coordinately with the progression of neurogenesis (Delalle
et al., 1999). Similarly, p27Kip1 gradually accumulates in cultured proliferating
oligodendrocyte progenitors (Durand et al., 1997). It has been proposed that when the
concentration of p27Kip1 reaches an appropriate level it causes cell cycle exit of progenitors
and differentiation (Durand and Raff, 2000). Mice lacking p27Kip1 show an increased body
size and enlarged brains (Fero et al., 1996; Nakayama et al., 1996). Specifically, less
progenitors exit the cell cycle during mid-neurogenesis, resulting in an increase in late born
cortical neurons and glial cells (Goto et al., 2004). Overexpression of p27Kip1 leads to an
increase in cell cycle exit of progenitors during mid-neurogenesis in the cortex, hence
augmenting neuronal production designed to deeper layers (Tarui et al., 2005), and in the
retina drives progenitors out of the cell cycle, hence promotes early cell fates at the expense
of later generated bipolar neurons and Müller glia (Dyer and Cepko, 2001). In Xenopus,
p27Kip1 is sufficient to increase neurogenesis when overexpressed, and is indispensable for
neuronal differentiation (Vernon et al., 2003). Other antiproliferative proteins such as
p57Kip2 and p19Ink4d, as well as p53 and p73, might play complementary roles in governing
differentiation of neural and glial progenitors (Billon et al., 2004; Coskun and Luskin, 2001;
Cunningham et al., 2002; Dyer and Cepko, 2001).
It has to be mentioned, however, that cell cycle regulators, such as p27Kip1 or Tis21, have
multiple roles and modes of action. Therefore, not all effects observed upon manipulation
of levels of cell cycle regulators act solely on cell cycle progression (Canzoniere et al., 2004;
Lim, 2006; Nguyen et al., 2006; Vernon et al., 2003). It has been suggested, nevertheless,
that lengthening of G1 phase per se might lay upstream of cell differentiation, rather than
being its consequence. Indeed, application of a Cdk inhibitor, which increased the G1 length
without blocking of the cell cycle, was shown to induce premature neurogenesis (Calegari
and Huttner, 2003).
1.1.5 Notch and bHLH transcription factors: the master and commanders
Multiple basic helix-loop-helix (bHLH) transcription factors are the major intrinsic
regulators of neurogenesis (Bertrand et al., 2002; Kageyama et al., 2005; Ross et al., 2003).
There are two classes of bHLH genes: the repressor and activator types.
Proneural bHLH genes
The activator bHLH genes are known as a family of proneural genes, and include Mash,
Math and Neurogenin, which are homologues of the Drosophila achete-scute complex and atonal.
The proneural genes are expressed at low levels by progenitors, and transient increase in
their expression mediates commitment of multipotent cells to the neuronal lineage;
consistently, upon misexpression they induce ectopic neurons (Blader et al., 1997; Kim et
al., 1997; Ma et al., 1996; Mizuguchi et al., 2001; Turner and Weintraub, 1994). The
proneural factors not only induce expression of pan-neuronal genes, but simultaneously
inhibit glial fates (Nieto et al., 2001; Tomita et al., 2000). Moreover, activator bHLH genes
are involved in the specification of progenitors to a particular subtype identity and are
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required for neuronal differentiation (Ben-Arie et al., 1997; Cau et al., 2000; Gowan et al.,
2001; Kay et al., 2001; Parras et al., 2002; Scardigli et al., 2001). The proneural genes bind to
their target promoters as heterodimers formed with ubiquitous bHLH E proteins, thereby
activate a cascade of neuronal differentiation genes, such as other bHLH factors of the
NeuroD family, which are expressed in immature neurons (Farah et al., 2000; Lee et al.,
1995). Expression of proneural genes causes cell cycle exit, presumably via induction of cell
cycle inhibitors, such as p27Kip1 (Farah et al., 2000).
Repressor-type bHLH genes : Hes  and Id  families
In the neural progenitor cells, the activity and transcription of proneural genes is
repressed by Hes/Her bHLH factors, homologues of Drosophila hairy and Enhancer of split
[E(spl)]. In the nervous system three Hes genes are expressed: Hes1, Hes3 and Hes5; and two
Hes-related genes Hesr1/Hey1 and Hesr2/Hey2 (Kageyama et al., 2005). The loss of Hes
genes leads to precocious exit of progenitors from the cell cycle and their differentiation
into neurons in vivo (Cau et al., 2000; Hatakeyama et al., 2004; Ishibashi et al., 1995; Ohtsuka
et al., 1999) and in vitro (Ohtsuka et al., 1999; Ohtsuka et al., 2001). Moreover, in double
Hes1/Hes5 and triple Hes1/Hes5/Hes3 knockout mice occurs massive differentiation of
progenitors (Hatakeyama et al., 2004). It has to be emphasised that in these mutant mice the
neuroepithelium initially forms properly, thus the neural stem cells change their
characteristics over time from Hes-independent to Hes-dependent, just prior to the closure
of the neural tube. Embryos lacking single Hes genes exhibit milder phenotypes (Ishibashi et
al., 1995; Ohtsuka et al., 1999), indicating that functions of Hes proteins are redundant. Not
only are the Hes genes essential for maintenance of progenitors, but upon misexpression of
Hes and Hesr genes, neuronal differentiation is inhibited and progenitors remain as radial
glial cells (Hirata et al., 2000; Ishibashi et al., 1994; Ohtsuka et al., 2001; Sakamoto et al.,
2003).
The second group of repressors are Id (Inhibitor of DNA binding) helix-loop-helix
factors (Ross et al., 2003). They miss the basic region, therefore are not capable of DNA
binding. Id proteins form heterodimers with E proteins, thus sequestering them from
bHLH factors and repressing differentiation into neurons and oligodendrocytes. In
addition, Ids stimulate cell cycle progression by relieving the transcription factor E2F from
retinoblastoma (Rb) mediated repression.
Notch signalling and its ro le in the maintenance of progenitors
An essential ability of the proneural proteins is to restrict their own activity to single
cells within the neuroepithelium in the process termed lateral inhibition, which is mediated by
the Notch signalling pathway (Artavanis-Tsakonas et al., 1995; Louvi and Artavanis-
Tsakonas, 2006; Yoon and Gaiano, 2005). In mammals, there are four Notch genes, which
are involved in maintenance of the progenitor pool. Notch receptors are activated by the
interaction with ligands Delta and Jagged/Serrate on the surface of adjacent cells. Notably,
Delta and Jagged are among the targets of proneural genes (Casarosa et al., 1999; Chitnis
and Kintner, 1996; Horton et al., 1999).
Notch and Delta are large single-pass transmembrane proteins rich in EGF and Ankyrin
repeats. Binding of the ligand initiates a series of proteolytic cleavages of Notch that leads to
the release of the inrtacellular domain of the receptor and its nuclear translocation
(Schroeter et al., 1998). Once in the nucleus, the Notch intracellular domain converts the
ubiquitous transcription repressor RBP-J /CBP1 complex (a homologue of Drosophila
suppressor of hairless) into an activator, leading to transcription of target genes (Fortini and
Artavanis-Tsakonas, 1994; Honjo, 1996; Kato et al., 1997). In neural progenitors, Notch
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controls expression of the Hes1 and Hes5 genes, which in turn confer the ability of Notch to
inhibit neuronal differentiation (Ohtsuka et al., 1999). It is important to note, however, that
Hes1 is likely to be regulated also by other signalling cascades and Hes3 expression is largely
Notch-independent (Hatakeyama et al., 2004; Hitoshi et al., 2002; Hitoshi et al., 2004;
Ohtsuka et al., 1999).
The activities of proneural genes and Notch are combined into a negative feedback
loop. The expression of a ligand in a cell committed for differentiation activates the Notch
signalling cascade in neighbouring cells, resulting in expression of Hes/Her inhibitory genes
and a block of differentiation. Thus, single progenitors can be selected for differentiation,
whereas others keep proliferating. In keeping with its role in activation of inhibitory bHLH
genes, sustained induction of Notch pathway by overexpressing Delta blocks differentiation,
while upon removal of Notch signalling with dominant negative Delta all progenitors exit
the cell cycle and differentiate into neurons (Henrique et al., 1997). Similarly, removal of
Notch-1 or RBP-J genes drives progenitors into premature differentiation (de la Pompa et al.,
1997; Lütolf et al., 2002), whilst overexpression of activated Notch results in an expanded
pool of progenitors and decrease in neuronal production (Lardelli et al., 1996). Consistently,
the function of Notch is indispensable for stem cell renewal in vitro (Alexson et al., 2006;
Hitoshi et al., 2002), however, as in Hes mutant embryos, formation and maintenance of
early neuroepithelial cells is not hampered by removal of Notch signalling in vivo (de la
Pompa et al., 1997; Hatakeyama et al., 2004) and in vitro (Hitoshi et al., 2002).
Onset of Notch1 expression proceeds in a pattern spatiotemporally correlated with
neurogenesis, when progenitor cells undergo asymmetric divisions (Hatakeyama and
Kageyama, 2006). Notch signalling is thought to keep a pool of cycling progenitors available
for the generation of later cell types. In agreement with this hypothesis, upon transient
expression of activated Notch, progenitors resume generating neurons destined to the
appropriate later fate once Notch signalling is relieved (Mizutani and Saito, 2005).
Moreover, constitutive activation of the Notch pathway in progenitors transforms them
into radial glia, which postnatally differentiate into astrocytes (Dang et al., 2006; Gaiano et
al., 2000). It has been speculated that Notch signalling supports the generation of distinct
progenitor subtypes (Yoon and Gaiano, 2005), and promotes asymmetric divisions of
progenitor cells (Hatakeyama and Kageyama, 2006).
1.1.6 Polarity of progenitor cells and asymmetric division
Neuroepithelial and radial glia cells are coupled via adherens junctions (Aaku-Saraste et
al., 1996; Chenn et al., 1998) and contribute to the formation and maintenance of the basal
lamina, which separates the neuroepithelium from the surface mesoderm (Hatakeyama et
al., 2004; Haubst et al., 2006; Thomas and Dziadek, 1993). These features provide the
foundation for histogenesis: loss of progenitors leads to the disruption of inner and outer
barriers of the neural tube and spilling of neurons into the lumen and surrounding tissues
(Hatakeyama et al., 2004; Junghans et al., 2005).
As their predecessors epithelial cells, neuroepithelial cells are polarised, showing distinct
basolateral and apical domains, whose integrity is maintained by tight junctions (Aaku-
Saraste et al., 1996; Aaku-Saraste et al., 1997; Chenn et al., 1998). With the neural tube
closure and the onset of neurogenesis, the neuroepithelium downregulates some of the
epithelial features. The tight junctions undergo remodelling, such as the loss of a structural
component occludin and of the paracellular barrier (Aaku-Saraste et al., 1996), which is
accompanied by downregulation of polarised transport of selected apical membrane
proteins (Aaku-Saraste et al., 1997). Moreover, at adherens junctions E-cadherin is replaced
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by N-cadherin (Nose and Takeichi, 1986). Nevertheless, progenitor cells express a panel of
tight junctional proteins, namely claudin-10, 15 and 18,  as well as show ultrastructural
features of tight junctions (Hatakeyama et al., 2004). Interestingly, zonula occludens 1
(ZO-1), a peripheral tight junction protein, appears to be upregulated at the onset of
neurogenesis (Aaku-Saraste et al., 1996).
It has been proposed that proliferative or asymmetric divisions of progenitor cells rely
on the cleavage plane orientation with respect to the apical plasma membrane and junctions
(Chenn and McConnell, 1995; Huttner and Brand, 1997; Kosodo et al., 2004; Wodarz and
Huttner, 2003). Asymmetric cell division resulting from unequal distribution of cell fate
determinants upon mitosis has been extensively studied in C. elegans and Drosophila
(Betschinger and Knoblich, 2004; Wodarz, 2005; Yu et al., 2006). In Drosophila neuroblasts,
the conserved complex PAR3/PAR6/aPKC (Partitioning defective/Atypical Protein
Kinase C) is localised to the apical cell cortex and governs polarised distribution of
differentiation determinants Numb and homeobox domain transcription factor Prospero to
the basal pole, as well as the positioning of the mitotic spindle, such that division occurs in
the apical-basal axis. Notably, Numb is a negative regulator of Notch signalling
(Schweisguth, 2004).
In vertebrates, the apical domain of neuroepithelial cells also harbours homologues of
the PAR3/PAR6/aPKC complex (Manabe et al., 2002). Moreover, mammalian Numb has
been shown to form an apical crescent in neural progenitors (Cayouette and Raff, 2003;
Cayouette et al., 2001). Despite that the majority of mitotic divisions occurs perpendicular
to the ventricular, i.e. apical, surface of the neuroepithelium (Kosodo et al., 2004; Lyons et
al., 2003; Reznikov et al., 1997), in radial progenitors the apical plasma membrane
constitutes a minute fraction of the total plasma membrane and can be distributed to one
daughter cell even upon vertical cleavage (Kosodo et al., 2004). Notably, in neurogenic
progenitors the cleavage plane bypasses the apical plasma membrane, whereas in
proliferative progenitors the cleavage plane divides the apical plasma membrane between
daughter cells (Kosodo et al., 2004).
Together, by analogy to Drosophila, it has been suggested that the loss of the apical
plasma membrane, and possibly junctional complexes, is associated with cell differentiation
(Gotz and Huttner, 2005; Huttner and Brand, 1997; Kosodo et al., 2004). In support, basal
progenitors before the final division lose the apical attachment (Miyata et al., 2004).
Junctional complexes also cluster proteins involved in the control of proliferation and tissue
morphogenesis, such as ZO-1, AF-6, PTEN, Cdc42, or -catenin (Matter and Balda, 2003),
most of which are expressed in neural progenitor cells (Aaku-Saraste et al., 1996; Cappello
et al., 2006; Chenn et al., 1998; Zhadanov et al., 1999). Loss-of-function or gain-of-function
experiments with these molecules showed complex roles of the apical domain in regulation
of progenitor maintenance and identity.
The loss of the apical-basal polarity and junctions observed in mice deficient in the Lgl1
gene, a mammalian homologue of Drosophila lethal giant larvae, is coupled with mislocalisation
of Numb and hyperproliferation of progenitors (Klezovitch et al., 2004). It has to be
mentioned, however, that the role of Numb in Notch signalling and neurogenesis in
mammals is tangled (Yoon and Gaiano, 2005). In turn, removal of Cdc42 specifically in the
cortex results in disorganisation of the apical components of ventricular zone progenitors,
namely the loss of PAR3/aPKC complex, -catenin, actin and a stem cell marker
prominin-1 (Cappello et al., 2006), which in the wild-type neuroepithelium localises to the
apical plasma membrane (Fargeas et al., 2006; Weigmann et al., 1997). These events are
paralleled by ventricular detachment of progenitors, and, as a consequence, their gradual
conversion to basal progenitors (Cappello et al., 2006). The most remarkable phenotype is
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associated with manipulation of -catenin, which has a dual role: as a structural component
of adherens junctions and as a transducer of the Wnt signalling pathway. Constitutive
activation of -catenin in the neuroepithelium leads to dramatic expansion of neural
progenitors (Chenn and Walsh, 2002; Chenn and Walsh, 2003; Zechner et al., 2003),
whereas loss of -catenin results in precocious neurogenesis (Zechner et al., 2003).
With regard to the basal domain of radial progenitors, it was proposed that asymmetric
inheritance of a basal process upon mitosis and, accordingly, an attachment to the basal
lamina, underlies an asymmetric fate of daughter cells (Fishell and Kriegstein, 2003; Miyata
et al., 2001). However, loss of the contact to the basal lamina by progenitor cells in the
laminin 1III4 knockout mice hampers neuronal migration and differentiation, but does not
influence progenitor proliferation or net neuronal production (Haubst et al., 2006), thus
suggesting that signals from the basal lamina are not controlling progenitor divisions
directly.
1.1.7 Neurogenesis in the adult brain
Although most of the neurons are born during the embryonic period, neurogenesis
persists in restricted regions of the adult brain: the striatal subventricular zone (SVZ) of the
lateral ventricle and the subgranular zone (SGZ) of the hippocampal dentate gyrus
(reviewed in: Alvarez-Buylla and Lim, 2004; Alvarez-Buylla et al., 2002; Emsley et al., 2005;
Kempermann et al., 2004) (Figure III).
Subventricular zone
In rodents, neurogenesis in the SVZ is linked with olfaction. Cells born in the SVZ
migrate in chains ensheathed by glial cells to the olfactory bulb where they differentiate into
interneurons (Lois and Alvarez-Buylla, 1994; Lois et al., 1996). Migratory neuroblasts form
the so-called rostral migratory stream (RMS). During the first two postnatal weeks, mouse
ventricular zone radial glia transform into multiciliated ependymal cells lining the ventricle
and SVZ astrocytes (Tramontin et al., 2003). It is a subpopulation of SVZ astrocytes, as
descendants of embryonic radial glia, that functions as stem cells in the adult brain (Doetsch
et al., 1999a; Doetsch et al., 1999b; Garcia et al., 2004; Tramontin et al., 2003). Slowly
dividing stem cells give rise to rapidly proliferating transient amplifying cells, which form
clusters scattered along neuroblasts of the RMS (Doetsch et al., 1999a; Doetsch et al., 1997)
(Figure III A, bottom panel). Intriguingly, some of SVZ astrocytes contact the ventricle and
extend a short primary cilium into the lumen, hence it was speculated that ventricular
contact may underly self-renewal of adult SVZ stem cells (Doetsch et al., 1999b; Tramontin
et al., 2003).
It should be noted that although chain migration of neuroblasts born in the SVZ has
been described in the macaque adult brain (Kornack and Rakic, 1999), the human germinal
zone is distinct. It contains a subependymal ribbon of dividing astrocytes, which have
properties of stem cells in vitro, yet the RMS is absent (Sanai et al., 2004).
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Figure III. Organisation of neurogenic niches in the adult brain. (A) Cross-section of the adult mouse brain rostrally
indicates the position of the lateral ventricle (LV); the expanded panel illustrate schematically the composition and
architecture of the subventricular zone (SVZ) (bottom panel). Above the ependymal layer (E), slowly dividing
astrocytes (As, green) form tunnels, in which chains of neuroblasts (NB, red) migrate to the olfactory bulb. Scattered
clusters of rapidly dividing precursors are found along the network of chains (P, light blue). Occasionally, astrocytes
extend a process between ependymal cells to contact the ventricle. (B) Caudal cross-section through the mouse brain
indicates the position of the hippocampus and its subdivisions: the Ammon’s horn (AH) and the dentate gyrus (DG).
The subgranular zone (SGZ) located at the base of granular cell layer (GCL) nests radial astrocytes (rAs, green), which
extend long processes that penetrate the GCL, and short tangential astrocytes lying parallel to the GCL (hAs).
Astrocytes in the SGZ enwrap and isolate from the hilus neuronal precursor cells (P , light blue), and maturating
neuroblasts (NB, red). Granule neurons are shown as open grey circles. (C) The lineage of both adult germinal zones
comprises slowly dividing stem cells with characteristics of astrocytes, which generate transient amplifying precursors
that divide and mature into new neurons. Modified from Alvarez-Buylla et al., 2002; Seri et al., 2004.
Dentate gyrus of the hippocampus
The hippocampus is derived from the medial part of the developing cortex, i.e. the
archicortex, which folds inwards acquiring a sea horse shape (Figure III B). Projection
pyramidal neurons of the hippocampus localise in the Ammon’s horn (Cornu Ammonis) and
arise from the embryonic VZ and SVZ, similarly as in other parts of the cortex (Altman and
Bayer, 1990b; Altman and Bayer, 1990c). At the end of cortical neurogenesis, a
subpopulation of SVZ progenitors build the outer shell of the granular cell layer (GCL) of
the U-shaped (or V-shaped) dentate gyrus opposing the Ammon’s horn pyramidal layer
(Altman and Bayer, 1990a). Postnatally, the interiorly located polymorph layer of the dentate
gyrus, also referred to as the hilus, nests proliferating derivatives of the SVZ progenitors
which eventually, in the juvenile period, settle at the base of the granule cell layer to form
the subgranular zone (SGZ) (Figure III B, bottom panel). These cells in the adult brain
contribute to continuous production of new granule neurons in an outside-in sequence
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(Altman and Bayer, 1990a; van Praag et al., 2002). Consequently, in the granule cell layer the
first born cells are found on the outside of the dentate gyrus, whereas newborn cells localise
interiorly. Although the function of hippocampal neurogenesis is obscure, it is increased
upon various stimuli, such as an enriched environment or voluntary physical activity
(Kronenberg et al., 2003). Notably, generation of new neurons in the dentate gyrus was
reported also in human patients (Eriksson et al., 1998), and is a subject to alteration in
various pathological conditions (reviewed in: Emsley et al., 2005).
Similarly as in the SVZ, the hippocampal putative stem cells have characteristics of radial
astrocytes with soma in the SGZ and processes reaching into the granule cell layer to
arborise in the molecular layer (Garcia et al., 2004; Seri et al., 2004; Seri et al., 2001).
Astrocytes in the SGZ divide slowly to give rise to proliferating transient amplifying
precursors, which eventually differentiate into new granule cells (Seri et al., 2001)
(Figure III C).
1.2 The Y-box family of nucleic acid binding proteins
The Y-box factors have the capacity to bind DNA and RNA, thereby regulating gene
expression from transcription to translation (Kohno et al., 2003; Matsumoto and Wolffe,
1998; Sommerville, 1999; Wolffe, 1994). They were identified due to, and named after, the
ability to bind the CCAAT sequence present in the Y-box regulatory element found in the
promoters and enhancers of the mammalian major histocompatibility complex class II
(MHC II) genes (Didier et al., 1988). Notably, the Y-box sequence is present in promoters
of various genes encoding growth and stress related proteins, such as cyclin D1, epidermal
growth factor receptor, proliferating cell nuclear antigen (PCNA), DNA polymerase,
thymidine kinase, topoisomerase II , and Y-box proteins were implicated in regulation of
proliferation and transformation (Ladomery and Sommerville, 1995; Swamynathan et al.,
1998).
In vertebrates, three distinct Y-box paralogues have been identified, which are highly
conserved between species. Identification of the same protein in a different functional
context by independent researchers led to a non-unified nomenclature and numbers
associated with Y-box factors reflect the chronology of discovery rather than indicating
orthologues. The nomenclature is summarised in Table I.
Species Y-box 1 Y-box 2 Y-box 3
mouse MSY1 MSY2 MSY3, YB3, MSY4, CSDA
human YB-1, p50, CSDB, dbpB (98%) dbpC, contrin (98%) CSDA, dbpA (86%)
rat EFIA, YB-1, rBYB1 (98%) * XM_220618 (98%) YB2/RYB-a, MY1 (99%)
rabbit YB-1, p50 (95%) - -
dog * XM_851016 (96%) * XM_546585 (98%) ZONAB (87%)
chicken YB-1 (89%) - chk-YB-2 (67%)
frog FRGY1 (80%) FRGY2,  mRNP4 (69%) -
Table I. Nomenclature of Y-box proteins. Othologous proteins are listed in columns and independent names of the
same protein are separated by commas; rows indicate paralogues in the same species. Asterisks mark predicted proteins
and their NCBI accession number is given. The percent of identity to mouse proteins is shown in brackets.
Abbreviations: dpb, DNA binding protein; CSD, cold shock domain; mRNP, messenger ribonucleoprotein particle;
ZONAB, ZO-1 associated nucleic acid binding protein.
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1.2.1 Structure of vertebrate Y-box proteins
Y-box proteins are characterised by a central, highly conserved, cold shock domain
(CSD) that consist of 80 amino acids and exhibits more than 40% identity to bacterial cold
shock proteins (Wolffe et al., 1992; Yamanaka et al., 1998). CSD-containing proteins are
found in all eukaryotes examined, with an exception of Saccharomyces cerevisiae (Matsumoto
and Wolffe, 1998). The CSD has a high content of aromatic and charged residues and forms
a five-stranded -barrel comprised of two -sheets that include two RNA binding motifs,
RNP1 and RNP2 (Kloks et al., 2002; Schindelin et al., 1994; Yamanaka et al., 1998). This is
the major nucleic acid binding domain of Y-box proteins and confers sequence specifity
(Bouvet et al., 1995; Matsumoto et al., 1996; Tafuri and Wolffe, 1991; Yu et al., 2003). In
vertebrates, the CSD is flanked by a variable alanine- and proline-rich N-terminal domain
(A/P) and a C-terminal domain (CTD), which has preserved structural organisation with
four clusters of alternating basic/aromatic and acidic residues, though is not strictly
conserved in the primary amino acid sequence. The A/P domain has been implicated in the
interaction with actin filaments (Ruzanov et al., 1999), and the CTD also participates in
RNA binding (Matsumoto et al., 1996; Skabkin et al., 2004), but primarily mediates
multimerisation of Y-box proteins (Ladomery and Sommerville, 1994; Tafuri and Wolffe,
1991). The domain structure of Y-box proteins is depicted in Figure IV.
Figure IV. General domain organisation of vertebrate Y-box family members. The N-terminal alanine- and proline-rich
domain (Ala/Pro) of Y-box proteins has the most variable sequence between different members of the family. The
highly conserved nucleic acid binding cold shock domain (CSD) is followed by the C-terminal domain containing
interchanging clusters of basic/aromatic and acidic amino acids (+++/- - -), which supports nucleic acid binding and
multimerisation. Additionally, Y-box 3 mRNA is a subject of alternative splicing, resulting in two isoforms different in
the C-terminal domain.
1.2.2 Y-box protein 1
YB-1 is the most ubiquitous and also best studied among Y-box factors. In bacteria,
cold shock proteins act as DNA/RNA chaperons being responsible for promoting the
correct folding of nucleic acids during adaptation to cold shock or other cellular stresses,
when improper secondary structures could be stabilised. Similarly, YB-1 has been implicated
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in a broad range of processes, such as DNA recombination, transcription, splicing,
oligonucleotide annealing and strand exchange, translation regulation and RNA stabilisation,
suggesting a general role in nucleic acid structural arrangements and packaging
(Evdokimova et al., 2006a; Evdokimova and Ovchinnikov, 1999; Skabkin et al., 2001).
YB-1 controls translation in a  dose-dependent  manner
All mRNAs in eukaryotic cells are associated with proteins to form messenger
ribonucleoprotein particles (mRNPs). YB-1, along with the poly(A)-binding protein
(PABP), is one of the two major and universal proteins tightly bound to cytoplasmic
mRNAs (Evdokimova et al., 1995). YB-1 represents approximately 0.1% of total protein in
COS-1 and HeLa cells, which is nearly equimolar to that of ribosomes and translation
initiation factors, being 5-10 fold higher than the mRNA level (Davydova et al., 1997). The
protein exhibits little sequence specifity and binds RNA with exceptionally high affinity
(2.5 x 108 M-1) (Minich et al., 1993).
Interestingly, translational status of mRNAs, i.e. whether they are a component of
inactive non-translated mRNPs or associated with actively translating polyribosomes,
correlates with a high and low molar ratio of YB-1 to the message, respectively. At the
YB-1/mRNA weight ratio of 2 or less, which is characteristic for polysomes, YB-1 binds to
mRNA as a monomer using the CSD and CTD; as this ratio is increased above 3, YB-1
molecules oligomerise via their CTD, which is concomitantly displaced from mRNA, into
globular particles of approximately 700 kDa (Skabkin et al., 2004). mRNA is exposed on the
surface of the globule and binding of YB-1 to mRNA involves only the sugar-phosphate
backbone of mRNA, leaving nucleotide bases free for interaction with other proteins
(Pisarev et al., 2002). Importantly, depletion of YB-1 from the reticulocyte lysate results in a
dramatic inhibition of translation initiation (Evdokimova et al., 1998), thus low amounts of
YB-1 are indispensable for protein synthesis, possibly because YB-1 promotes binding of
the 40 S ribosomal subunit to RNA and formation of the 48 S pre-initiation complex
(Pisarev et al., 2002). On the contrary, high molar ratios of YB-1 to mRNA result in
inhibition of translation in vitro (Evdokimova et al., 1998) and in vivo (Bader et al., 2003;
Bader and Vogt, 2005; Davydova et al., 1997; Evdokimova et al., 2001). YB-1 binds in close
proximity to the mRNA cap structure and displaces initiation factors eIF4G and eIF4E,
thereby blocking formation of the pre-initiation complex, which leads to mRNA silencing
(Evdokimova et al., 2001; Nekrasov et al., 2003). However, binding of YB-1 to the cap does
not simply result in translation repression but also mediates significant mRNA stabilisation,
presumably by protecting mRNA from decapping and exonucleolytic degradation
(Evdokimova et al., 2001). Notably, the association of YB-1 with RNA within the storage
particles is dynamic and YB-1 easily migrates from one mRNA molecule to another
(Skabkin et al., 2004), suggesting that mRNAs can easily be recruited into translation upon
modification of YB-1 affinity to RNA or alterations in its local concentration.
In addition to the universal function as an mRNA packaging protein in somatic cells,
MSY1 was found to be bound to stored messages in maturating sperm cells (Mastrangelo
and Kleene, 2000; Tafuri and Wolffe, 1993).
YB-1 associates with mRNAs involved in growth and signalling
The messages associated with YB-1 mRNPs were identified in K-Ras transformed
NIH3T3 cells by immunoprecipitation and microarrays (Evdokimova et al., 2006a). Among
1457 transcripts bound to YB-1, 302 were not detected in the total RNA pool, suggesting
that a specific mRNA subset may be selectively enriched within YB-1 complexes.
Interestingly, low abundance messages encoding cell growth and maintenance molecules
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constituted one-third of the unique YB-1 bound transcripts. Additionally, a higher
proportion of YB-1 messages compared to the total RNA encodes transcription and growth
factors, receptors and signal transduction proteins, suggesting that many growth-related
mRNAs are kept silent in the complex with YB-1. This hypothesis is supported by the fact
that some of the abundant messages, e.g. ribosomal protein L32 mRNA, are not associated
with YB-1. The fraction of mRNAs bound by YB-1 appears to be regulated in response to
transformation by oncogenes K-Ras or ETV6-NTRK3 (gene fusion in congenital
fibrosarcoma with the helix-loop-helix dimerisation domain of the transcription factor
ETV6 fused to the protein tyrosine kinase domain of NTRK3). In transformed cells, a
different set of mRNAs was found to be associated with YB-1 compared to
non-transformed NIH3T3 cells, despite the constant level of these transcripts in the total
cellular RNA pool (Evdokimova et al., 2006b). It has been suggested that phosphorylation
of YB-1 on Ser-102 located within the CSD by Akt kinase is responsible to relieve the
translational repression (Evdokimova et al., 2006a; Sutherland et al., 2005). Notably,
overexpression of YB-1 overcomes PI3K- and Akt-induced oncogenesis by inhibiting
protein synthesis (Bader et al., 2003; Bader and Vogt, 2005). Another mechanism to relieve
translational repression is mediated by displacing YB-1 from mRNPs by association with
other proteins, such as the YB-1-associated acidic protein (YBAP1)/p32 (Matsumoto et al.,
2005).
In addition to global effects on translation, YB-1 exhibits a preference for binding to the
Y-box recognition consensus sequence (YRS) 5’-U/C/A-C/A-C-A-U/C-C-A/C/U first
revealed in the 3’ untranslated region (UTR) of the protamine 1 mRNA (Coles et al., 2004;
Davies et al., 2000; Giorgini et al., 2001), and exerts specific functions on various mRNAs.
YB-1 was implicated in YRS-dependent stabilisation of mRNAs encoding vascular
endothelial growth factor (VEGF) and interleukin 2 (IL-2) in concert with polypyrimidine
tract binding protein (PTB) and nucleolin, respectively (Chen et al., 2000; Coles et al., 2004).
YB-1 also stabilises granulocyte-marocphage colony stimulating factor (GM-CSF) mRNA
via binding to AU-rich instability elements (ARE) present in its 3’UTR (Capowski et al.,
2001). Binding of YB-1 to the YRS of its own message represses translation at
concentrations, which are stimulatory for general protein synthesis (Skabkina et al., 2005).
Interestingly, YB-1 binds to a similar sequence present in the CD44 pre-mRNA and
increases alternative exon inclusion (Stickeler et al., 2001). Binding of YB-1 to a splicing
factor SRp30c has been reported (Raffetseder et al., 2003). Thus, specific recognition of
sequences and binding to various proteins modulates the function of YB-1 in mRNA
metabolism.
YB-1 in transcript ion, DNA repair and cancer
YB-1 contains in its CTD a non-canonical nuclear localisation signal (NLS) and a
cytoplasmic retention signal (CRS), which prevails over the NLS (Bader and Vogt, 2005;
Sorokin et al., 2005), therefore the YB-1 protein localises predominantly in the cytoplasm
(Bader and Vogt, 2005; Davydova et al., 1997; Funakoshi et al., 2003; Raffetseder et al.,
2003; Sorokin et al., 2005; Stenina et al., 2001). However, YB-1 translocates to the nucleus
at G1/S transition in HeLa cells (Jurchott et al., 2003). Translocation to the nucleus has also
been reported upon various cellular stresses and stimuli, such as UV irradiation (Koike et
al., 1997), hypothermia (Stein et al., 2001), treatment with genotoxic agents (Okamoto et al.,
2000; Zhang et al., 2003) and after an infection with adenovirus type 5 (Holm et al., 2002).
In accordance, several drug resistant cancer cell lines exhibit nuclear YB-1 (Ohga et al.,
1996). Upon treatment with DNA damaging agents, but not after other cellular stresses, the
CRS of YB-1 is specifically cleaved by the proteasome and YB-1 translocates to the nucleus
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(Sorokin et al., 2005). Similar cleavage was observed after induction of endothelial cells with
thrombin (Stenina et al., 2001). Interestingly, the cleaved form of YB-1 is unable to bind
RNA. Moreover, various YB-1 deletion mutants in which RNA binding is impaired exhibit
the nuclear localisation (Bader et al., 2003; Bader and Vogt, 2005), suggesting that RNA
binding is one of the mechanisms sequestering YB-1 in the cytoplasm. It is plausible that
nuclear YB-1 becomes associated with mRNA concomitantly with transcription, as it was
shown for the dipteran YB-1-like protein (Soop et al., 2003), and exported from the nucleus
together with the message. The Y-box-protein associated acidic protein (YBAP1), which
binds to and releases YB-1 from mRNA, might facilitate nuclear translocation of YB-1
(Matsumoto et al., 2005). Release of YB-1 from mRNA and its nuclear translocation in the
MCF-7 cell line depends on the presence of Ser 102, which can be phosphorylated by Akt
(Sutherland et al., 2005).
YB-1 was thought to be implicated in the control of cell proliferation (Ladomery and
Sommerville, 1995). The YB-1 knockout mice show growth retardation leading to severe
hypoplasia in multiple organs, improper neural tube closure and exencephaly, and,
eventually, late embryonic or perinatal death (Lu et al., 2005). YB-1 deficient cells exhibit
slower proliferation, accelerated senescence and growth arrest in hypothermia (En-Nia et
al., 2005; Lu et al., 2005; Matsumoto et al., 2005). The slower growth rate was attributed to
faster accumulation of G1-specific cell cycle inhibitors p16Ink4a and p21Kip1. Conversely,
overexpression of YB-1 in the MCF-7 breast cancer cell line grown in soft agar resulted in
increase in size and number of colonies (Sutherland et al., 2005). Accordingly, YB-1 is
frequently overexpressed in various tumours (summarised in Table II), and in highly
proliferative tissues, such as the developing and regenerating liver (Grant and Deeley, 1993),
infarcted heart (Kamalov et al., 2005) and colorectal epithelial glands (Shibao et al., 1999).
Moreover, in cancer tissues, YB-1 often shows nuclear localisation, which correlates with
tumour progression and is a poor prognostic factor (Kuwano et al., 2004) (see also
Table II). Nuclear YB-1 expression is linked with multidrug resistance and the activation of
expression of the multidrug resistance 1 (MDR1) gene encoding the transmembrane ATP
binding cassette transporter (Kuwano et al., 2004). YB-1 has been also implicated in positive
regulation of promoters of other genes associated with growth and metastasis, such as
matrix metalloproteinase 2 (Mertens et al., 1997; Mertens et al., 2002), topoisomerase II
(Shibao et al., 1999), cyclin A and B1 (Jurchott et al., 2003), and DNA polymerase  (En-
Nia et al., 2005), as well as downregulation of growth arrest factor p53 (Lasham et al., 2003)
and pro-apoptotic Fas (Lasham et al., 2000).
Cancer type References
breast carcinoma Bargou et al., 1997*; Fujita et al., 2005*; Janz et al., 2002*;
Rubinstein et al., 2002
colorectal cancer Shibao et al., 1999
hepatocellular carcinoma Yasen et al., 2005*
non-small cell lung carcinoma Gessner et al., 2004; Shibahara et al., 2001*; Yao et al., 2002
osteosarcoma Oda et al., 1998*
ovarian carcinoma Kamura et al., 1999*; Yahata et al., 2002*
prostate cancer Gimenez-Bonafe et al., 2004*
synovial sarcoma Oda et al., 2003*
thyroid anaplastic carcinoma Ito et al., 2003*
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Table II. YB-1 is upregulated in various cancers. Asterisks mark reports in which nuclear localisation of YB-1 was
reported and associated with the multidrug resistance and/or poor clinical outcome.
The YB-1 protein is implicated in resistance to genotoxic stress. Depletion of MSY-1 in
embryonic stem cells or mouse embryonic fibroblasts increases sensitivity to cisplatin and
mitomycin C, and to oxidative stress (Lu et al., 2005; Shibahara et al., 2004). Consistently,
elevated YB-1 levels in a number of drug resistant cell lines are linked with increased
resistance to DNA damaging agents (Ohga et al., 1996). Thus, concentration of YB-1
appears to correlate inversely with cellular sensitivity to DNA cross-linking in cancer cells
and there is an evidence for YB-1 playing a role in DNA repair. YB-1 interacts with
proliferating cell nuclear antigen (PCNA) (Ise et al., 1999) and p53 (Okamoto et al., 2000),
proteins essential for DNA repair. Moreover, it preferentially binds to single stranded,
abasic and cisplatin-modified DNA and posses 3’ 5’ exonuclease activity (Hasegawa et al.,
1991; Ise et al., 1999; Izumi et al., 2001). It has been suggested that YB-1 brings p53 to the
damage site, as p53 alone is not capable to interact with modified nucleic acids (Izumi et al.,
2001), and as a DNA chaperone structurally organises the repair machinery.
1.2.3 Y-box protein 2
Y-box protein 2 is a cytoplasmic protein expressed exclusively in germ cells in the
mouse (Gu et al., 1998), human (Kohno et al., 2006; Tekur et al., 1999), and frog (Tafuri
and Wolffe, 1990). Translational regulation represents the major mechanism of gene
regulation in germ cell differentiation and early embryogenesis. During spermatogenesis,
diploid spermatogonia undergo the meiotic division, differentiate into haploid spermatids
and eventually spermatozoa. This process is accompanied by vast cellular growth,
morphogenesis and reorganisation of the nucleus. The mRNAs encoding proteins involved
in the final step of differentiation, particularly packaging of DNA, are synthesised in large
quantities and maintained silent until the protein product is required (Kleene, 2003). The
growth of the oocyte is also associated with accumulation of large quantities of mRNAs,
which are translationally repressed until the last step of differentiation and then fertilisation.
Particularly rich in stored mRNAs are amphibian oocytes, in which translation of maternally
deposited mRNAs supports protein production throughout multiple divisions during early
development until zygotic gene expression is turned on. Mouse MSY2 functions in
translational repression and stabilisation of mRNAs in both male and female germ cells
(Herbert and Hecht, 1999; Yu et al., 2001; Yu et al., 2002), while its Xenopus orthologue,
FRGY2, is a major protein of oocyte mRNPs (Deschamps et al., 1992), which mediates
stabilisation and translational repression of stored mRNAs (Bouvet and Wolffe, 1994;
Matsumoto et al., 1996; Tafuri and Wolffe, 1993; Yurkova and Murray, 1997). The MSY2
protein constitutes approximately 0.7 and 2% of the total soluble protein in the maturating
sperm and in the oocyte, respectively (Yang et al., 2005a; Yu et al., 2001). Function of
Y-box protein 2 appears to be essential for germ cells, as absence of MSY2 results in male
and female infertility (Yang et al., 2005b; Yu et al., 2004). Reduction of MSY2 leads to
general reduction of protein synthesis (Yu et al., 2004), likely due to mRNA destabilisation.
MSY2 binds to the YRS of the protamine 1 mRNA, and this sequence is responsible for
proper repression of the message in elongating spermatids in vivo (Giorgini et al., 2001).
Protamines are small arginine-rich proteins that are involved in chromatin condensation in
the nucleus of spermatozoa, and protamine mRNAs are not translated until cessation of
transcription in elongated spermatids (Kleene, 2003; Steger, 2001). Moreover, MSY2 and
FRGY2 posses moderate sequence specifity for the YRS in vitro and in yeast three-hybrid
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assay (Bouvet et al., 1995; Giorgini et al., 2001; Matsumoto et al., 1996; Yu et al., 2001),
hence it was concluded that this motif targets mRNAs for MSY2-mediated silencing.
However, a recent report in which a set of MSY2 bound messages was identified, suggested
that there is no apparent consensus sequence in vivo (Yang et al., 2005a). Notably, the
promoters of corresponding genes contain Y-box sequences, suggesting that MSY2,
similarly as FRGY2 (Bouvet and Wolffe, 1994; Ranjan et al., 1993), might be associated with
messages concomitantly with transcription. Although MSY2 and its orthologues in human
and frog are localised predominantly in the cytoplasm (Kohno et al., 2006; Ranjan et al.,
1993; Yu et al., 2001), chromatin immunoprecipitation (ChIP) from male germ cells
revealed MSY2 association with Y-boxes of germ cell specific genes, but not cell growth and
maintenance genes, whose mRNAs are not bound by MSY2 and are immediately translated
(Yang et al., 2005a). Similarly as for YB-1, mRNA binding might play a role in cytoplasmic
retention of Y-box protein 2, as the RNA binding activity of MSY2 is required for its
cytoplasmic localisation (Yu et al., 2003). Likewise, the CTD contains sequences responsible
for the cytoplasmic localisation, since deletion mutants are localised in the nucleus (Yoshida
et al., 2006b; Yu et al., 2003).
Human dbpC shows wide expression in malignancies, particularly in testicular
seminomas and ovarian dysgerminomas but also in many cancer cells in other organs
(Kohno et al., 2006), although in normal tissues dbpC is restricted to germ cells. Notably,
even tumours classified as negative based on the abundance of dbpC expression, showed
scattered dbpC-positive cells. It has been suggested that dbpC belongs to a growing group
of germ cell specific factors designated as cancer/testis (CT) antigens, whose upregulation
results in aberrant expression of germline genes and leads to immortalisation, aneuploidy,
migration and metastasis of cancer cells (Kohno et al., 2006; Simpson et al., 2005). As the
CT antigens are often detected in spermatogonia or spermatogonial stem cells, and the
expression of the CT antigens is frequently found in only a small proportion of cells in
cancer tissues, it is plausible that some of the CT antigens could be stem cell markers for
tumour stem cells (Simpson et al., 2005). dbpC in cancer tissues, as well as in germ cell
tumour cell lines, was found exclusively in the cytoplasm (Kohno et al., 2006; Yoshida et al.,
2006b), suggesting that the main function of dbpC is related to the stability of mRNA and
translational regulation rather than transcription.
1.2.4 Y-box protein 3
Mouse MSY3 (also designed MSY4/YB3), rat YB2/RYB-a, and human dbpA are highly
expressed in the testis (Davies et al., 2000; Ito et al., 1994; Iuchi et al., 2001; Kohno et al.,
2006; Mastrangelo and Kleene, 2000). Moderate levels of expression are found in
trophoblast, skeletal muscle and heart, and low in the kidney, brain and retina. Alternative
splicing leads to expression of two forms of the protein, different in the CTD in all species
analysed (see Figure IV, p. 19), yet functional differences between these splice variants were
not reported.
Y-box protein 3 is a translat ional repressor in  germ cells
Expression of Y-box protein 3 in testes is detected in spermatogenic cells from
pachytene spermatocytes until elongating spermatids (Davies et al., 2000; Iuchi et al., 2001;
Kohno et al., 2006; Mastrangelo and Kleene, 2000). MSY3 is one of the major proteins
present in cytoplasmic stored mRNPs, and, in concert with MSY2, specifically binds and
represses the protamine 1 mRNA (Davies et al., 2000; Giorgini et al., 2002; Giorgini et al.,
2001; Mastrangelo and Kleene, 2000). Notably, prolonged expression of MSY3 in
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spermatids, and hence extended translational repression of messages encoding for proteins
playing a role in sperm morphogenesis, leads to the disruption of spermatogenesis and
sterility with severe defects in sperm morphology (Giorgini et al., 2002). In this study,
authors also speculated that MSY3-mediated repression requires the YRS, since analysis of
several mRNAs showed that only mRNAs which contained the YRS were affected. MSY3
might play a general role in repression and packaging of mRNAs in germ cells, as its
expression in oocytes has been reported (Davies et al., 2000).
Y-box protein 3 in proliferation and transcription
The canine Y-box protein 3 was identified in the MDCK epithelial cell line based on the
interaction with the SH3 domain of the tight junction protein ZO-1, and therefore
designated ZO-1-associated nucleic acid binding protein (ZONAB) (Balda and Matter,
2000). In epithelial cell lines, overexpression of ZONAB, but also of human dbpA, induces
cell proliferation and results in increased cell density in mature monolayers, whereas
depletion of ZONAB reduces cell density and proliferation (Balda et al., 2003; Sourisseau et
al., 2006). Moreover, manipulation of the level of ZONAB interferes with cyst formation by
MDCK cells in 3-D cultures (Sourisseau et al., 2006), suggesting it functions in epithelial
tissue morphogenesis. The subcellular localisation and function of ZONAB depend on the
cell density: at a low cell density, a pool of ZONAB is nuclear and acts as a transcription
factor, while at high cell densities, ZONAB relocates from the nucleus to the cytoplasm and
junctions, where it interacts with ZO-1 (Balda and Matter, 2000) and RalA, a member of the
Ras superfamily of small GTPases (Frankel et al., 2005). Nuclear ZONAB/dbpA, via
binding to Y-box sequences, activates expression of cyclin D1 and PCNA (Sourisseau et al.,
2006), and negatively regulates the activity of the ErbB-2 promoter (Balda and Matter, 2000).
ZO-1 is believed to inhibit ZONAB by cytoplasmic sequestration. Since ZONAB also
binds cyclin dependent kinase 4 (Cdk4), the cytoplasmic retention of ZONAB results in
reduced nuclear Cdk4, thereby inhibiting G1/S transition (Balda et al., 2003). Additionally,
dbpA directly inhibits the kinase activity of Cdk4 and neuron-specific Cdk5 in vitro
(Moorthamer et al., 1999).
Consistent with the role of ZONAB in promoting cell proliferation, rat RYB-a and
mouse MSY3 are highly expressed in the foetal and regenerating liver, whereas its
expression is undetectable in the adult intact tissue (Ito et al., 1994; Kajino et al., 2001).
Notably, dbpA is associated with advanced stages of hepatocellular carcinoma and its
nuclear localisation is linked with poor prognosis for patients (Yasen et al., 2005). dbpA was
found as a target of transcription factor E2F, which is often elevated in cancer tissues
(Arakawa et al., 2004). Moreover, ZONAB signalling is positively regulated by the heat
shock protein 110/Apg-2, which competes with ZONAB for binding to ZO-1 (Tsapara et
al., 2006), and was found to be upregulated in hepatocellular and pancreatic carcinomas
(Gotoh et al., 2004; Nakatsura et al., 2001).
MSY3 in the nervous system
In the adult central nervous system, MSY3 was detected in oligodendrocytes and
astrocytes throughout the brain, as well as in retinal neurons, where it colocalises with ZO-1
and ZO-2 at gap junctions (Ciolofan et al., 2006; Penes et al., 2005). The function of the
protein in this context, however, has not been investigated.
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1.3 Aims of this study
Persistence of multipotent progenitors throughout development is essential for the
generation of cellular diversity; in the adult organism somatic stem cells as descendants of
embryonic progenitors continue to produce differentiated progeny for tissue renewal, repair
and plasticity. All major signalling pathways are implicated in the control of stem cell
decisions, but what are the inherent mechanisms that rule proliferation and maintenance of
stem cells? In particular, deregulation of gene expression in transformation and cancer
provides cues as to the intrinsic regulation of proliferation and differentiation. With this in
mind, Y-box proteins, as multifunctional coordinators for the control of gene expression in
the nucleus and the cytoplasm, in homeostasis and pathology, are excellent candidates for
such factors.
This study aims to examine the expression of MSY3 in the developing murine nervous
system and elucidate its putative role in the regulation of proliferation and differentiation of
neural progenitors. Two following premises are at the base of this study: i) MSY3 promotes
proliferation of epithelial cells in a manner opposite to junctional protein ZO-1; ii)
neuroepithelial cells downregulate some of the epithelial features before the switch from
proliferation to neurogenesis, simultaneously upregulating expression of ZO-1.
A separate project aimed to reveal whether the asymmetric distribution of the
antiproliferative Tis21 protein during the cell division could be associated with distinct fates
of the daughter cells. Specifically, it was speculated that the daughter cell which inherited the
protein upon the cytokinesis would become a neuron or a basal progenitor. This project was
conducted during the first year of my thesis work and is presented in the first part of the
Results, which reflects the chronological order. However, as this study was not continued, it
is not considered in the Discussion section.
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2 RESULTS
PART I
2.1 Asymmetric distribution of the Tis21 protein during mitosis
In animal development there are numerous examples of cell fate specification by the
asymmetric distribution of fate determinants upon the mitosis (reviewed in: Betschinger and
Knoblich, 2004). Since it was observed that the immunoreactivity of the affinity purified K4
antibody, which was raised against the Tis21 protein, exhibited an asymmetric distribution
during the cytokinesis in cultured neuroepithelial cells (Lilla Farkas, unpublished results), the
attempt to reveal the link between this distribution and the cell fate was undertaken.
2.1.1 Distribution of the K4 immunoreactivity in cultures of neuroepithelial cells
To confirm the original finding, neuroepithelial cell clusters derived from the embryonic
day 10.5 (E10.5) telencephalon and cultured in defined media in a presence of bFGF were
stained with the K4 antibody. Indeed, in some mitotic figures an asymmetric distribution of
the immunoreactivity could be observed (Figure 1 A). The frequency of an unequal
distribution of the K4 immunoreactivity was lower (4.6%; n=136 cells) than previously
observed (40%), perhaps due to different preparation of cultures.
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Figure 1. Distribuiton of the K4 immunoreactivity at the cytokinesis in vitro. Neuroepithelial cell cluster cultures grown
in a presence of bFGF were stained with the K4 antibody directed against Tis21 (red). Nuclei are visualised with DAPI
(cyan). Cells in the cytokinesis are marked by asterisks. Examples of (A) asymmetric and (B) symmetric distribution of
the K4 immunoreactivity.
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2.1.2 Specifity of the K4 antibody
Before investigating the distribution of Tis21 in the neuroepithelium, the monospecifity
of the K4 antibody for the Tis21 protein was tested. The rabbit polyclonal K4 antiserum
was raised against a peptide corresponding to the C-terminal 12 amino acids of the mouse
Tis21 and affinity purified. As no immunostaining was observed in rat E13 embryos, which
also express Tis21, it was concluded that the substitution of Ala-155 of the mouse Tis21 by
a threonine in the rat protein destroys the K4 epitope and hence the antibody recognises
only the Tis21 protein.
In immunoblotting of COS7 cells transfected with the Tis21 expression plasmid, but not
of control mock transfected cells, the K4 antibody recognised a 17 kDa band corresponding
to the molecular weight of the Tis21 protein (Figure 2 A, left panel). The same band was
recognised by the second antibody against Tis21 (Figure 2 A, right panel). Similarly,
Tis21-transfected cells were immunoreactive in fluorescent staining (Figure 2 B). Therefore,
the K4 antibody can recognise the Tis21 protein in misexpressing cells, as previously
reported (Iacopetti et al., 1999).
Figure 2. K4 antibody recognises Tis21 ectopically expressed in Cos7 cells. Cos7 cells were transfected with the Tis21
expression plasmid or mock transfected as a control. The Tis21 protein was detected either by (A) immunoblotting, or
(B) immunofluorescence, using the K4 or 1511 antibodies, which were raised against peptides residing in the C-terminal
domain of Tis21 (Iacopetti et al., 1999). Both antibodies recognise a band of approximately 17 kDa, only when the
Tis21 plasmid was included. In (B) nuclei are visualised with DAPI (cyan); magnification, 400x.
The K4 antibody was applied on sections from E10.5 mouse and E12 rat embryos
employing two protocols, which differed in time of treatment with Triton X-100, a non-
ionic detergent used to permeabilise cells. In the first protocol, 0.3% Triton X-100 was
applied for 15 min at the beginning of the procedure, whereas in the second protocol the
detergent was used additionally in a blocking step and during incubation with antibodies.
Interestingly, a pattern of the K4 immunoreactivity in both species differed significantly
according to the staining protocol. By applying Triton X-100 throughout the staining, the
expected gradient of immunoreactivity corresponding to neurogenesis, as well as a intensive
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labelling in the neuronal layers, were observed in the mouse tissue (Figure 3A, and data not
shown). No staining in the rat could be detected using this protocol (Figure 3B). Short
Triton X-100 treatment of mouse sections, however, resulted in even staining throughout
the neuroepithelium without a gradient (Figure 3 C, and data not shown). In contrast, when
this protocol was used for the rat tissue, the ventricular zone exhibited staining in a gradient
which parallel the onset of neurogenesis (Figure 3 D and data not shown). The subcellular
pattern of staining was similar to that observed in the mouse, although the signal was
weaker. Additionally, strong immunoreactivity in neurons could be observed (data not
shown). It is important to note that the original conclusion that the K4 immunoreactivity,
and hence the Tis21 protein, marks neurogenic progenitors was based upon the
immunostaining pattern revealed using 0.1% Triton X-100 throughout the staining
procedure (Iacopetti et al., 1999). Therefore, for all subsequent experiments
0.3% Triton X-100 was used for all steps of immunostaining.
Figure 3. The K4 immunoreactivity in the mouse and rat tissue differs according to time of the Triton X-100 treatment.
Saggital cryosections from the E10.5 mouse (A,C), and E12 rat telencephalon (B,D), which are equivalent stages of
development, were stained with the K4 antibody. Apical is towards bottom. (A ,B ,B’) In a presence of 0.3%
Triton X-100 during the whole procedure, the K4 antibody stains neuroepithelial cells and neurons in the mouse neural
tube (A), whereas in the rat tissue gives a negative signal (B); (B’) shows a control without the primary antibody. (C,D)
The short treatment with Triton X-100 yields even staining in the mouse neuroepithelium, and staining in the rat tissue
similar to that observed in mouse upon longer treatment with this detergent. Magnification, 1000x.
Next, the K4 antibody was applied on sections from homozygous Tis21 knock-in
embryos, in which the first exon of the Tis21 gene was substituted by GFP sequence
followed by a polyadenylation (polyA) signal. In this transgenic animal no full length Tis21
protein could be detected by immunoblotting (Haubensak, 2002; Haubensak et al., 2004).
Surprisingly, the overall and subcellular pattern of staining was indistinguishable from wild
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type mouse embryos (Figure 4). Since the second exon of the Tis21 gene is still present in
the genome and little amount of longer mRNA containing this exon, probably as a result of
read through the single polyA signal, can be detected by RT-PCR (Ji Feng Fei, personal
communication) it cannot be excluded that the N-terminally truncated Tis21 protein is still
expressed in the neuroepithelium by unknown mechanism and hence recognised by the K4
antibody.
Figure 4. The K4 immunoreactivity in Tis21 homozygous knock-in mouse embryos is not diminished. (A,C) Sections
from E10.5 wild type; and (B,D) E11 Tis21GFP/GFP embryos were stained with the K4 antibody. Despite the lack of the
full-length protein in the homozygous knock-in embryos, the K4 immunoreactivity exhibits pattern identical to the wild
type tissue with differential staining in the ventricular zone cells and strong labelling of neurons (arrowheads).
Continuous and dashed lines delineate the pial and ventricular surfaces, respectively. Magnification: (A,B) 400x; (C,D)
1000x.
To further characterise the specifity of the K4 antibody, it was applied on sections from
E11.5 heterozygous Tis21-GFP embryos and the fluorescence staining was investigated by
confocal microscopy. If the K4 antibody specifically recognises Tis21 it should be present
only in GFP positive cells. As shown in Figure 5, this is not the case. In addition to double
positive K4+/GFP+ (filled arrowheads) and double negative K4 /GFP  cells (empty
arrows), both the K4+/GFP  (empty arrowheads) and K4 /GFP+ (filled arrows) progenitor
cells could be observed.
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Figure 5. The K4 immunoreactivity does not overlap with Tis21-GFP. Sections from the E11.5 heterozygous
Tis21-GFP mouse embryo were stained with the K4 antibody (red). Nuclei are visualised with DAPI (blue). GFP
(green) carries a nuclear localisation signal and is expressed from the Tis21 locus, reflecting expression of the Tis21
mRNA. All four combinations of fluorescence can be observed: filled arrowheads, K4+/GFP+; empty arrowheads,
K4+/GFP ; filled arrows, K4 /GFP+; empty arrows, K4 /GFP . Images are single optical sections (1 m). Continuous and
dashed lines delineate the pial and ventricular surfaces, respectively. Scale bar equals 20 m.
Although slightly shorter half life of the Tis21 mRNA compare to the GFP mRNA has
been recorded (Ji Feng Fei, unpublished results), it is unlikely that the revealed discrepancy
between GFP fluorescence and the K4 immunoreactivity results from different half-lives of
the GFP and Tis21 proteins, because both last sufficiently long to be inherited by newborn
neurons (Haubensak et al., 2004; Iacopetti et al., 1999). Moreover, since GFP is inserted
into the Tis21 locus, its expression is driven by endogenous regulatory sequences, and as a
consequence it reflects precisely the Tis21 mRNA expression (Haubensak, 2002; Haubensak
et al., 2004), excluding the possibility that the endogenous protein can be detected before
GFP. Taken together, it is plausible that the K4 antibody cross-reacts with other protein
than Tis21, and therefore is not suitable to detect Tis21 in the neuroepithelium.
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2.1.3 Distribution of the K4 immunoreactivity in the neuroepithelium
Regardless the nature of the K4 epitope, its distribution in mitotic figures in vivo was
investigated by confocal microscopy in proliferating and neurogenic progenitors, as
identified by GFP expression in heterozygous Tis21-GFP embryos. It is believed that the
GFP positive progenitors which divide at the apical surface of the neuroepithelium undergo
neurogenic asymmetric divisions (Haubensak et al., 2004; Kosodo et al., 2004), therefore, if
unequal distribution of the K4 epitope is to be a cell fate determinant, it should be observed
in GFP positive cells. As shown in Figure 6, the K4 immunoreactivity was present as a
diffused weak staining in the cytoplasm and also strongly associated with lateral membranes
and junctions, whereas the staining in cultured cells was mainly cytoplasmic (compare with
Figure 1). The cytoplasmic staining did not exhibit an unequal distribution in GFP positive
(n=5), as well as in GFP negative cells (n=3). It was not possible to conclude about the
distribution of the lateral staining, since it could not be assigned to a particular cell.
To summarise, although the K4 immunoreactivity was unequally distributed during the
mitosis in some of in vitro cultured neuroepithelial cells, the pattern of immunostaining
observed in vivo was distinct. This dissimilarity can be attributed to the difference in the
staining protocol used for tissue sections and cell cultures, as the latter were stained applying
only a short treatment with Triton X-100 or other permeabilising agents (0.2% saponin,
acetone). Several other antisera and affinity purified antibodies raised against Tis21 during
time of this work also did not yield a specific signal. Thus, this project was not continued.
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Figure 6. Distribution of the K4 immunoreactivity in mitotic cells in vivo. Cryosections from E11.5 heterozygous
Tis21-GFP embryos were stained with K4 (red), and pan-cadherin (white) antibodies. Nuclei are visualised with DAPI
(blue). (A) proliferative division, as marked by absence of GFP. (B,C) GFP-positive neurogenic asymmetric divisions.
GFP is localised in the cytoplasm despite its nuclear localisation signal as a result of nuclear envelope breakdown upon
mitosis. The K4 immunoreactivity is diffused in the cytoplasm and is strong at lateral membranes marked by
pan-cadherin staining, without apparent asymmetric distribution. Images are maximum intensity projections from
several optical sections.
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PART II
2.2 Characterisation of the expression of mouse Y-box protein 3
(MSY3) during central nervous system development
2.2.1 Two splice variants of the MSY3 protein are expressed in the developing embryo
To study the MSY3 protein in the mouse central nervous system, a panel of antibodies
directed against this protein was generated and characterised (for details see Materials and
Methods). In immunoblotting of protein extracts from mouse embryos, all antibodies
recognised a similar set of immunoreactive bands of approximately 58-60 and 47 kDa
(Figure 7 A, red arrows). Although predicted molecular weights for the long and short
MSY3 isoform are 38.8 and 30.7 kDa, respectively, Y-box proteins due to a high content of
basic amino acids and asymmetric structure tend to migrate at much higher molecular
weights (Tafuri and Wolffe, 1991). Moreover, migration pattern of the canine ZONAB
protein is very similar (Balda and Matter, 2000). Pre-immune sera (Figure 7 A, lanes 1, 3, 5)
or a non-related serum (Figure 7 B, lane 1) did not reveal such a pattern of
immunoreactivity.
Figure 7. Characterisation of antibodies against the MSY3 protein. Protein lysate from (A) E9.5, or (B) E10.5 embryos
was analysed by immunoblotting using antibodies directed against the MSY3 protein as follows: (A) Rabbit polyclonal
antisera from the third bleed (#3, lanes 2, 4, 6) and the corresponding pre-immune sera (PI, lanes 1, 3, 5); affinity
purified serum 0182 (lane 7); and affinity purified rabbit polyclonal antibody AP4912 (lane 8). (B) A control guinea pig
serum (lane 1) and three guinea pig antisera (lanes 2-4); the AP0182 rabbit antibody is shown as a control (lane 5).
Arrows indicate immunoreactive bands recognised by all antibodies. The additional, weaker bands do not relate to the
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MSY3 protein, as the corresponding proteins are not immunoprecipitated with anti-MSY3 antibodies and are not
routinely detected on immunoblots. The position of prestained apparent molecular weight markers is indicated.
To evaluate whether these bands correspond to the MSY3 protein, HeLa cells were
transiently transfected with expression plasmids carrying cDNA corresponding to either the
short or long MSY3 splice variant, and analysed by immunoblotting along with the protein
extract from mouse embryos. Indeed, as shown in Figure 8, the AP4912 antibody
recognised bands migrating at 47 kDa and 58-60 kDa in cells transfected with the short or
long MSY3 variant, respectively (Figure 8, lanes 2 and 3, red arrows). No band was detected
in cells transfected with the empty vector (Figure 8, lane 1). Notably, the same set of
immunoreactive bands was observed in the extract prepared from E9.5 mouse embryos
(Figure 8, right panel lane 4), with the long splice variant of MSY3 being the major form. It
is interesting to note that in each case the antibody recognised doublets of immunoreactive
bands, possibly due to phosphorylation of MSY3. The identical pattern of immunoreactive
bands was observed with the AP0182 antibody (data not shown).
Figure 8. Both splice variants of MSY3 are expressed in the mouse embryo. Detergent extracts from HeLa cells
transiently transfected with the expression vector encoding short or long splice variant of the MSY3 cDNA (lanes 2 and
3), or the empty vector as a negative control (mock, lane 1), and from E9.5 embryos (lane 4) were analysed by
immunoblotting with the affinity purified antibody AP4912 against MSY3. The right panel shows 10-times longer
exposure of the same membrane as the left panel. Arrows indicate bands corresponding to the MSY3 protein isoforms.
The position of prestained apparent molecular weight markers is indicated.
2.2.2 Expression of MSY3 is associated with neuronal progenitors
We first asked whether MSY3 is expressed in the developing CNS. Double staining for
MSY3 and a marker of new-born neurons, III-tubulin, revealed that MSY3 is expressed in
the germinal zone (Figure 9, red) but not in the neuronal layer (Figure 9, green). Within the
neuronal layer, blood vessels, as identified by morphology, are also brightly stained (Figure 9
and Figure 12, arrowheads). Since blood vessels often trap antibodies nonspecifically, it
cannot be concluded that this staining reflects presence of the MSY3 protein. MSY3 was
Results
37
also expressed in most other tissues between E10.5 and E12.5, namely skin, mesenchyme,
heart, somites and peripheral ganglia (Figure 12, and data not shown; see also Lu et al.,
2006).
Figure 9. MSY3 is expressed in progenitors, but absent from neuronal layer. Transverse cryosections through a mouse
rhombencephalon at E10.5 (A-C), and diencephalon at E12.5 (D-F), stained for neuronal marker, III-tubulin (green),
and MSY3 (red). MSY3 expression is confined to the ventricular zone (VZ), where progenitors reside. Neuronal layers
(NL, demarcated by dotted line in F) at different stages of embryogenesis are negative for MSY3. Images are single
optical sections (1 m). Continuous and dashed lines delineate the pial and ventricular surfaces, respectively; v, ventricle;
arrowheads point to stained blood vessels within the neuronal layer; scale bars equal 50 m.
To investigate further expression of MSY3 in progenitors, the sections of the
telencephalon from E8, E11.5 and E14 embryos were analysed by colabelling with the RC2
monoclonal antibody. The RC2 antibody stains radially oriented cells with the soma in the
ventricular zone and the process reaching the pia as early as E9.5 (Gadisseaux et al., 1992;
Misson et al., 1988). The RC2 immunoreactivity is associated with intermediate filaments,
and most likely indicates posttranslational modification of nestin (Chanas-Sacre et al., 2000).
At the neural plate stage, i.e. at E8, MSY3 was expressed in all neuroepithelial and
ectodermal cells (Figure 10 A, and data not shown). No RC2 staining could be detected at
this time point (Figure 10 B). At E11.5 and E14.5, RC2 labelled radially oriented cells
showing little overlap with the MSY3 immunoreactivity (Figure 10 G,K). This apparent lack
of colocalisation could be explained by a different subcellular localisation of both antigens.
Whereas MSY3 is perinuclear, RC2 stains intermediate filaments. Indeed, higher
magnification images revealed that most of MSY3 positive cells are also stained for RC2,
which is particularly evident in rounded mitotic cells (Figure 10 O, open arrowhead).
However, not all RC2 positive cells express also MSY3 (Figure 10 O, arrows).
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Figure 10. MSY3 is expressed in a subset of RC2 positive progenitors. Cryosections through (A-D) the prospective
forebrain at E8, (E-H) the lateral telencephalon at E11.5, and (I-P) the lateral cortex at E14.5, stained for MSY3 (red)
and RC2 (green). Nuclei were visualised with DAPI (blue). (A-D ) MSY3 is expressed before the onset of RC2
expression. (E-L) At E11.5 and E14.5, the RC2 antibody labels radial cells. Note that RC2 gives a filament-like staining
and MSY3 stains mainly the perinuclear cytoplasm. (M-P) As seen at higher magnification, RC2 positive progenitors are
also MSY3 immunoreactive (arrowheads). MSY3 is not expressed in all RC2 positive cells (arrows). Mitotic cells at the
apical surface are indicated by empty arrow and arrowhead. Images are single optical sections (A-L, 2 m; M-P, 1.5 m).
Apical surface is towards bottom. The continuous and dashed lines delineate pial and ventricular surfaces, respectively.
ap, apical; NL, neuronal layer; VZ, ventricular zone; SVZ, subventricular zone. Scale bars indicate 20 m.
Similar results were obtained from a preparation of acutely dissociated cells from
telencephali of E11.5 embryos. 8 h after plating, vast majority of MSY3 positive cells was
positive for progenitor marker nestin (97%, n=89; Figure 11 A-D), and simultaneously most
of nestin immunoreactive cells was positive for RC2 (93%, n=42; Figure 11 E-H). The
coexpression of nestin and the RC2 antigen in the same progenitors has already been
reported, and both antigens are associated with proliferating cells (Chanas-Sacre et al., 2000;
Hartfuss et al., 2001).
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Figure 11. Colocalisation of MSY3, nestin and RC2 in acutely dissociated cells. Cells were fixed 8 h after plating and
double immunostained for (A-D) MSY3 and nestin, or (E-H) nestin and RC2, as indicated in the figure. Nuclei are
visualised by DAPI (blue). Note that the MSY3 expressing cells also contain nestin, and nestin immunoreactive cells
express also RC2. Images are maximum intensity projections of Z-stacks. Scale bar equals 20 m.
2.2.3 Expression of the MSY3 protein in the developing CNS is downregulated in
temporal and spatial correlation with neurogenesis
Expression of MSY3 was analysed further with regard to the wave of neurogenesis in
the developing mouse brain. The onset, and termination, of neurogenesis proceeds in a
posterior to anterior gradient in brain vesicles, i.e. from the hindbrain to the telencephalon,
and in the spinal cord from rostral to caudal. Thus, already at E8.5 some neurons are born
in the ventral hindbrain and midbrain, at E9 in the spinal cord, by E9.5-10 in the
diencephalon, and at E10.5 in the rostral telencephalon. Furthermore, in the telencephalon,
the longitudinal neurogenic gradient proceeds from anterior towards posterior, whereas
transverse gradients set from the ventrolaterall towards dorsomedial telencephalon, as well
as ventromedially (Bayer and Altman, 1991; Gardette et al., 1982; Haubensak, 2002;
Haubensak et al., 2004; McConnell, 1981; Nornes and Carry, 1978).
Two regions of the developing mouse brain along its rostrocaudal axis, i.e. the
telencephalon and rhombencephalon, of various developmental stages were analysed by
immunostaining on transverse cryosections derived from Tis21-GFP embryos (Figure 12).
Since Tis21-GFP marks neurogenic, but not proliferating, progenitors, it is a useful tool to
visualise progression of neurogenesis. As reported previously (Haubensak et al., 2004), in
the rostral telencephalon, first GFP positive cells appear at E10.5 (Figure 12 C), and by
E15.5 they reach 60% fraction of the progenitor cells in this region. Notably, the MSY3
immunoreactivity decreases in the telencephalon starting at E11.5 (Figure 12 F), and is
dramatically down-regulated at E12.5 (Figure 12 H), when a significant proportion (ca. 20%)
of progenitor cells generate neurons. Later, between E14 and E18, MSY3 expression
remains at constant low level in the germinal zone (Figure 12 J).
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Figure 12. Spatial and temporal expression of MSY3 in the heterozygous Tis21-GFP mouse embryos. Transverse
cryosections through (A-J) the rostral telencephalon, and (K-R) lateral rhombencephalon, at indicated developmental
stages were stained for MSY3 (red, middle panels). Images are single optical sections (3 m) acquired with the same
settings in the middle of a tissue section. Ventricle is towards bottom. GFP carries a nuclear localisation signal and
marks neurogenic progenitor cells (green, right and left panels). Note that MSY3 immunostaining is decreasing with
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development, and is lower in the rhombencephalon than in the telencephalon at each developmental stage, in inverse
pattern to Tis21-GFP. The MSY3 labelling is detected also in the surface ectoderm (ec), and mesenchyme (mes). The
continuous and dashed lines delineate the pial and ventricular surfaces, respectively. NL, neuronal layer; VZ, ventricular
zone; SVZ, subventricular zone; CP, cortical plate; IZ, intermediate zone; arrows, blood vessels; scale bar equals 50 m.
In the brain, first neurons are born in the rhombencephalon, and already at E9.5 many
cells in this region are Tis21-GFP positive (Figure 12 L). Remarkably, for each
developmental time point analysed, the MSY3 immunoreactivity is lower in the
rhombencephalon than in the telencephalon (compare left and right panels in Figure 12).
MSY3 expression declines also in relation to the ventrodorsal gradient of neurogenesis,
which is particularly striking in the rhombencephalon at E10.5 onwards. As illustrated in
Figure 13, the MSY3 immunoreactivity appears lower in more ventral region (Figure 13 A,
towards left), where neurogenesis is more advanced than dorsally (Figure 13 B,C).
Moreover, in the telencephalon, MSY3 is downregulated in ventrolateral to dorsomedial
gradient (Figure 17 A, p.47), corresponding to the neurogenic wave (Bayer and Altman,
1991).
Figure 13. MSY3 is down-regulated in a ventral to dorsal gradient. A transverse cryosection through the ventro-lateral
rhombencephalon of the E10.5 heterozygous Tis21-GFP embryo stained with antibodies against MSY3 and
III-tubulin. Ventral is towards left. Neurogenesis proceeds in ventral-to-dorsal gradient, as visualised by abundance of
Tis21-GFP positive progenitors (B, green), and accumulation of neurons (C, white). Images are single optical sections
(4 m). Dashed and continuous lines indicate the ventricular and pial surfaces, respectively; bv, blood vessel; scale bar,
50 m.
To corroborate the immunostaining data, MSY3 expression was analysed by
immunoblotting. Protein extracts were prepared from whole E8.5 embryos, or telencephali
and hindbrains dissected out from embryos aged between E9.5 and E14.5, and from the
adult brain. As shown in Figure 14, MSY3 is strongly expressed at E8.5 and at E9.5 in the
telencephalon, when only few neurons are born. With the onset of neurogenesis, however,
MSY3 is progressively downregulated, being below the detection level in the adult brain. In
agreement with immunostaining, at any given stage this downregulation is more prominent
in the hindbrain than in the telencephalon.
Results
42
Figure 14. MSY3 is downregulated at the onset of neurogenesis. 20 g of protein extracts prepared from E8.5 embryos
and from telencephali or hindbrains at indicated developmental stages, and from the adult brain, were analysed by
immunoblotting with antibodies against proteins expressed in neuronal progenitors, i.e. MSY3 (AP4912), ZO-1, nestin,
prominin-1, as well as actin, as indicated. Note that only MSY3 is downregulated during the neurogenic period. The
position of prestained apparent molecular weight markers is indicated.
Since neurons, which do not express MSY3, accumulate with the progression of
neurogenesis, it could be argued that the MSY3 level is constant in progenitors and
observed down-regulation of MSY3 is accounted for by diluting a protein fraction derived
from progenitors by other cell types. Therefore, it is of importance that other proteins
expressed in progenitors, but not in neurons, i.e. zonula occludens-1 (ZO-1), nestin and
prominin-1 (Aaku-Saraste et al., 1996; Hatakeyama et al., 2004; Hockfield and McKay, 1985;
Lendahl et al., 1990; Weigmann et al., 1997), do not exhibit such downregulation in time
and space (Figure 14). The expression of nestin actually increases between E9.5 and E10.5,
and remains constant, as previously reported (Hockfield and McKay, 1985). Only the
increase in actin immunoreactivity is likely resulting from changes in cellular composition of
the samples.
Taken together, the MSY3 protein is downregulated precisely at the onset of
neurogenesis. Importantly, the reported pattern was seen with all antibodies against MSY3.
2.2.4 MSY3 is not expressed in specialised regions of the neural tube
After the closure of the neural tube, cells at its dorsal and ventral aspects form the
morphologically distinct roof and floor plate, which specify and pattern the neural tissue
along the dorsoventral axis (Fuccillo et al., 2006; Liu and Niswander, 2005; Placzek and
Briscoe, 2005). Remarkably, MSY3 expression is very low in some of these regions. In the
E12.5 brain, derivatives of, and tissues located immediately to, the embryonic dorsal
midline, namely the lamina terminalis (Figure 15 D-F), anlage of the choroid plexus (Figure
15 G-I), and the cortical hem (Figure 15 J,K) are devoid of MSY3 expression. At earlier
stages, i.e. E10.5-E11.5, MSY3 expression in equivalent regions is lower than in a
surrounding tissue (data not shown). In the spinal cord, already at E10.5 MSY3 is not
expressed in the floor plate (Figure 15 A-C).
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Figure 15. MSY3 is not expressed in non-neurogenic regions of the neural tube and in the cortical hem. Transverse
cryosections of heterozygous Tis21-GFP embryos stained with antibodies against MSY3 (red) and III-tubulin (white).
(A-C) the E10.5 spinal cord; (D-F) the E12.5 hypothalamus; (G-K) the E12.5 medial telencephalon showing the anlage
of the choroid plexus (G-I) and the cortical hem (J,K). The floor plate (fp), lamina terminalis (lt) and choroid plexus,
which contain post-mitotic cells and do not generate neurons, as seen by absence of Tis21-GFP positive progenitors
(green) and neurons, are negative for MSY3. Dorsal is towards up. Images are single optical sections (4 m for A-I,
3 m for J,K). v, ventricle. Scale bar equals 50 m.
Cells of the floor and roof plate, including the lamina terminalis, do not generate
neurons, which can also be seen by absence of Tis21-GFP positive progenitors and
III-tubulin positive neurons. It is important to note that by the time of the analysis these
cells has largely withdrawn from the cell cycle (Baek et al., 2006; Kahane and Kalcheim,
1998).
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Bilaterally, from the cells of the dorsal midline in the anterior telencephalon, and
prosteriorly from cells near the dorsal midline, develops the cortical hem (Currle et al., 2005;
Hebert et al., 2003). The hem, through expression of multiple members of Wnt and BMP
families, is indispensable for development of abutting regions: laterally the hippocampus,
and medially the telencephalic choroid plexus epithelium (Grove et al., 1998; Lee et al.,
2000; Yoshida et al., 2006a). This region is a source of reelin-positive Cajal-Retzius cells
(CR), which migrate out onto the surface of the cortex, playing an essential role in proper
layering (Takiguchi-Hayashi et al., 2004; Yoshida et al., 2006a). Notably, by E12.5, i.e. when
MSY3 is downregulated, generation of CR cells is largely accomplished, and the hem is
composed of thinning neuroepithelium, which shrinks further until E16.5 (Takiguchi-
Hayashi et al., 2004; Yoshida et al., 2006a).
The choroid plexus produces the cerebrospinal fluid and its epithelium is the only
nonneural tissue that develops from the neural tube. It differentiates at three locations: in
the hindbrain roof, anterior diencephalic roof and bilaterally at dorsomedial edges of the
telencephalon (Currle et al., 2005; Hebert et al., 2003). Transition of the choroid plexus
epithelium into a simple columnar to cuboidal cells contiguous with adjacent
pseudostratified neuroepithelium is complete at the time of analysis (Sturrock, 1979), its
cells being mostly postmitotic (Hebert et al., 2003).
Thus, it becomes evident that in the neural tube MSY3 expression is associated solely
with highly proliferative and not differentiated cell types.
2.2.5 MSY3 expression in neurogenic versus proliferating progenitors
Because proliferating and neurogenic progenitors co-exist in the ventricular zone, and
MSY3, although downregulated, is still expressed when neurogenesis is ongoing, it was
interesting to determine in which of these populations the MSY3 protein is present. To
address this question, MSY3 immunostaining and Tis21-GFP fluorescence in the lateral
midbrain and ventral telencephalon of E11.5 heterozygous embryos were compared as
explained in Material and Methods and in Figure 16. Single cells in the neuroepithelium were
delineated by concanavalin A staining, as described previously (Noctor et al., 2002).
Concanavalin A is a lectin, which binds -mannopyranosyl and -glucopyranosyl in the ER
and on the cell surface (Figure 16 A,B). Following, the cells were graded for the MSY3
immunoreactivity as strong, middle and weak (Fig. 16 D,D’; red, yellow and blue arrows,
respectively), and for the Tis21-GFP fluorescence as strong, middle, weak or none (Figure
16 E,E’; white, pale green, dark green and grey circles).
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Figure 16. Analysis of MSY3 expression in neurogenic versus proliferating progenitors.
(A ) Coronal cryosections of E11.5 heterozygous Tis21-GFP embryos were stained with MSY3 (red) and
concanavalin A, (Con A; white), nuclei were visualised by DAPI (blue). (B) Single cells were identified in several
consecutive optical sections based on Con A and DAPI staining and delineated with yellow line. Note that for clarity a
single optical section of 1 m is shown, and several cells - whose overlay, but not the cell body, is visible - are present in
other optical sections. (C ) Merge for MSY3 and Tis21-GFP. (D ,D’) Delineated cells were scored for MSY3
immunofluorescence using the rainbow scale (F) as strong (red arrows), middle (yellow arrows) and weak (blue arrows).
(E,E’) Delineated and marked for MSY3 cells were then scored for Tis21-GFP fluorescence using the rainbow scale (F)
as strong (white circle), medium (absent from this section), weak (dark green circles) and negative (grey circles). Scale
bar equals 20 m.
As summarised in Table 1, for the lateral midbrain, majority of cells that express high
levels of Tis21-GFP, simultaneously express low levels of MSY3 (74%). This tendency does
not reflect the abundance of the latter in the whole population, which is about one-third
(32%). Cells expressing lower level of Tis21-GFP show random pattern of MSY3
expression. In the ventral telencephalon, however, no inverse regulation of the two proteins
could be observed. Notably, in the ventral telencephalon fewer cells are weakly stained for
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MSY3, than in the midbrain (15% vs. 32%), which is in agreement with the general pattern
of MSY3 downregulation along the rostrocaudal axis of the embryo.
EGFP
MSY3
strong medium weak none total MSY3
lateral midbrain
strong 2 9 51 124 186   (42%)
medium 5 11 32 66 114   (26%)
weak 20 14 32 72 141   (32%)
ventral telencephalon
strong 1 5 27 100 133   (52%)
medium 5 5 27 48 85   (33%)
weak 1 4 9 24 38   (15%)
Table 1. Semiquantitative analysis of MSY3 and Tis21-GFP expression levels. Each cell was assigned two estimated
values: MSY3 immunoreactivity (rows; strong, medium and weak) and Tis21-GFP fluorescence (columns; strong,
medium, weak or none) as shown in Figure 16. Numbers represent cell counts for each category, pooled from total of
four sections per region from two age-matched embryos. The last column (total MSY3) gives the total number of cells
scored for MSY3 as strong, medium and weak; in brackets the percentage of cells in a given category over the total
number of cells is indicated. Whereas in the lateral midbrain strongly Tis21-GFP positive cells are largely week for
MSY3, no such correlation could be observed in the ventral telencephalon.
Thus, although a general pattern of MSY3 expression is inversely regulated to
Tis21-GFP, present data, albeit suggestive for some regions, is not sufficient to conclude
that MSY3 is specifically excluded from the neurogenic progenitors.
2.2.6 MSY3 is down-regulated in radial glia
MSY3 expression was analysed during the transition of neuroepithelial cells to radial glia.
Only radial glia express markers characteristic to differentiated astrocytes, such as GLAST
(astrocyte-specific glutamate transporter) and BLBP (brain lipid binding protein). GLAST
expression is broader than BLBP and most, if not all, BLBP positive cells express also
GLAST (Anthony et al., 2004; Hartfuss et al., 2001). MSY3 expression in GLAST positive
radial glia was examined by immunostaining on sections from E12.5 embryos (Figure 17).
At this stage, the onset of GLAST and BLBP expression in the telencephalon appears in
correlation with the initiation of neurogenesis and radial glia directed neuronal migration
(Anthony et al., 2004; Gotz and Huttner, 2005; Hartfuss et al., 2001).
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Figure 17. MSY3 expression is downregulated during the transition from neuroepithelial to radial glial progenitors.
Immunostaining for MSY3 (red) and GLAST (green) on a transverse cryosection through the E12.5 brain. Nuclei are
visualised with DAPI. (A-D) Downregulation of MSY3 proceeds in a lateral to caudomedial gradient (arrow), which
corresponds to the onset of GLAST expression (arrowheads). Image is a composite of single optical sections (3 m).
(E-H) and (I-L) are enlarged images of the rostral and caudolateral cortex, respectively. cx, cortex; dienc, diencephalon;
LGE, lateral ganglionic eminence; MGE, medial ganglionic eminence; LV, lateral ventricle. Scale bar equals 20 m
(E-L).
As reported previously, GLAST staining in the telencephalon appeared in a rostrolateral
to caudomedial gradient (Figure 17 B,C, arrowheads) (Anthony et al., 2004). Moreover, in
regions where GLAST expression was initiated, all radial glia were GLAST immunoreactive
(Figure 17 J). Notably, MSY3 expression decreases in an opposite gradient (Figure 17 A,C,
arrow). Both antigens colocalise only in a narrow domain of the diencephalon. As the onset
of GLAST expression defines the transition from neuroepithelial cells to radial glia, MSY3
is downregulated upon this switch.
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2.2.7 Expression of MSY3 in Hes5-GFP transgenic mouse line
In the developing rodent CNS, the expansion and maintenance of self-renewal of
progenitors requires Notch signalling. First Notch-dependent precursors appear at E8.5
with onset of its expression (de la Pompa et al., 1997; Hitoshi et al., 2002; Hitoshi et al.,
2004; Reaume et al., 1992). After E8.5 onward, bHLH transcription factors Hes1 and Hes5
are essential effectors of Notch signalling. The onset of Hes5 expression coincides with that
of Notch and Delta (de la Pompa et al., 1997; Hatakeyama and Kageyama, 2006), and in the
RBP-J null embryos, in which the Notch signalling is abolished, Hes-5 is not expressed (de la
Pompa et al., 1997). Therefore, the Hes5 gene regulatory sequences can be utilised to
visualise activation of Notch signalling.
MSY3 expression in relation to Notch signalling was investigated by immunostaining in
Hes5-GFP transgenic embryos (kindly provided by Onur Basak and Verdon Taylor,
Freiburg). In this reporter line, GFP expression is entirely dependent on Notch. The GFP
expression pattern, in contrast to the previously reported Hes5-EGFP line (Ohtsuka et al.,
2006), precisely reproduces that of the endogenous Hes5 mRNA. The onset of GFP
expression commences in a gradient preceding by approximately 1 day the onset of
neurogenesis. By E11.5 it is expressed in progenitor cells throughout the entire brain, except
for the diencephalon and midbrain at the rostral and dorsal extremities, respectively (Figure
18 B,F). Once induced, GFP expression is homogenous among progenitors in a given
region. Then, as a consequence of lateral inhibition, scattered progenitors are selected for
differentiation and downregulate Hes5-GFP. As presented in Figure 18, MSY3 and
Hes5-GFP expression overlaps, particularly in the lateral and ventral telencephalon (Figure
18, empty arrows). However, in the cortical hem, where GFP expression is particularly
strong, MSY3 is virtually absent (Figure 18, empty arrowheads). In the midbrain,
diencephalon, and caudal ganglionic eminence the onset of GFP expression is accompanied
by downregulation of MSY3 (Figure 18, solid arrowheads; and Figure 19 for higher
magnification). Inversely, regions showing strong MSY3 immunostaining are still negative
or weak for GFP (Figure 18, solid arrows; Figure 19).
Figure 18. Expression of MSY3 in the Hes5-GFP transgenic embryo. Coronal cryosections of the E11.5 Hes5-GFP
embryo, in which GFP expression driven from the Hes5 promoter is a marker of active Notch signalling, were stained
for MSY3 (red) and GFP (green). (A-C) rostral, and (D-F) caudal sections. (A-C) In the telencephalon, expression of
MSY3 and GFP are partially overlapping (open arrows) except for the cortical hem (open arrowheads). (D-F) In the
diencephalon, and also the caudal telencephalon, strong MSY3 labelling coincides with low GFP expression (arrows); in
reverse, induction of Notch signalling is accompanied by downregulation of MSY3 (arrowheads). Images are
composites of single optical sections (3 m). dienc, diencephalon; mb, midbrain; tel, telencephalon. Scale bar equals
300 m.
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Interestingly, in the areas located between the regions of strong and weak Notch
activation, such as the dorsolateral midbrain and diencephalon, it was frequently observed
that scattered groups of cells which begin to express GFP simultaneously downregulate
MSY3 (Figure 19 G-I, arrows). It is likely that these cells are clonally related, since after the
division daughter cells often remain in a close contact (Cai et al., 1997b). Such clusters of
cells are coupled via gap junctions, and are synchronised with respect to the cell cycle and
interkinetic nuclear migration (Cai et al., 1997b; Lo Turco and Kriegstein, 1991; Pearson et
al., 2005).
Figure 19. Onset of expression of Hes5-GFP in the midbrain coincides with downregulation of MSY3. Cryosections of
the E11.5 Hes5-GFP embryo through (A-C ) the dorsal midbrain, (D-F) the ventrolateral midbrain, and (G-I)
dorsolateral midbrain, were stained for MSY3 (red) and GFP (green). Images are single optical sections (1 m) acquired
with the same settings; (A-F) were acquired from the same tissue section. Induction of Hes5-GFP is coupled with
downregulation of MSY3, also in individual cells (G-I, arrows). Cells with weak Notch activation remain strongly
immunoreactive for MSY3 (G-I, empty arrowheads). Ventricle is towards bottom. small arowheads, blood vessels. Scale
bar equals 20 m.
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Progenitors downregulate Notch signalling with commitment to differentiation. Because
the expression of MSY3 correlates with proliferation, it was plausible that cells with low
levels of Notch signalling also express MSY3 to a lesser extent. To test this hypothesis,
MSY3 expression was examined at a cellular resolution in the ventral telencephalon of
E11.5 Hes5-GFP embryos. In this area, individual cells express variable levels of Hes5-GFP.
As shown in Figure 20, all four possible combinations of fluorescent labelling could be
detected (i.e. GFP+/MSY3+, GFP+/MSY3-, GFP-/MSY3+, and GFP-/MSY3-) at
random frequencies. Thus, there is no apparent correlation between MSY3 expression and
Notch signalling.
Figure 20. Expression of MSY3 does not correlate with Notch signalling in individual cells after the onset of
neurogenesis. Cryosections through the ventral telencephalon of the Hes5-GFP embryo at E11.5 were stained for
MSY3 (red) and GFP (green). All four possible combinations of expression of both proteins can be detected.
Progenitors that downregulated Notch signalling no longer express GFP from the Hes5 promoter, and show low or
high MSY3 immunoreactivity (open arrows and arrowheads, respectively). Among progenitors with high levels of
Notch signalling, MSY3 is also expressed at the low or high levels (solid arrows and arrowheads, respectively). Lines
delineate the pial surface. NL, nuclear layer; VZ, ventricular zone. Scale bar equals 20 m.
2.2.8 MSY3 expression is not reduced in Notch1-deficient progenitors
Expression of MSY3 is downregulated coincidentally with an increase in neurogenic
divisions in the neuroepithelium, yet neither a cellular comparison with Tis21-GFP
expression or Notch signalling could by far prove this correlation in individual cells. If
downregulation of MSY3 is a part of a differentiation process, it should also be induced
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prematurely when precocious neurogenesis is triggered experimentally. To test this
hypothesis, MSY3 expression was analysed after conditional ablation of Notch1 in
ventricular zone progenitors, which causes the premature onset of neurogenesis.
Conditional ablation of Notch1 gene using Cre-Lox system allows to circumvent the
developmental arrest and early lethality of Notch1 null embryos (Swiatek et al., 1994).
Recombination between LoxP sites flanking the first coding exon of Notch1 results in a null
allele restricted to cells which express the Cre recombinase (Radtke et al., 1999). For this
study, homozygous Floxed Notch1 mice were crossed with a transgenic line expressing Cre
in the midbrain-hindbrain boundary from the Engrailed2 promoter enhancer (Lütolf et al.,
2002; Zinyk et al., 1998). In addition, the Floxed Notch1 line is combined with the R26R
allele, which consists of the Floxed PGK neo cassette inserted into the ROSA26 locus and
downstream a -galactosidase gene. Cre-mediated recombination leads to expression of
-galactosidase, thus allowing to follow the fate of Cre-expressing cells and their progeny
(Soriano, 1999). The midbrain-hindbrain region regulate anterior-posterior pattering and
formation of the caudal midbrain and the cerebellum (Hidalgo-Sanchez et al., 2005; Reifers
et al., 1998). Cre recombination starts at E9, and by E10 cells in the cerebellar primordium
show drastic reduction of Notch1 and Hes5 expression, accompanied by upregulation of
Notch1 ligands Dll1 (Delta-like) and Dll3, which are normally expressed in differentiating
cells (Lütolf et al., 2002). Furthermore, ectopic expression of a proneural genes Math 1 and
Mash1 at E10, followed by upregulation of Tis21-GFP at E11.5, indicate the premature
initiation of a differentiation program. Nonetheless, the Notch1-deficient cells do not
complete differentiation but instead are eliminated by apoptosis (Lütolf et al., 2002; and
Verdon Taylor, unpublished data).
MSY3 expression was examined in Notch-depleted cells at E11.5 on transverse sections
through the midbrain-hindbrain boundary. Expression of -galactosidase confirmed
efficient Cre-recombination in the medial cerebellar primordium, as previously reported
(Figure 21 A,B, arrow) (Lütolf et al., 2002). Surprisingly, however, MSY3 expression was
not affected (compare Figure 21 C and D). Therefore, it can be concluded that
downregulation of MSY3 is not an early marker of differentiation.
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Figure 21. MSY3 expression is not affected in Notch1-deficient progenitors. Transverse cryosections through the
midbrain-hindbrain region E11.5 embryos stained for (A,B) -galactosidase, and (C,D) MSY3. Dorsal is up. Expression
of Cre from the Engrailed2 promoter enhancer results in generation of a null Notch1 allele and also allows for expression
of -galactosidase from the reporter ROSA26 locus. (A,B) Despite strong background staining resulting from
prolonged incubation with the X-gal staining solution, -galactosidase expression can be detected in the medial
cerebellar primordium of En2-Cre expressing embryos (arrow in B), but not in the En2-Cre negative neural tube (arrow
in A). (C,D) MSY3 expression is not altered in Notch1 mutant embryo ( / ) as compared with wild type (lox/lox).
Images in (C,D) are single optical sections (1.9 m). Continuous line delineates the pial surface. bv, blood vessels. Scale
bar equals 50 m.
2.2.9 Subcellular localisation of MSY3
It has been previously reported that the canine and human orthologues of MSY3
(ZONAB and dbpA/CSDA) in epithelial cell lines colocalise at tight junctions with zonula
ocludens-1 (ZO-1) (Balda and Matter, 2000; Sourisseau et al., 2006). Moreover, in the
proliferating subconfluent cells, ZONAB/dbpA is present in the nucleus, where it acts as a
transcription factor for genes encoding growth related proteins (see Introduction). In attempt
to understand MSY3 function in the neuroepithelial cells, first its subcellular localisation was
investigated by light and electron microscopy.
Sections from embryos at E8 and at E10.5, i.e. prior and at the onset of neurogenesis,
were stained for MSY3 and ZO-1. Before the closure of the neural tube, the
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neuroepithelium consists of columnar cells which elongate and form a pseudostrarified
epithelium as progenitor cells expand. This process is accompanied by bringing closer
junctional complexes and morphological changes within the apical plasma membrane
(Marzesco et al., 2005). As presented in Figure 22, ZO-1 immunostaining appeared at
junctions with a honey comb pattern, visible on single optical sections as puncta at the
apical side of neuroepithelial cells. At both stages, MSY3 immunoreactivity was reduced at
junctions compare to the adjacent cytoplasm (Figure 22, arrows). The same pattern of
expression was observed also later, at E12 (data not shown), throughout the
neuroepithelium. Moreover, MSY3 was never detected in the nucleus.
Immunogold electron microscopy confirmed that the MSY3 immunoreactivity is present
throughout the cytoplasm (Figure 23). In agreement with fluorescence data, MSY3 was not
found in the nucleus or at junctions. In some sections, MSY3 appeared associated with the
endoplasmic reticulum (ER), although without enrichment in this subcellular compartment.
Figure 22. MSY3 subcellular distribution in the mouse neuroepithelium. Cryosections through (A-C) the prospective
forebrain at E8, and (D-F) the telencephalon at E10.5, were stained for ZO-1 (green) and MSY3 (red). DNA was
visualised with DAPI (blue). The apical surface is towards bottom. The MSY3 immunoreactivity is not detected in the
nucleus nor is concentrated at junctions (arrows). (G,H) Fluorescence intensity profiles for ZO-1 (green curve) and
MSY3 (red curve) along the regions indicated by dashed lines in (C) and (F). Note that picks of ZO-1
immunofluorescence coincide with falls in the MSY3 staining. Images are single optical sections (1 m). Scale bar equals
10 m.
Results
55
Figure 23. Immunogold electron microscopy shows the cytoplasmic localisation of MSY3. Ultrathin sections of the
E10.5 telencephalon were stained for MSY3 followed by protein A-10 nm gold. Arrows indicate some of the
immunogold particles. (A) MSY3 is detected throughout the cytoplasm, but not in the nucleus (N), (B) or at the
junctional complexes (asterisk). (C,D) Enlargement of boxed areas in (A) and (B). Some of the gold particles are
associated with ER (double-headed arrows). ap, apical; N, nucleus; np, nuclear pore. Scale bar equals 100 nm.
The subcellular localisation of MSY3 appears to be different in neuroepithelial cells than
reported previously for its orthologues in epithelial cell lines, yet it cannot be excluded that
the epitope recognised by the antibodies is masked in the tissue. However, the same pattern
of expression was observed when: i) two independent antibodies were used, one directed
against the whole N-terminal domain; ii) different fixation (1-4% PFA or
4% PFA + 0.1% glutaraldehyde) or permeabilisation (0.2% saponin, 0.3 % Triton X-100 or
0.01% SDS) methods were employed. Additionally, the guinea pig GP2 antiserum against
the mouse MSY3 protein can detect tight junction associated and nuclear forms of ZONAB
in MDCK cells (Karl Matter, personal communication).
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2.3 Manipulation of  the MSY3 protein levels in the
neuroepithelium
2.3.1 Knockdown of MSY3 in proliferating progenitors
The developmental profile of MSY3 expression would suggest that it is involved in
maintenance of symmetric proliferative divisions of progenitor cells, and/or its
downregulation is necessary for a differentiation process. To test directly whether MSY3 is
essential for proliferation of precursors, its expression in progenitors was reduced by RNA
interference in vivo prior to the onset of neurogenesis.
Endonuclease prepared small interfering RNAs (esiRNAs; a mixture of short interfering
RNAs) directed against MSY3 were electroporated in one side of the brain of E9.5
embryos, along with a reporter GFP plasmid. Expression of GFP indicates the
electroporated region and enables to follow the fate of targeted cells. After electroporation,
embryos developed in a whole embryo culture for 48 h. Immunostaining revealed robust
reduction of the MSY3 protein in the targeted region (Figure 24 A,C; upper left panels)
when compared to the control non-electroporated side (Figure 24 A,C; upper right panels)
of the neural tube or embryos electroporated with luciferase esiRNAs (Figure 24 B,D). GFP
positive cells were similarly distributed between the ventricular zone and neuronal layer after
MSY3 knockdown and in control embryos (Figure 24 A,B; bottom panels). The thickness
of the neuronal layer or contribution of targeted cells to neuronal progeny were not altered,
despite targeting of a large proportion of progenitors (Figure 24 A,B; middle panels).
Moreover, MSY3 knockdown did not promote ectopic neurogenesis in the rostral
diencephalon, which do not generate neurons at examined age (Figure 24 C,D; middle
panels). Thus, downregulation of MSY3 did not trigger the cell cycle exit of neuroepithelial
cells.
Because endogenous downregulation of MSY3 parallels the switch of neuroepithelial
cells to radial glia, it is plausible that knockdown of MSY3 would induce radial glia, which
are normally absent in the E11.5 telencephalon. However, radial glia marker GLAST was
not upregulated in the targeted area (data not shown).
Next, the abundance of basal progenitors was examined. To date, basal progenitors can
be identified unambiguously based on their abventricular mitosis, therefore
phosphohistone 3 positive mitotic figures at the basal aspect of the ventricular zone were
quantified in targeted and control hemispheres. After downregulation of MSY3, the number
of abventricular mitoses in the targeted area per section (4.7±2.1 SD; n=14 sections) was
similar to the control hemisphere (4.6±1.5 SD; n=14). Therefore, MSY3 downregulation
also did not promote symmetric terminal divisions via basal progenitors.
 Taken together, although applied technique resulted in strong reduction of MSY3 in the
germinal ventricular zone, performed analysis did not reveal an alteration in a proliferative
potential or lineage of MSY3-dpeleted progenitors.
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Figure 24. Konckdown of MSY3 by esiRNAs does not increase neurogenesis. Brains of E9.5 embryos were
electroporated with esiRNAs directed against MSY3 (A,C) or luciferase as a control (B,D) along with the GFP reporter
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plasmid, followed by development in a whole embryo culture for 48 h. Coronal cryosections through (A,B) the basal
telencephalon, and (C,D) the rostral diencephalon were stained for MSY3 (white) and III-tubulin (red). The targeted
hemisphere, as identified by GFP fluorescence (green) shows remarkable decrease of MSY3 expression compared to
the control hemisphere (right panels) or control embryos (B,D). Electroporated cells of targeted and control embryos
are similarly distributed in the ventricular zone and neuronal layer, suggesting that proliferation and differentiation of
progenitor cells was not perturbed. Expression of a neuronal marker III-tubulin appears not altered, and no ectopic
neurons are generated upon MSY3 knockdown in the rostral diencephalon (C). Images are single optical sectios (3 m).
Dorsal is up; continous and dashed lines delineate the pial and ventricular surfaces, respectively. Scale bar equals 50 m.
2.3.2 Overexpression of MSY3 in progenitors undergoing neurogenic divisions
In a second approach to reveal a potential role of MSY3 in proliferation or
differentiation, the protein was ectopically expressed in progenitors after the onset of
neurogenesis. The MSY3 and reporter monomeric red fluorescent protein (mRFP)
expression plasmids were electroporated in the lateral telencephalon of embryos at E10.5 or
E12.5. This two developmental time points enable, respectively: i) to maintain expression of
MSY3 through the period it is being physiologically downregulated; and ii) to introduce and
maintain MSY3 at the time it is already reduced. The electroporated embryos developed for
36 and 48 h in whole embryo culture or in utero, respectively.
Electroporated cells, marked by mRFP fluorescence, showed strong expression of
MSY3 in both experimental conditions (Figure 25 C,E and Figure 26 C, green), which
confirmed previously reported high ratio of coelectroporation (Saito and Nakatsuji, 2001).
Subset of targeted cells reside in the ventricular zone and exhibit elongated morphology of
neuroepithelial/radial glia precursors. At the time of analysis – i.e. at E12 and E14.5 when
electroporation was performed at E10.5 or at E12.5, respectively – neurogenesis is
advanced. When mRFP alone was misexpressed, a large proportion of electroporated cells
left the ventricular zone and accumulated in the forming neuronal layer at E12 (Figure 25 B)
or migrated into the intermediate zone and the cortical plate at E14.5 (Figure 25 D).
Additionally, at E14.5 electroporated cells underwent tangential migration from the lateral
intermediate zone towards the basal telencephalon in the lateral cortical stream (Figure 26 D
and data not shown) (Bayer and Altman, 1991; McCarthy et al., 2001). Indistinguishable
distribution and abundance of mRFP expressing cells in the outer layers were observed also
in control embryos (Figure 25 A, and Figure 26 C). In addition, mRFP positive cells in the
neuronal layers express a neuronal marker III-tubulin (Figure 25 A, and data not shown).
It is important to note that in the employed method only progenitor cells which are facing
the ventricle, but not neurons, can receive DNA. Thus all neurons expressing mRFP are
derived from cycling precursors. Overexpression of MSY3 at E10.5 also did not perturb
expression of Tis21-GFP by E12 in the lateral cortex or ganglionic eminences (compare the
control and targeted hemisphere in Figure 25 A and B; and data not shown).
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Figure 25. Overexpression of MSY3 at E10.5 does not prevent neurogenic divisions. Heterozygous Tis21-GFP embryos
were electroporated at E10.5 with the MSY3 expression plasmid together with the mRFP reporter plasmid (A,C,E), or
with the mRFP plasmid alone as a control (B ,D ), and developed for 36 h in whole embryo culture. Coronal
cryosections through the lateral telencephalon were stained for III-tubulin (A,B, white), or MSY3 (C-E, green). (A,B)
In the ventricular zone, many GFP positive cells indicate neurogenic divisions, which show similar pattern after MSY3
overexpression and in control embryos (middle panels). Many targeted cells reside in the neuronal layer (upper panels)
and express III-tubulin (bottom panels). (C-E) mRFP positive cells show elevated MSY3 immunostaining (green)
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compared to the non-electroporated controlateral hemisphere only when MSY3 plasmid was included. (E) enlargement
of boxed area in (C). Images are single optical sections (2 m). Continuous and dashed lines delineate the pial and
ventricular surfaces, respectively. Scale bar equals (A-D) 50 m, (E) 20 m.
Figure 26. Overexpression of MSY3 at E12.5 does not affect the fate of progenitors. Embryos were electroporated at
E12.5 with the MSY3 expression plasmid together with the mRFP reporter plasmid (A,C), or with the mRFP plasmid
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alone as a control (B ,D ), and were allowed to develop for 48 h in utero. (A ,B ) Phase contrast images of coronal
cryosections, boxes indicate regions shown in (C,D). (C,D) Targeted cells show strong immunostaining for MSY3
(green), which colocalises with mRFP (yellow in C) and is not observed in control electroporation (D). mRFP positive
cells in both conditions are located in the germinal ventricular and subventricular zone (VZ, SVZ) or migrated into the
intermediate zone (IZ) and the cortical plate (CP) delineated with dotted lines. Images are single optical sections (3 m).
Dorsal is up. Continuous and dashed lines indicate the pial and ventricular surfaces, respectively. CP, cortical plate; IZ,
intermediate zone; MZ, marginal zone; SVZ, subventricular zone; VZ, ventricular zone. Scale bar equals 100 m.
In conclusion, overexpression of MSY3 did neither maintain or revert progenitors to
undergo proliferative instead of neurogenic divisions. Because virtually all neurons derived
from targeted cells also express MSY3 from the ubiquitous CAGGS promoter used in this
experiment, it suggests that maintained expression of this protein did not interfere with
neuronal differentiation and/or their response to environmental cues which guide
migration.
2.4 MSY3 expression in progenitor cells in neurospheres
Isolated progenitor cells derived from the embryonic neuroepithelium or from adult
germinal zones can proliferate in vitro in a presence of bFGF or EGF as free-floating
aggregates called neurospheres (Gritti et al., 1999; Gritti et al., 1996; Reynolds and Weiss,
1996), which consist of relatively rare stem cells and fast proliferating but more restricted
transient amplifying cells (Reynolds and Rietze, 2005). Neurospheres may be dissociated and
subcultured repeatedly, this feature being used to evaluate the maintenance and expansion
of neural stem and progenitor cells. Thus, the neurosphere assay offers an alternative, and
due to prolonged culture time more sensitive, method to address the role of MSY3 in
maintenance and proliferation of progenitor cells.
Expression of MSY3 was analysed by immunofluorescence in EGF-dependent
neurospheres derived from the postnatal brain (P1). During growth, the neurosphere
acquires a three-dimensional structure with proliferating cells present towards the edge,
whilst more differentiated cells are found in the centre, along with apoptotic and necrotic
cells (Campos, 2004; Lobo et al., 2003). Neurospheres after several passages were grown for
2, 3 and 5 days, and immunostained for MSY3 (Figure 27), as well as markers for
progenitors (nestin), astrocytes (GFAP) and neurons ( III-tubulin and neurofilament-160)
(Figure 27; Figure 28). While most of cells expressed MSY3 after 2 days of culture (Figure
27 A,C), only a subset of cells at the periphery are immunoreactive in spheres grown for
5 days (Figure 27 E,G). Neurospheres grown for 3 days exhibited a transition pattern (not
shown). Strongly positive cells were found mainly on the surface of neurospheres. Strikingly
similar pattern of expression was observed for nestin (Figure 27 B,F), yet not all nestin
positive cells were also immunoreactive for MSY3 (Figure 27 C,G). Additionally, MSY3 was
found in some, but not all, mitotic figures (Figure 27 A,D; and Figure 28 B; arrows and
arrowheads, respectively).
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Figure 27. MSY3 is expressed in nestin positive progenitors in neurospheres. Neurospheres were grown in
EGF-supplemented medium for 2 (A-D), and 5 days (E-F), and stained in suspension for MSY3 (A,E) and nestin
(B,F). Nuclei are visualised with DAPI (D,H, cyan). After 2 days, most of cells in the neurosphere are nestin positive
progenitors, and after 5 days they become restricted to the periphery. MSY3 expression exhibits a similar pattern and is
absent from differentiated and apoptotic cells residing in the centre of older neurospheres. Moreover, it can be
observed in some mitotic figures (arrow). Images are single optical sections (1 m) through the middle of a
neurosphere. Scale bar equals 20 m.
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Figure 28. MSY3 is not expressed in differentiated cells in neurospheres. (A-B”) Neurospheres were grown in
EGF-supplemented medium for 3 days and stained for MSY3 and GFAP; or (C-E”) for 5 days and stained for MSY3
and III-tubulin, as indicated. Nuclei are visualised with DAPI (blue). (B-B”), (D-D”), and (E-E”) are enlargement of
the areas boxed in (A) and (C). MSY3 is largely excluded from GFAP positive astrocytes and III-tubulin stained
neurons, though adjacent cells show strong MSY3 expression. Arrows and arrowheads indicate two mitotic figures,
which show variable levels of the MSY3 immunoreactivity. Images are single optical sections (1 m) through the middle
of a neurosphere. Scale bars equal 20 m.
Expression of MSY3 was also largely excluded from GFAP-positive astrocytes (Figure
28 A-B”) and neurons (Figure 28 C-E”), the latter present only in neurospheres cultured
for 5 days. These data implicate that MSY3 is associated with proliferating progenitor cells
not only in vivo, but also in vitro.
2.4.1 Knockdown of MSY3 in neurospheres
In order to downregulate MSY3 in neurospheres, RNAi triggered by small hairpin RNAs
(shRNAs) was employed. To maintain high expression of interfering RNAs and achieve
efficient knockdown in proliferative cells, hairpins were expressed in a context of natural
microRNA precursor sequences (mir-30). Such a strategy allows proper processing by
Drosha and Dicer and yields higher levels of silencing compare to conventional shRNAs
(Dickins et al., 2005; Silva et al., 2005). Interfering RNAs complementary to the MSY3
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mRNAs at position 647, 1077 and 1363 were chosen, the last one being located in the
3’UTR (Figure 29 A). To evaluate their performance, hairpin constructs driven by the U6
promoter were transiently transfected into Neuro-2A cells, which endogenously express
MSY3. Immunoblotting of protein extracts prepared 2 days post-transfection revealed that
expression of hairpins MSY3-1077 and MSY3-1363 resulted in efficient depletion of MSY3
(Figure 29 B), whereas expression of the control luciferase hairpin or the GFP plasmid
alone did not affect the expression levels of MSY3.
Figure 29. shRNAs design and performance. (A) Scheme depicts the positions of shRNAs target sites on the MSY3
message. (B) Protein lysates from Neuro-2A cells transiently transfected with a GFP plasmid alone (lane 1), with MSY3
shRNAs as shown in (A) (lanes 3-5), or with control luciferase shRNA (lane 2), were analysed by immunoblotting for
MSY3 expression. Hairpins 1077 and 1363 (lanes 4 and 5) triggered efficient knockdown of the MSY3 protein 2 days
after transfection. Ponceau S staining of the same membrane shows equal protein loading.
MSY3-1077, -1363 and luciferase shRNAs were inserted into the pAAV-hrGFP
plasmid. This plasmid contains hrGFP, a codon optimised green fluorescent protein derived
from Renilla and distinct from the GFP protein commonly used, which serves as a lineage
tracer. In a preliminary experiment these constructs were transfected into neurospheres
grown for 1 day. 3 days after transfection, neurospheres were fixed, stained for MSY3 along
with nestin, GFAP or III-tubulin/NF-160 lineage markers and examined by confocal
microscopy (Figure 30). Approximately 23% of control transfected cells were positive for
MSY3 (n=119 cells; 10 neurospheres) (Figure 30 A-D, arrow), whereas only 3% of cells
transfected with MSY3-1363 shRNA construct (n=162 cells; 8 neurospheres) showed
MSY3 immunofluorescence, which was never strong, indicating high efficiency of silencing
(Figure 30 E-H, arrowheads). Some of cells transfected with MSY3-1077 shRNA were
positive for MSY3 and therefore not included in further analysis.
Double labelling for nestin and MSY3 (Figure 30 A-H) revealed that a large proportion
of control transfected and targeted cells comprises nestin positive progenitors (control 89%,
n=46 cells of 4 neurospheres; MSY3 knockdown 69%, n=91 cells of 4 neurospheres), and
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in the control transfection almost half of them was also positive for MSY3 (48%). MSY3
positive but nestin negative cells were not detected, in agreement with previous
observations that MSY3 labels a subpopulation of progenitor cells. GFAP stains mostly
cellular processes, which complicates colocalisation analysis. Nevertheless, 29 and 18% of
transfected cells in control and MSY3 knockdown neurospheres, respectively, appeared
positive for GFAP (control n=73 cells of 6 neurospheres; MSY3 knockdown n=71 cells of
5 neurospheres). All GFAP positive astrocytes were negative for MSY3 (Figure 30 I-P).
Since EGF-dependent neurospheres do not generate many neurons, 3 days after
transfection very few neurospheres contained single III-tubulin positive cells in both
experimental conditions.
Figure 30. MSY3 knockdown in neurospheres. Neurospheres were transfected with the pAAV-hrGFP vector carrying
either (A-D  and I-L) luciferase shRNA as a control, or (E-H  and M-P) MSY3 shRNA-1363, and were stained for
MSY3 and nestin (A-H) or GFAP (I-P) three days post-transfection. Transfected cells are identified by hrGFP
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expression. (A-H) A subset of control transfected cells is double positive for nestin and MSY3 (arrow), whereas
MSY3-1363 targeted cells do not show MSY3 immunostaining (arrowheads). (I-P) GFAP positive transfected cells do
not express MSY3 and are observed in the control and after MSY3 knockdown (empty arrows and arrowheads). Images
are single optical sections (1 m) through the middle of neurospheres. Scale bar equals 20 m.
This experiment demonstrates that using designed strategy it is possible to transfect
progenitor cells and downregulate MSY3 in neurospheres. Differences in ratios of nestin
and GFAP positive cell populations between the control and MSY3 knockdown are likely to
account for by a variability observed among neurospheres and a relatively small number of
spheres analysed. Nonetheless, MSY3 knockdown did not induce neuronal differentiation in
the neurospheres cultured in presence of EGF.
2.5 Expression of MSY3 in the postnatal brain
Generation of new neurons persists in the adult brain in the SVZ (subventricular zone)
of the lateral ventricle and in the hippocampal dentate gyrus. Since MSY3 is present in
neurospheres derived from the postnatal brain, it is likely that also in vivo progenitors in the
adult neurogenic regions express MSY3. To test this hypothesis, the expression pattern of
MSY3 was investigated by immunostaining in brains obtained from heterozygous
Tis21-GFP mice at different time points after birth.
In both germinal niches, cells along the lineage from stem cells to differentiated neurons
express different set of molecular markers. The putative astrocytic stem cells show staining
for GFAP, as well as for nestin and vimentin (Doetsch et al., 1997; Kronenberg et al., 2003;
Seri et al., 2001). Transient amplifying neuronal precursors are initially nestin positive, but
with lineage progression exhibit increasingly differentiated phenotypes, namely expression
of microtubule binding protein doublecortin (Dcx) and polysialylated neural adhesion cell
molecule (PSA-NCAM), followed by loss of nestin (Brown et al., 2003; Doetsch et al., 1997;
Kronenberg et al., 2003; Seri et al., 2004). Expression of doublecortin is downregulated
when cells are acquiring the mature phenotype (Brown et al., 2003).
Shortly after birth, expression of MSY3 was detected neither in the SVZ (Figure 31 A-C)
nor in the dentate gyrus (Figure 32 B). However, at the end of the second postnatal week
(P13), MSY3 became reexpressed in both germinal zones (Figure 31 E; Figure 32 E) and
persisted until adulthood (P5W) (Figure 31 H; Figure 32 K).
In the SVZ, MSY3 was detected in clusters of cells above the ependyma, and almost
entirely overlapped with Dcx, indicating that it is expressed in transient amplifying
precursors. Since no Dcx-negative and MSY3-positive cells close to the ventricle could be
detected, MSY3 is not present in the SVZ astrocytes, which do not stain for Dcx (Brown et
al., 2003). Furthermore, MSY3 was largely excluded from Tis21-GFP positive cells.
Postnatally, the Tis21-GFP expression labels a subpopulation of Dcx-positive precursors at
their terminal divisions and is inherited by newborn neurons (Allessio Attardo and Klaus
Fabel, personal communication). Interestingly, the pattern of MSY3 expression coincides
with anatomical transition between the embryonic ventricular zone and the adult SVZ
(Tramontin et al., 2003). At birth, radial glia are still present in the ventricular zone of the
lateral ventricle and continue to generate neurons. Accordingly, radially arrayed progenitors
in the ventricular zone of P4 mice were positive for Sox2 transcription factor, which is
expressed in VZ progenitor cells (Figure 31 C) (Ferri et al., 2004). Lack of MSY3 in the
postnatal VZ is consistent with its downregulation in radial glia during embryonic
development. However, during the next two weeks radial glia progressively transform into
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ependymal cells and astrocytes, and the adult anatomy of the SVZ is established (Tramontin
et al., 2003).
Figure 31. MSY3 is expressed in transient amplifying precursors in the adult SVZ. Coronal sections through the lateral
ventricle derived from heterozygous Tis21-GFP mice at different time points after birth were stained for MSY3 and a
progenitor cell marker Sox2 or doublecortin (Dcx), as indicated in the figure. (A-C) At day 4, Sox2 is expressed by
radial glia progenitors in the remaining VZ, however, MSY3 is not expressed at this age. (D-F) At day 13, MSY3 is
coexpressed with Dcx, which marks transient amplifying precursors and young neurons. Only few MSY3 positive cells
express Tis21-GFP. (G-I) At 5 weeks the number of MSY3/Dcx-positive cells decreased and does not overlap with
Tis21-GFP. v, ventricle; arrowheads, unspecific fluorescence of blood vessels. Images are single optical sections (1 m).
Scale bars equal 50 m.
In the dentate gyrus, similarly as in the SVZ, MSY3 was detected in the Dcx-labelled
transient amplifying precursors (Figure 32 D-L), being downregulated in cells expressing
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Tis21-GFP. The appearance of MSY3 positive cells also coincides with establishment of the
adult hippocampal germinal zone (Altman and Bayer, 1990a).
Figure 32. MSY3 is expressed in transient amplifying precursors in the dentate gyrus. Coronal sections of the
hippocampus derived from heterozygous Tis21-GFP mice at different time points after birth were stained for MSY3
and doublecortin (Dcx), as indicated in the figure. Stem cells of the dentate gyrus reside at the base of the granular cell
layer (GCL) forming the subgranular zone (SGZ). In the GCL the newborn cells localise interiorly, whereas earlier born
cells are found on the outside. (A-C) During the first postnatal week, progenitor cells from the embryonic SVZ migrate
Results
69
to the dentate gyrus to populate the hilus (h) and SGL, and granule cells undergo differentiation. MSY3 is not detected
at this time point. (D-L) During following weeks, MSY3 becomes expressed in Dcx-positive cells (D-I) and persist until
the adulthood (J-L). MSY3 and Tis21-GFP expression patterns are largely exclusive, particularly in older animals. h,
hilus; arrowheads, unspecific fluorescence of blood vessels. Images are single optical sections (1 m). Scale bars equal
20 m.
At two weeks some of the Tis21-GFP expressing cells were positive for MSY3 in both
neurogenic regions (Figure 31 E, Figure 32 E), however, with time these populations
became exclusive (Figure 31, Figure 32 H,K). To summarise, MSY3 is expressed in
proliferating transient amplifying precursors in the adult neurogenic zones and is
downregulated as cells are entering a differentiation program. The abundance of labelled
cells decreased with time, which is in agreement with the decrease of neuronal production
with age (Emsley et al., 2005).
Surprisingly, during the first two postnatal weeks MSY3 was transiently re-expressed in
the pyramidal neurons in the neocortex (Figure 33 A-D) and CA fields of the hippocampus
(data not shown). It is important to note that until E18 cortical neurons are negative for
MSY3 (Figure 9; Figure 12 J; data not shown). Eventually, in juvenile (P3W) and adult
(P6W) brains MSY3 was not detected (Figure 33 E, F; data not shown).
Figure 33. MSY3 is transiently expressed in cortical neurons after birth. Coronal sections through the frontal cortex
derived from heterozygous Tis21-GFP mice at different time points after birth were stained for MSY3 (red), nuclei were
visualised with DAPI (blue). (A,B) and (C,D) MSY3 is expressed in pyramidal neurons during two first postnatal weeks.
(E,F) In the adult cortex, MSY3 is not detected. Dorsal is up. Images are single optical sections (1 m). Scale bar equals
50 m.
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2.6 Biochemical characterisation of MSY3
2.6.1 MSY3 is recovered in RNase A-sensitive complexes
Since MSY3 was detected solely in the cytoplasm applying immunostaining (Figure 22;
Figure 23), its subcellular localisation was further analysed by differential centrifugation.
Fractions enriched in nuclei (NE), mitochondria and membranes (P15),
polysomes/ribosomes and microsomes (P100), and cytosol (S100) were prepared from
E10.5 embryonic brains or whole embryo homogenates, and analysed by immunoblotting
for MSY3. Most of the MSY3 protein was found in the P100 fraction and only small
amounts were detected in other fractions, indicating that MSY3 is included in a large
complex in the cytoplasm (Figure 34 A).
Figure 34. Subcellular distribution of MSY3 protein upon fractionation of homogenate prepared from E10.5 mouse
embryos depends on RNA integrity. Homogenate from (A-B) whole embryos, or (C) embryonic brains at E10.5, was
subjected to differential centrifugation to yield fractions enriched in nuclei (NE), membranes and mitochondria (P15),
microsomes, ribosomes and polyribosomes (P100), and cytosol (S100). An equal proportion of each fraction was
analysed by immunoblotting for MSY3 and in (C) for ZO-1. (A) MSY3 is recovered mostly in the P100 fraction. (B)
Upper panel: treatment of the postmitochondrial supernatant (S15) with 1 mg/ml RNase A at 37ºC in absence or
presence of 25 mM EDTA, but not with EDTA alone, released MSY3 to the S100 supernatant; bottom panel: the
postmitochondrial supernatant was treated with 0.5 M NaCl, 2% Triton X-100, or 25 mM EDTA at 4ºC; only high salt
affects sedimentation of MSY3 into the P100 fraction. (C) The P100 pellet was treated with RNase A at 4ºC, resulting
only in partial release of MSY3 into the supernatant. ZO-1, which is also recovered in the P100 fraction, is not affected
by the RNase A treatment.
Given that MSY3 is pelletable upon ultracentrifugation, the question arises about the
nature of the MSY3-containing complexes. Y-box proteins are characterised as translational
regulators, and the P100 fraction contains various ribonucleoprotein particles (RNPs). In
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the cytoplasm, translationally silenced mRNA is associated with non-ribosomal particles
(free mRNPs), whereas translationally active mRNA species are associated with ribosomes.
To test directly whether sedimentation of MSY3 in the P100 fraction depends on RNA, the
postmitochondrial supernatant (S15) was treated with RNase A or EDTA and
ultracentrifuged. Immunoblot analysis showed that after the RNase A treatment at 37ºC
virtually all MSY3 protein is recovered in the supernatant, which was not altered by
presence of EDTA (Figure 34 B). The RNase A treatment at 4ºC releases only 30-50% of
MSY3 into the supernatant (Figure 34 C), suggesting that at the physiological temperature
the enzyme is more active or that unwinding of RNA exposes it to the cleavage. The control
incubation at 37ºC in the absence of RNase A did not affect MSY3 sedimentation (Figure
34 A,B). Moreover, the distribution of ZO-1, which was also found in the P100 fraction was
not perturbed by the RNase A treatment (Figure 34 C). MSY3 was released in the
supernatant also upon a treatment with high salt (0.5 M NaCl) (Figure 34 B), which disrupts
many protein-protein interactions and releases majority of proteins from mRNA, but
preserves polysomes (Auerbach and Pederson, 1975; Corbin et al., 1997; Kumar and
Lindberg, 1972). On the contrary, in a presence of EDTA, which dissociates ribosomes into
subunits, thus releases mRNA from polysomes (Henshaw, 1968), MSY3 remained in the
P100 fraction (Figure 34 B). Distribution of MSY3 into the P100 fraction was also resistant
to 2% Triton X-100 solubilisation (Figure 34 B), suggesting that sedimentation of MSY3
was not due to association with membranes.
2.6.2 MSY3 co-fractionates with translating ribosomes
To further characterise the MSY3-containing complexes, the embryo postmitochondrial
supernatant was fractionated on a sucrose gradient and fractions were analysed for MSY3 by
immunoblotting (Figure 35). MSY3 was distributed in fractions 3 to 8 from the top of the
gradient (Figure 35 A). Ribosomal RNA showed similar distribution, suggesting that some
of the MSY3 protein is associated with polysomes. In agreement with this hypothesis, in
response to the EDTA treatment MSY3 shifted to lighter fractions, alike ribosomal RNA
(Figure 35 B). Upon the RNase A digestion MSY3 was found free floating on the top of the
gradient (Figure 35 C). The RNA digestion was not complete under this condition, as short
RNA species could be detected in fractions 3-6. Notably, MSY3 was found in
corresponding fractions, whereas complete digestion of RNA results in a complete shift into
a soluble fraction (see Figure 34 B; and data not shown). Because RNase A cleaves single
stranded RNA, these partly protected RNA species must be highly structured or assembled
with proteins and likely represent ribosomal RNA (Auerbach and Pederson, 1975),
suggesting that in this fractions MSY3 turns to be associated with rRNA. Such unspecific
interaction was already reported for YB-1 (Nekrasov et al., 2003).
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Figure 35. MSY3 co-fractionates with ribosomal/polyribosomal fractions. The postmitochondrial supernatant from
E10.5 embryos was centrifuged on a 15-50% linear sucrose gradient. Fractions 1 to 12 were collected from the top to
the bottom and equal proportions of each fraction and the pellet (P) were analysed by immunoblotting with an antibody
against MSY3 (upper panels, arrows). Extracts were prepared (A ) in a presence of Mg2+, or pre-treated with (B)
25 mM EDTA, or (C) 1 mg/ml RNase A. Bottom panels show the ethidium bromide staining of RNA extracted from
each fraction. The position of prestained apparent molecular markers is indicated.
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In order to confirm polysomal association of MSY3, the translation process was
disrupted with puromycin, which causes premature chain termination by acting as an
analogue of the 3’ terminal end of aminoacyl-tRNA and thereby inhibits protein synthesis.
Neuro-2A cells or embryos in whole embryo culture were treated with puromycin for 3 and
4 h, respectively, and postmitochondrial supernatant obtained from them was fractionated
on a sucrose gradient. Immunoblotting analysis revealed that after the puromycin treatment,
MSY3 partly shifted from heavy to lighter fractions in Neuro-2A cells and to a lesser extent
in embryos (Figure 36). Similar shift was observed for the S6 ribosomal protein and for
ribosomal RNA, and also after the EDTA treatment of Neuro-2A cells. Such a behaviour is
characteristic for proteins associated with actively translating ribosomes (Stefani et al.,
2004). It is likely that the puromycin treatment of embryos was less effective because
penetration of the drug into tissue is not as efficient as in monolayer of cultured cells.
Additionally, embryos cultured in a presence of puromycin showed bloody effusions and
slower heartbeat than in the control, indicating toxicity, which did not permit longer
incubation times. Interestingly, in control Neuro-2A cells, the MSY3 distribution is bimodal
with two peaks corresponding to a large ribosome/large mRNP fractions (fractions 2-3) and
to small polyribosomes (fraction 6). This phenomenon was not observed in the embryo.
Thus, MSY3 in the neuroepithelium, as well as in the neuroblastoma cell line, is partly
associated with translating ribosomes, suggesting the role in regulation of translation.
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Figure 36. MSY3 associates with actively translating polyribosomes. (A) Neuro-2A cells, or (B) E10.5 embryos, were
cultured in control conditions or treated with 100 g/ml puromycin for 3 and 4 h before lysis, and analysed on sucrose
density gradients as in Figure 35. Immunoblotting was performed with antibodies against MSY3 and the ribosomal
protein S6. In (A) a sample pre-treated with 25 mM EDTA is shown as a control.
2.6.3 MSY3 co-immunoprecipitates with RNA and YB-1
To investigate what RNA species and proteins are associated with MSY3,
immunoprecipitation was employed. The MSY3 protein was immunoprecipitated from
Neuro-2A cells or E9.5 embryos in a presence of Mg2+ or EDTA with the GP2 antiserum
against MSY3, but not with a control serum (Figure 37 A). Remarkably, the MSY3 antibody
precipitated also RNA in both treatment conditions (Figure 37 B). Most of RNA detected in
the MSY3 immunoprecipitate constitutes ribosomal RNA, but a smear on the gel suggests a
presence of mRNA. However, after addition of EDTA, partial degradation of RNA was
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observed, also in the unbound fraction. It is plausible that EDTA renders RNA susceptible
to RNases by opening its secondary structure and disrupting association with proteins.
Figure 37. MSY3 co-immunoprecipitates with RNA and YB-1. MSY3 was immunoprecipitated from Neuro-2A cell
lysate in a presence of Mg2+ or EDTA. (A) 10% of bound fractions (IP) and 3% of unbound and input protein lysate
were analysed by immunoblotting for MSY3, eIF4E, and S6 ribosomal protein, or under the same experimental
conditions for YB-1, as indicated. YB-1 can be co-immunoprecipitated with MSY3. Arrows indicate analysed proteins;
asterisks mark unspecific bands of IgG; diamond points to an unspecific band recognised by all antibodies after longer
exposure times; brackets indicate unspecific bands recognised by secondary antibodies after use of protein A sepharose.
(B) Ethidium bromide staining of RNA extracted from 50% of bound fractions and 5% of the unbound and input
lysate. MSY3 co-imunoprecipitates with RNA, in particular with rRNA. A smear and low molecular bands visible in
EDTA-treated samples likely result from partial degradation of RNA. (C ) YB-1 was immunoprecipitated from
Neuro-2A cell lysate and analysed as in (A). A weak band corresponding to the molecular weight of MSY3 can be
detected. The position of prestained molecular marker is indicated on the left.
After immunoprecipitation of MSY3 from 40 embryos (3 litters) in a presence of Mg2+,
4 g of RNA could be recovered from the bound fraction, which constitutes approximately
2.8% of the input. Efficiency of RNA co-immunoprecipitation suggests that i) MSY3
associates with ample rRNA species by direct or indirect association with ribosome itself, or
it binds to a large range of mRNAs; and ii) MSY3 is an abundant protein. In support for the
latter notion, similar amounts of RNA could be recovered from bound fractions after
immunoprecipitation of MSY3 and YB-1 (data not shown), an mRNPs major protein
present in the cell in molar amounts similar to ribosomal proteins (Davydova et al., 1997).
MSY3 also co-immunoprecipitates with YB-1, and this association was weaker in a presence
of EDTA (Figure 37 A,C), suggesting it is mediated primarily by binding to the same RNA
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molecule, possibly mRNA, further supporting the hypothesis that MSY3 is involved in
translation. Surprisingly, neither ribosomal protein S6 or eIF4E were detected in the MSY3
immunoprecipitate (Figure 37 A). The question whether MSY3 binds RNA directly and
what are its target messages awaits further investigation.
2.6.4 Manipulation of MSY3 levels does not influence total translation rates
To determine if levels of MSY3 would affect the rate of total protein synthesis, MSY3
was downregulated or elevated in Neuro-2A cells by transient transfection of esiRNAs or
the MSY3 expression plasmid, respectively (Figure 38 A,B). 48 h post-transfection, the total
protein synthesis rate was measured by quantifying the incorporation of 35S-labelled amino
acids for 10, 20 and 30 min. As presented in Figure 38, neither knockdown nor upregulation
of MSY3 affected global translation.
Figure 38. Manipulating the MSY3 protein levels does not affect global protein synthesis rates. Neuro-2A cells were
either mock transfected or transfected with MSY3 esiRNAs or MSY3 expression plasmid and analysed 48 h
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post-transfection by: (A) immunofluorescence; (B) immunoblotting with antibody against MSY3. In (A) the upper left
panel shows staining without the primary antibody. In (B) two exposures (10 s and 30 s) of the same membrane are
shown. (C-E) Neuro-2A cells were pulse-labelled with 35S for 10, 20 and 30 min and protein extracts were analysed by
12% SDS-PAGE and radiography (C); (D) shows Coomassie stain of the same gel. M, the molecular weight markers.
(E) Quantification of the radiogram shown in (C); an arbitrary value 1.0 was attributed to the signal in the first lane,
bars represent relative intensity of the signal normalised to the amount of loaded protein quantified after Coomassie
staining.
2.6.5 Developmental downregulation of the MSY3 protein is not shared by all
proteins involved in translation regulation
With increased cell cycle length and differentiation, which occur in the course of
neurogenesis, it is plausible that neuroepithelial cells downregulate their translational
apparatus and protein synthesis rates. Hence, downregulation of MSY3, which coincides
with these processes, might be a general feature of the translational machinery. To evaluate
this hypothesis, developmental profile of expression of some other proteins involved in
translation was analysed, namely eukaryotic initiation factor 4E (eIF4E), Y-box protein 1
(YB-1/p50) and fragile X mental retardation protein (FMRP). eIF4E is a limiting factor for
translation initiation and its level, as well as the phosphorylation state, are tightly coupled
with cellular need for protein synthesis, therefore it is a good sensor for monitoring the state
of the translation machinery in context of proliferation and differentiation. FMRP is an
RNA binding protein, which acts as a translational repressor, possibly in the microRNA
pathway. The loss of the fmr1 gene, which encodes the FMRP protein, results in defective
neuronal differentiation and in vitro in increased neuronal production at the expense of glia
(Castren et al., 2005). Its function is indispensable for neurons, though FMRP is also highly
expressed in progenitors (Abitbol et al., 1993). In patients, absence of FMRP protein causes
mental retardation (fragile X syndrome) (Bagni and Greenough, 2005; Khandjian et al.,
2004). YB-1 was included in the analysis as another member of the Y-box family.
Interestingly, expression of these proteins was not downregulated during development
(Figure 39).
Figure 39. Developmental expression of eIF4E, YB-1 and FMRP in the mouse embryo. 40 g of protein lysates
prepared from embryos at indicated developmental stages was analysed by immunoblotting with antibodies against
eIF4E, YB-1 and FMRP, as indicated. Equal amount of protein lysates from various cell lines were loaded as a control.
The position of prestained apparent molecular weight markers is shown.
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3 DISCUSSION
The aim of this work was to understand whether MSY3 could play a role in formation of
the nervous system, particularly in maintenance of proliferation of neural progenitors. It is
illustrated here that the expression of the MSY3 protein is related to proliferative divisions
of neuronal precursors in embryogenesis, but also in the adult brain. The presented work
provides some hints as to possible role of MSY3 in neural progenitors.
3.1 Expression of MSY3 in the central nervous system coincides
with proliferation
3.1.1 MSY3 expression is downregulated in spatiotemporal correlation with
neurogenesis
It has been shown here that the MSY3 protein in the developing CNS is associated
solely with progenitor cells and not neurons. Firstly, the protein is abundantly expressed in
the neuroepithelium before the onset of neurogenesis (Figure 10; Figure 14). Secondly, after
the onset of neurogenesis, MSY3 is confined to the ventricular zone, but absent from
neuronal layers (Figure 9). Thirdly, in acutely dissociated cells it is restricted to
nestin-positive progenitors (Figure 11).
In the course of neurogenesis, neuroepithelial cells switch from proliferative to
neurogenic divisions, and the proportion of the latter is progressively increasing (Cai et al.,
2002; Haubensak et al., 2004; Takahashi et al., 1996). Concurrently, expression of MSY3
declines, which was shown by two independent approaches: morphologically, i.e. using
immunofluorescence and confocal microscopy, and biochemically. Specifically, it was
revealed that the reduction of MSY3 expression proceeds with known gradients of
neurogenesis: i) from caudal to rostral along the anteroposterior axis of the brain (Figure 12;
Figure 14); ii) from ventral do dorsal (Figure 13); iii) in the telencephalon from rostrolateral
to caudomedial (Figure 17); iv) in the cortical hem prior to other regions (Figure 15). In
addition, by E12.5 MSY3 was absent from specialised regions of the neural tube, namely the
floor plate, the roof plate, and the choroid plexus epithelium, which are largely composed of
non-proliferating cells (Figure 15). In contrast, highly proliferative neuroepithelium
immediately adjacent to these areas is strongly positive for MSY3. Thus, a general pattern of
MSY3 expression coincides with proliferative divisions of neuroepithelial cells.
Nonetheless, at the beginning of neurogenesis MSY3 did not appear to be
downregulated in neurogenic progenitors compare to proliferative ones at a single cell
resolution (Figure 16). Expression of MSY3 was examined by confocal microscopy using
Tis21-GFP heterozygous knock-in embryos, in which GFP expression marks cells that
generate neurons (Haubensak et al., 2004). However, this analysis had large technical
limitations and in this regard is only preliminary. First, progenitor cells are highly elongated
and juxtaposed in the ventricular zone, consequently immunostaining of only little portion
of the cytoplasm surrounding the nucleus could be estimated, neglecting the apical and basal
processes. Second, confocal microscopy does not allow quantifying the real intensity of
immunostaining, because of its narrow range of light detection for any given settings. Third,
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lateral scattering and unequal penetration of antibodies in a tissue section cause more
superficial optical slices to appear brighter than deeper ones, therefore, are also interfering
with the estimation. This important question could be addressed more profoundly by FACS
analysis.
3.1.2 MSY3 is downregulated upon the switch from neuroepithelial to radial glia cells
Neural progenitor cells pass through stereotyped patterns of gene expression during
development, and distinct antigenic profiles are characteristic of particular developmental
stages and progenitor types (Anthony et al., 2004; Gotz and Huttner, 2005; Hartfuss et al.,
2001; Malatesta et al., 2003). It was shown here that the MSY3 downregulation parallels the
developmental progression of GLAST induction (Figure 17). Since the onset of BLBP and
GLAST expression defines the transition from neuroepithelial cells to radial glia, MSY3
appears to be specifically downregulated in radial glia.
3.1.3 MSY3 is downregulated at the onset of Notch signalling activation
It has been presented here, using the transgenic Hes5-GFP mouse line, in which GFP
expression is dependant on active Notch signalling (Basak and Taylor, 2006), that MSY3 is
reduced concomitantly with the initiation of Notch signalling (Figure 18). Furthermore,
such downregulation was observed also in individual cells (Figure 19).
Neuroepithelial cells during development change their dependence on Hes genes and
Notch signalling. Neural induction and initial expansion of the neuroectoderm occurs in
absence of both. At E7.5 in mouse, i.e. at the neurula stage, the neuroepithelium starts to
express Hes1 and Hes3, while Noch1 is absent (Hatakeyama and Kageyama, 2006; Hitoshi et
al., 2004). Around E8.5 Hes3 expression is gradually downregulated in a ventral to dorsal
gradient, which corresponds to induction of Notch1, its ligand Dll1, and Hes5 (Allen and
Lobe, 1999; de la Pompa et al., 1997; Hatakeyama et al., 2004; Hatakeyama and Kageyama,
2006; Hitoshi et al., 2004). Thus, early progenitor cells proceed from Notch- and
Hes-independent, to Notch-independent and Hes-dependent, and finally Notch- and
Hes-dependent characteristics. This sequence was recapitulated also in vitro (Hitoshi et al.,
2002; Hitoshi et al., 2004). Once induced, Notch promotes, and is necessary for, progenitor
maintenance (Kageyama et al., 2005; Louvi and Artavanis-Tsakonas, 2006). However, loss
of Hes genes, which is accompanied by precocious neurogenesis, is associated also with
accelerated Notch1 expression (Hatakeyama and Kageyama, 2006), and active Notch not
only supports progenitor maintenance, but also transforms them into later progenitor type,
radial glia (Dang et al., 2006; Gaiano et al., 2000). In addition, expression of BLBP, a radial
glia marker, is dependent on Notch signalling (Anthony et al., 2005; Patten et al., 2006).
Therefore it has been suggested that Notch signalling is associated with the switch of
neuroepithelial cells from proliferative to asymmetric divisions, and necessary for
progenitors while neurogenic cues are present (Hatakeyama and Kageyama, 2006).
Downregulation of MSY3 expression in the ventricular zone is not complete and
progenitors maintain medium to low levels of MSY3 labelling throughout the neurogenic
period. Comparison of MSY3 immunofluorescence with Hes5-GFP at a single cell
resolution after the onset of neurogenesis did not reveal the correlation between the MSY3
expression and Notch signalling (Figure 20). During the neurogenic period, Notch signalling
is essential for the maintenance of progenitors and inhibition of neurogenesis (Alexson et
al., 2006; de la Pompa et al., 1997; Lütolf et al., 2002). Furthermore Hes5-GFP negative
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progenitors are not capable of self-renewal in vitro (Basak and Taylor, 2006), hence
Hes5-GFP expression is likely to be a marker of self-renewing progenitors. This would
suggest that medium versus low levels of the MSY3 protein are not indicating whether
progenitor cells undergo self-renewing divisions or terminal symmetric neurogenic divisions.
Nevertheless, it is not formally excluded that Hes5-GFP-negative, but MSY3-positive
progenitors undergo Notch-independent self-renewing divisions, for example by virtue of
expressing Hes1 under the control of Wnt signalling (Issack and Ziff, 1998).
Consistently, MSY3 expression was not affected in Notch1-deficient progenitors in the
cerebellar primordium (Figure 21), which prematurely express markers of neuronal
commitment, i.e. Mash1 and Math1 proneural genes, Notch ligands Dll1 and Dll3, as well as
Tis21-GFP (Lütolf et al., 2002). However, these progenitors do not differentiate into mature
neurons, but instead commit programmed cell death (Lütolf et al., 2002).
Altogether, downregulation of MSY3 concomitantly with Notch activation is coherent
with its reduction in radial glia and switch of ventricular zone progenitors to asymmetric
divisions. After this transition, the level of MSY3 seems not to distinguish between
neurogenic asymmetric and terminal divisions, identified by the lack of Hes5-GFP, but also
by expression of Tis21-GFP. However, these analyses were performed at E11.5, when
majority of cells still expresses MSY3; it is plausible that at later time points such a
correlation exists.
3.1.4 Expression of MSY3 after the onset of neurogenesis
Although there are differences in the MSY3 immunolabelling intensity between
individual cells, brightly labelled progenitors are rare in the ventricular zone from
E12.5-E13 onwards (Figure 12). Since throughout the neurogenic period a pool of
progenitors undergoes symmetric proliferative divisions (Cai et al., 2002; Haubensak et al.,
2004; Miyata et al., 2004), the association of MSY3 with proliferation appears questionable.
However, several studies employing retroviral labelling and time lapse microscopy showed
that after the onset of neurogenesis the ventricular zone is a mosaic of specialised precursor
cells and relatively infrequent multipotent stem cells. Already at E9.5 many of ventricular
zone progenitors seem to be restricted to glial or neuronal fates (McCarthy et al., 2001). In
the telencephalon, there is no significant number of progenitors that would undergo
symmetric proliferative divisions for several cell cycles as very few large clones can be
retrovirally labelled during the early and mid- phase of neurogenesis (Cai et al., 2002;
Halliday and Cepko, 1992; Walsh and Cepko, 1988; Walsh and Cepko, 1992; Walsh and
Cepko, 1993), and the size of clones decreases with time (Cai et al., 2002). Similarly, in time
lapse studies of organotypic slice cultures from embryos in mid- to late neurogenesis, it was
revealed that a relatively small fraction of progenitors (21-23%) undergoes symmetric
proliferative divisions with both daughter cells staying in the ventricular zone (Miyata et al.,
2001; Miyata et al., 2004; Noctor et al., 2004). Furthermore, in vitro, less than 10% of E10
progenitors are stem cells, which generate more restricted precursor cells attributed to glial
or neuronal lineages; moreover, this capability is reduced with developmental progression
(Davis and Temple, 1994; Qian et al., 1998; Qian et al., 2000).
All told, proliferative progenitor cells before and after the onset of neurogenesis seem
not equivalent, and this change in potential is accompanied by downregulation of MSY3.
Other parameter that is not equal between the proliferative fraction of early progenitors, i.e.
before and at the onset of neurogenesis, and in the mid-neurogenesis is the cell cycle length,
which increases by approximately 36% from E10.5 until E14.5 (Calegari et al., 2005a).
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Therefore, it could be concluded that a high level of MSY3 expression marks a fast
proliferating sub-population of symmetrically dividing progenitors. Figure 40 summarises
the relation of MSY3 expression in a lineage of progenitor cells in the developing CNS.
Figure 40. MSY3 is downregulated during transition from proliferating to neurogenic divisions of progenitor cells.
Neural progenitor cells change their characteristics over time (Hatakeyama and Kageyama, 2006): 1) Initially,
neuroepithelial cells (NE) proliferate in absence of Notch and Hes expression. 2) At E7.5-E8.5, neuroepithelial cells
initiate expression of the Hes3 and Hes1 genes, simultaneously becoming dependent on the presence of anti-neurogenic
action of Hes transcription factors (Hatakeyama et al., 2004; Hatakeyama and Kageyama, 2006). At this time,
progenitors undergo symmetric proliferative divisions and express high levels of MSY3 protein, which is present in the
neuroepithelium before nestin. 3) At the onset of neurogenesis, expression of Hes genes, and therefore progenitor
maintenance, becomes dependent on Notch signalling (de la Pompa et al., 1997), which is accompanied by reduction of
the MSY3 protein. Following, progenitor cells upregulate radial glial markers, such as BLBP and GLAST (Anthony et
al., 2004; Hartfuss et al., 2001), and downregulate MSY3 to low levels, which persist in the ventricular zone by the end
of the neurogenic period. Most of radial glial (RG) cells undergo asymmetric divisions (Miyata et al., 2004; Noctor et al.,
2001). 4) Neuroepithelial and radial glial cells give rise to basal progenitors (BP) (Miyata et al., 2004; Noctor et al., 2004),
which express Tis21-GFP (Haubensak et al., 2004) and variable levels of MSY3 protein at the onset of neurogenesis.
MSY3 is absent from neurons (N), which are postmitotic cells. NE, neuroepithelial cell; RG, radial glial cell; BP, basal
progenitor; N, neuron.
3.1.5 Expression of MSY3 in transient amplifying precursors of the adult brain
Preliminary results indicate that in the postnatal and adult brain, MSY3 expression sets
in the germinal zones while they are acquiring the mature organisation, i.e. at the end of the
second week (Figure 31; Figure 32). MSY3 was detected in the transient amplifying
progenitors, as suggested by the overlapping pattern of MSY3 and Dcx (doublecortin)
expression. Dcx labels highly proliferating precursors and migrating neurons, but not
mature neurons or astrocytic stem cells (Brown et al., 2003; Kempermann et al., 2004).
Remarkably, in both regions MSY3 is not present in the Tis21-GFP-positive cells. Thus, as
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in the embryo MSY3 is downregulated while whole population of progenitor cells is
progressing in development and being gradually restricted in lineage and proliferation
competence, in the adult germinal zones it declines with the lineage progression and
differentiation from a precursor cell to a neuron. To confirm that MSY3 is not present in
differentiated cells, other markers of maturating neuroblasts and fully differentiated neurons
should be used, such as Prox-1, NeuN, Calbindin and Calretinin in the dentate gyrus, and
III-tubulin in the SVZ (Doetsch et al., 1997; Kempermann et al., 2004). Proliferative state
of MSY3 labelled cells could be established employing BrdU. Although not tested directly,
the presented data suggests that MSY3 is absent from GFAP-positive astrocytes, given it is
limited to Dcx-positive cells.
After birth, both the lateral ventricle wall and the dentate gyrus undergo radical
histological rearrangements. In the lateral ventricle, radial glia of the embryonic ventricular
zone transform into ependymal cells and subventricular zone astrocytes (Tramontin et al.,
2003). In the dentate gyrus, majority of proliferative cells found in the hilus and derived
originally from the embryonic subventricular zone differentiate into granule neurons by the
end of the third postnatal week, expanding the thickness of the granule cell layer (Altman
and Bayer, 1990a). The remaining progenitors populate the subgranular zone and generate
locally new granule cells. Thus, in both germinal zones MSY3 is not expressed during time
of increased cell differentiation, instead its expression is reestablished with appearance of
transient amplifying population.
Although the picture emerges, in which expansion of progenitors via symmetric
proliferative divisions and expression of MSY3 in the embryonic and adult brain are linked,
it has to be emphasised that particularly in the hippocampus proliferation of transient
amplifying cells is limited (Brown et al., 2003; Hayes and Nowakowski, 2002; Seri et al.,
2001). The average cell cycle length of proliferating cells in the murine dentate gyrus was
estimated as 12-14 h (Hayes and Nowakowski, 2002); similar average cell cycle length is
characteristic for progenitors of E13-E14 developing cerebral cortex, which is after the
MSY3 is downregulated (Takahashi et al., 1995). The average cell cycle length of progenitors
in the rat subventricular zone appears even longer, being estimated as 14 h (Smith and
Luskin, 1998) or 19 h (Zhang et al., 2006). However, it is difficult to compare the relative
intensity of MSY3 immunostaining in embryonic and adult tissues because of differences in
the molecular composition (e.g. extracellular matrix content or protein-protein interactions)
and processing for staining (see Materials and Methods), which may influence antigen
accessibility.
3.1.6 Expression of MSY3 in neurospheres
Stem and progenitor cells isolated from embryonic or adult germinal zones have capacity
to proliferate and self-renew in in vitro, forming free-floating aggregates of proliferating and
differentiating cells called neurospheres (Gritti et al., 1996; Reynolds and Rietze, 2005;
Reynolds and Weiss, 1996). Here it was shown that MSY3 is expressed in a subset of
nestin-positive precursors of neurospheres grown in EGF-containing medium. The
population of nestin expressing cells is heterogeneous, containing stem cells with
theoretically infinitive self-renewal capacity and proliferating precursors (Lendahl et al.,
1990; Reynolds and Rietze, 2005; Reynolds and Weiss, 1996; Suslov et al., 2002), however
molecular markers to unambiguously discriminate between these different populations of
proliferating cells are currently not available. Hence, the heterogeneity of MSY3 expression
in the nestin-positive precursors remains unexplained. It is noteworthy that the majority of
EGF-dependent neurospheres is derived from the transient amplifying precursors rather
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than bona fide stem cells, at least in the ventricular zone (Doetsch et al., 2002), and it is the
former that expresses MSY3 in vivo. Therefore, it could be speculated that in vitro MSY3 is
expressed in fast proliferating precursors.
Neural stem cells can be cultured in a presence of EGF or bFGF. EGF and bFGF act
on separate populations of embryonic neural progenitors stimulating their growth and
renewal by independent mechanisms (Tropepe et al., 1999). bFGF-responsive stem cells
emerge earlier in development (around E8.5) than EGF-responsive stem cells (around
E13.5), and the latter can be derived from bFGF-grown neurospheres (Hitoshi et al., 2002;
Hitoshi et al., 2004; Tropepe et al., 1999). Given that primary bFGF-responsive progenitors
cells exhibit longer cell cycle than EGF-responsive cells in vitro, which likely reflects distinct
proliferative kinetics of progenitors in vivo (Martens et al., 2000), it would be interesting to
compare MSY3 expression in these two cell populations. If MSY3 is linked with fast
growth, it should be expressed at a lower level in neurospheres grown bFGF-containing
medium.
3.1.7 Expression of MSY3 in other cell types of the central nervous system
Surprisingly, during the two first postnatal weeks, MSY3 was found in cortical neurons
with pyramidal morphology (Figure 33). This is in contrast to earlier absence of this protein
in cortical neurons during the whole neurogenic period (Figure 9; Figure 12). During
maturation of the nervous system, immature neurons are selected for survival or undergo
apoptosis, establish synaptic connections and associate with glia (Rao and Jacobson, 2005).
Any of these processes could require function of MSY3. However, the ability of MSY3 to
inhibit Cdk5 kinase in vitro is in this context of particular interest (Moorthamer et al., 1999).
Cdk5 is functionally a brain specific serine/threonine kinase (Tsai et al., 1993) and Cdk5-null
embryos demonstrate block of neuronal migration (Gilmore et al., 1998) and,  as a
consequence, inverted pattern of cortical layering (i.e. outside-in). It is plausible, that MSY3
could inhibit Cdk5 in young neurons of the cortical plate once they reached the proper
position. Nevertheless, such a role would only be auxiliary, as MSY3-overexpressing
neurons during embryogenesis do not fail to migrate (see next section). On the other hand,
the overexpression of MSY3 was performed between E12.5 and E14.5, i.e. at the emergence
of the cortical plate (Bayer and Altman, 1991), and a block of neuronal migration into the
cortical plate of the Cdk5 knockout embryos occurs shortly after splitting the preplate into
the marginal zone and the subplate, therefore the early cortical plate start to form (Gilmore
et al., 1998). Thus, to evaluate a putative role of MSY3 in neuronal migration, misexpression
of MSY3 ought to be performed at later stages.
Another cell type, which is not related to neuronal progenitors and expresses high levels
of MSY3 protein appears as bipolar cells in the neuronal layers of the ventral portion of the
hindbrain and spinal cord at E12.5, and at E14.5 in the thalamus (data not shown). These
cells are not labelled by III-tubulin antibody, therefore unlikely represent neurons.
Although the nature of these cells awaits further investigation, the spatiotemporal pattern of
their appearance suggests they might be oligodendrocyte precursors (Thomas et al., 2000). It
is interesting to note that oligodendrocyte precursors are proliferative progenitors (Ono et
al., 2001; Yuan et al., 2002), and in vitro embryonic glial progenitors undergo vast expansion
before maturation into glia (Qian et al., 2000).
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3.2 MSY3 is not an essential player in the control of precursor
proliferation
MSY3 is expressed in proliferating progenitors, being downregulated when they switch
to neurogenic divisions. But is the high level of MSY3 expression causally related to cellular
proliferation or is just a marker associated with rapid cell growth? This question was
addressed here by acutely manipulating the level of MSY3 in the neuroepithelium.
Premature downregulation of MSY3 in the neuroepithelium between E9.5 and E11.5
employing RNAi did not affect proliferation of targeted cells, based on the following
observations: i) similar proportion of targeted cells remained in the ventricular zone in the
control and RNAi-induced embryos; ii) RNAi did not promote ectopic neurogenesis in the
regions of the neural tube that do not generate neurons at analysed developmental time
point, such as the rostral diencephalon; iii) downregulation of MSY3 did not induce radial
glia prematurely; iv) the abundance of basal progenitors did not increase.
Furthermore, overexpression of MSY3 at E10.5 or E12.5 for 36 or 48 h, respectively,
did not affect the cell cycle exit, differentiation or commitment of targeted cells: i)
overexpressing cells at both developmental ages contribute to neuronal production similarly
as progenitors targeted with a control plasmid only; ii) MSY3 overexpression did not reduce
the number of Tis21-EGFP positive cells; iv) position of MSY3-overexpressing and control
neurons within the neuronal layers exhibited indistinguishable pattern.
Together, these results indicate that, within the scope of the experiments, neither is
MSY3 indispensable for the maintenance of progenitor proliferation, nor is its
downregulation obligatory to enter a differentiation pathway. Therefore, the MSY3 protein
is not a decisive node governing proliferation or differentiation in the neuroepithelium. In
agreement, Lu and colleagues reported recently generation of the MSY3 knockout mouse
(Lu et al., 2006). The MSY3 null animals are viable, and gross anatomical examination
revealed that the major organs, including brain, show similar morphologies and sizes as wild
type littermates. MSY3 appears essential only in the testis, as MSY3-deficient males exhibit
degeneration of seminiferous tubules and increased spermatocyte apoptosis, which lead to
reduced fertility.
Nonetheless, MSY3 might play a supplementary fine-tuning role in maintenance of
progenitor cells in proliferation. It is not excluded that MSY3 null mice exhibit mild
alteration of neural development, e.g., a premature onset of neurogenesis, a change of cell
cycle kinetics or a difference in cortical layering, which might be revealed by thorough
examination.
Given that MSY3 is expressed in vitro, the neurosphere assay could offer a quantitative
analysis of proliferative capacities of MSY3-deficient progenitors (Alexson et al., 2006;
Reynolds and Rietze, 2005): i) neurospheres can be repetitively passaged and this ability
reflects self-renewal property of neural stem cells; ii) the number of secondary spheres
obtained after dissociation of a single sphere provides an estimation of the number of
proliferative divisions, as only cells that divide symmetrically can expand the number of
secondary spheres; iii) the average number of cells per a neurosphere allows to deduce
proliferation rates of progenitors; iv) BrdU incorporation might provide additional cues as
to the cell cycle kinetics and proliferation. The downregulation of MSY3 in progenitor cells
by shRNA in a preliminary experiment provides a tool to address some of these questions.
The plasmid used in this experiment can be packaged into adeno-associated viral particles,
which infect neural progenitors with high efficiency (Verdon Taylor, personal
communication). However, it needs to be mentioned that the integration of an adenovirus
into the cellular DNA is rare and the adenoviral genome stays episomal being inherited only
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by one daughter cell upon the division. Therefore, the adenoviral infection is not suitable to
assay the stem cell maintenance, which requires prolonged culture. Alternatively,
neurospheres could be prepared from the MSY3 null mice.
3.3 Towards the cellular function of MSY3
3.3.1 Subcellular localisation of MSY3
Y-box proteins are multifunctional regulators of gene expression at the level of
transcription and translation, and often are linked with proliferation and cancer (see
Introduction). In agreement, the MSY3 orthologues in the dog (ZONAB) and human (dbpA)
epithelial cell lines, acting as transcription factors, promote G1/S transition, hence increase
proliferation and final cell density in mature monolayers (Balda et al., 2003; Sourisseau et al.,
2006). In neural progenitor cells, the MSY3 protein, as investigated by subcellular
fractionation (Figure 34), immunofluorescence (Figure 22) and immunoelectron microscopy
(Figure 23), was detected throughout the cytoplasm, and unlike ZONAB/dbpA was not
found in the nucleus or at junctions.
Nuclear localisation of ZONAB/dbpA is linked with its function in promoting
proliferation (Balda and Matter, 2000; Sourisseau et al., 2006). However, ZONAB/dbpA is
localised to the nucleus only in subconfluent cells, and translocates to the cytoplasm as cells
form functional tight junctions and cease proliferation (Balda and Matter, 2000). In the
developing neural tube, neuroepithelial cells are linked by adherence/tight junctions to form
continuous tissue, yet, unlike the mature monolayer of MDCK cells, are highly proliferative.
The proposed pro-proliferative action of MSY3 in progenitor would rather employ other
mechanism than transcriptional regulation. Nevertheless, it cannot be excluded that a
minute fraction of the protein localises to the nucleus and exerts its function as a
transcription factor. Despite cytoplasmic localisation and function as an mRNA binding
protein, the other member of the Y-box family, MSY2, is associated with certain
Y-box-containing promoters in germ cells, possibly linking transcription with mRNA
storage (Yang et al., 2005a). The cytoplasmic localisation of MSY3 in neuroepithelial cells
could also be mediated by RNA binding. Work presented here shows that the MSY3
protein in the developing mouse embryo, as well as in the Neuro-2A cell line, is associated
with RNA. In various cell lines, cytoplasmic retention of another Y-box protein YB-1 is
attributed to mRNA binding (Bader et al., 2003; Bader and Vogt, 2005; Sorokin et al., 2005).
The YB-1 nuclear localisation is induced by stress or is a peculiarity of transformed cell lines
and cancer tissues. In this regard, MDCK cells are also immortal cell line, and nuclear
expression of ZONAB might image a tumour state.
The interaction of ZONAB/dbpA with ZO-1 and RalA at tight junctions is believed to
sequester the protein from the nucleus, thereby inhibiting its function as a transcription
factor (Balda and Matter, 2000; Frankel et al., 2005). Moreover, junctional ZONAB
sequesters from the nucleus its binding partner, Cdk4 (Balda et al., 2003). Despite high
levels of expression of ZO-1 and MSY3 in the neuroepithelium shown here, these two
proteins do not colocalise in progenitor cells. However, ZONAB shows also diffuse
cytoplasmic staining, and to visualise junctional association of ZONAB, MDCK cells are
pre-treated with Triton X-100 prior to the fixation, which partly extracts the cytoplasmic
pool of the protein (Balda and Matter, 2000; Frankel et al., 2005). Therefore, it is not
excluded that ZONAB, and hence MSY3, inactivation mediated by ZO-1 is not direct and
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independent of ZONAB junctional localisation. Given the ability of MSY3 to bind mRNA
it is also possible that specific localisation of ZONAB/dbpA mediates tethering of
messages to junctions and local protein synthesis.
Progenitor cells are coupled via adherens and tight junctions (Aaku-Saraste et al., 1996;
Chenn et al., 1998; Hatakeyama et al., 2004), though closure of the neural tube is
accompanied by remodelling of thight junctions: loss of occludin expression is coupled with
loss of paracellular barrier (Aaku-Saraste et al., 1996). Simultaneous upregulation of ZO-1
expression has been reported in the chick neural tube (Aaku-Saraste et al., 1996);
nevertheless, biochemical analysis presented here (Figure 14), as well as confocal
microscopy (Figure 22) did not reproduce such a phenomenon in the mouse
neuroepithelium. Though, the immunofluorescence staining on cross-sections presented by
Aaku-Saraste and colleagues might be misleading, as during transition from columnar to
elongated pseudostratified epithelium, separate punctae of junctions are brought in the
proximity and appear as a continuous line under the epifluorescent microscope. This gross
morphological change, however, may not reflect amount of the ZO-1 protein associated
with each individual cell.
Two isoforms of ZO-1 result from alternative splicing and differ by internal 80 amino
acid domain, termed  (Balda and Anderson, 1993; Willott et al., 1992). ZO-1  is
associated with structurally dynamic junctions, such as junctions of endothelial cells, Sertoli
cells and podocytes, whereas ZO-1 + is associated with less dynamic junctions of epithelial
cells (Balda and Anderson, 1993). Interestingly, mouse neuroepithelium expresses mostly
ZO-1  isoform, as indicated by immunoblotting in comparison with the extract prepared
from the liver (data not shown), which expresses both ZO-1 isoforms (Balda and Anderson,
1993). Although not confirmed by RT-PCR or isoform-specific antibodies, this preliminary
finding further supports the notion that neuroepithelial tight junctions are not equivalent of
the mature junctions of epithelial cells. The assembly of tight junctions during the early
pre-implantation development is a step-wise process that initiates from recruitment of the
ZO-1  isoform and rab13 upon the E-cadherin adhesion (Fleming et al., 2000; Sheth et al.,
1997; Sheth et al., 2000). The final phase in the tight junction formation requires ZO-1 +
isoform, which is indispensable for junctional localisation of occludin (Furuse et al., 1994;
Sheth et al., 1997). Notably, both proteins are absent from the neuroepithelial cells. It is
plausible that only ZO-1 + isoform supports junctional localisation of
ZONAB/dbpA/MSY3. Indeed, in MCF-10A-JB cells, which lack functional tight junctions,
dbpA is not present at cell contacts, while in the MCF-10A-95 subclone, which forms
functional tight junctions, dbpA colocalises with ZO-1 at the cell periphery (Sourisseau et
al., 2006). The MCF-10A-JB clone express ZO-1 and occludin at junctions in a
non-continuous punctuate pattern.
In the adult brain and retina, MSY3 protein localises at glial and neuronal gap junctions,
respectively (Ciolofan et al., 2006; Penes et al., 2005). In these studies, the antibody directed
against the C-terminus of MSY3 showed sparse puncta of immunoreactivity when applied
on MSY3-overexpressing HeLa cells (Ciolofan et al., 2006). However, the anti-MSY3
antibodies reported here, which were raised against the N-terminal domain, in
MSY3-overexpressing HeLa cells recognise granular staining throughout the cytoplasm,
resembling that in the neuroepithelium or Neuro-2A cells (data not shown). It is therefore
plausible that differential accessibility of the epitopes located in the N- or C-terminus of
MSY3 contributes to a different apparent subcellular localisation. Since the corresponding
antibody against the C-terminal domain of MSY3 is now commercially available, it will be
possible to address this issue.
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3.3.2 MSY3 associates with actively translating ribosomes – does it bind mRNA?
Subcellular fractionation (Figure 34), immunoprecipitation (Figure 37) and polysomal
analysis (Figure 35; Figure 36) performed in this study revealed that the MSY3 protein in the
developing embryo, as well as in Neuro-2A cells, is associated with RNA and on a sucrose
density gradient co-fractionates with ribosomes and actively translating polysomes.
Disruption of polysomes by EDTA or puromycin results in a shift of MSY3 to fractions
containing ribosomal subunits. Two possible explanations of this result come in hand.
Firstly, MSY3 could be bound to the ribosome itself, and, secondly, to be associated with
mRNA released from the polysomes. It is important to note that the EDTA-dissociated
mRNAs, though separated from ribosomes, are associated with proteins and have a similar
sedimentation coefficient to ribosomal subunits (Henshaw, 1968). Indeed, the protein
content of EDTA- or puromycin-dissociated mRNPs comprises about 60% of the weight
of the complexes (Henshaw, 1968; Kumar and Lindberg, 1972; Perry and Kelley, 1968),
therefore it is plausible that sedimentation of MSY3 is caused by association with mRNA.
Majority of MSY3 in germ cells is bound directly to stored mRNA, devoid of ribosomes
(Davies et al., 2000). The immunoprecipitation of MSY3 in a presence of EDTA revealed
its association with rRNA, yet in this condition rRNA was partially degraded and most
probably released from the ribosome, suggesting that this interaction is unspecific, as it was
reported for YB-1 (Nekrasov et al., 2003). To investigate whether MSY3 associates with
ribosome or mRNA in proliferating cells, oligo(dT)-cellulose can be used to separate the
components of EDTA-dissociated polysomes into an unbound ribosome fraction and a
fraction retained by the resin that contains mRNA associated with proteins (Corbin et al.,
1997; Lindberg and Sundquist, 1974).
High salt environment results in removal of more than 50% of proteins from polysomal
mRNPs, nevertheless, polysomes remain intact (Kumar and Lindberg, 1972). MSY3 is
solubilised by treatment with 0.5 M NaCl, implicating it does not act as an mRNP core
protein, such as YB-1 or PABP, which retain binding to mRNA in high salt (Auerbach and
Pederson, 1975; Lindberg and Sundquist, 1974). It is unknown whether MSY3 binds RNA
directly or association with RNA is mediated by a protein. To solve this question, MSY3
could be immunoprecipitated under stringent conditions from [3H]-uridine labelled cells
after UV-crosslinking and partial RNase digestion. Radioactive labelling of MSY3 would
indicate that the protein binds directly to mRNA, since only molecules in direct contact can
be covalently crosslinked by UV.
3.3.3 What is the role of MSY3 in translation?
Translation of mRNA into protein represents the final step in the gene expression
pathway (for review see: Gebauer and Hentze, 2004). Two general modes of translational
control are utilised by cells: the global control, in which translation of most mRNAs in the
cell is regulated; and mRNA-specific control, whereby the translation of a defined group of
mRNAs is modulated by binding of regulatory protein complexes to specific elements
present in the messages, usually in their 3’ or 5’ UTRs (Gebauer and Hentze, 2004;
Kuersten and Goodwin, 2003).
Overexpression or downregulation of MSY3 in Neuro-2A cells did not affect global
protein synthesis rates. This result, however, does not exclude possibility that MSY3 acts as
a general translational regulator. The global translation regulation in eukaryotic cells is
achieved mostly by modification of levels and activity of translation initiation factors
(Gebauer and Hentze, 2004; Gingras et al., 1999; Richter and Sonenberg, 2005). Translation
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of nuclear-encoded mRNAs requires binding of rate-limiting eIF4E to the mRNA cap
structure. eIF4E subsequently recruits the scaffolding protein eIF4G and the RNA helicase
eIF4A, which facilitates the ribosome binding and scanning along the 5’ UTR towards the
initiation codon. The requirement for eIF4E binding and eIF4A helicase activity is
proportional to the degree of mRNA 5’ secondary structure, and messages with extensive
secondary structure in their 5’ UTRs are less competitive for translation initiation (Kornack
and Rakic, 1998; Koromilas et al., 1992; Svitkin et al., 2001). Computational analysis of
5’ UTRs of human genes revealed that the class of mRNAs which contain lengthy
untranslated regions with a high degree of secondary structure consists of mRNAs encoding
transcription factors, growth factors and their receptors, proto-oncogens, and other
regulatory proteins which are poorly translated under normal conditions (Davuluri et al.,
2000). Thus, this class of mRNAs is a primary target for the translational control.
Consequently, an increase in eIF4E amount or activity does not lead to elevated rates of
global translation (Saghir et al., 2001), but instead results in increased translation of a subset
of mRNAs (Graff and Zimmer, 2003). In this context, it is tempting to speculate that
MSY3, through its RNA chaperoning functions characteristic to Y-box proteins, supports
translation of non-competitive, highly structured mRNAs.
Importantly, removal or overexpression of YB-1 does not affect the global translation
rate (Davydova et al., 1997; Lu et al., 2005), despite the fact that YB-1 is a major mRNP
protein (Evdokimova et al., 1995) and its loss affects cell growth and is lethal for embryos
(En-Nia et al., 2005; Lu et al., 2005; Matsumoto et al., 2005). Instead, overexpression of
YB-1 represses translation of reporter mRNAs (Bader et al., 2003; Bader and Vogt, 2005;
Davydova et al., 1997; Evdokimova et al., 2001), or influences protein synthesis in cell-free
systems (Evdokimova et al., 1998; Nekrasov et al., 2003; Pisarev et al., 2002).
Lu and colleagues in the aforementioned work (Lu et al., 2006) presented that double
YB-1/MSY3 null embryos showed more severe developmental defects than animals
deficient in YB-1 only. YB-1 null embryos die perinatally, whereas embryonic death of
double knockout embryos occurs between E8.5 and E11.5. Since at E11.5 expression of the
MSY3 protein declines, this data indicate that MSY3 can rescue functions of YB-1 during
early embryogenesis (when it is expressed), and suggest that both proteins share similar
function(s). Moreover, YB-1 can be co-immunoprecipitated together with MSY3, as shown
here. Co-immunoprecipitation is partly abolished by presence of EDTA, hence suggesting
that it is mediated by mRNA.
Since MSY3 displays very specific expression profile in the developing CNS, being
present only in proliferative progenitors (with minor exceptions), as compared to YB-1,
which is also highly expressed in neurons (Funakoshi et al., 2003; and data not shown), it is
possible that MSY3 modulates the function of YB-1. MSY3 could also act additively with
YB-1, or have an additional separate function important for development. It is to be
mentioned that YB-1 forms large multimeric complexes, and dimerisation is mediated by
the C-terminal domain (CTD) (Skabkin et al., 2004; Tafuri and Wolffe, 1991). Interestingly,
the CTD of MSY3 expressed in E. coli as a GST-fusion protein aggregates (data not shown),
therefore it is not formally excluded that the MSY3 could heterodimerise with YB-1 via
their CTDs. To investigate whether YB-1 associates directly with MSY3,
immunoprecipitation could be carried in the presence of RNase. To get an insight into
relation of MSY3 and YB-1, it would be essential to compare polysomal profile of YB-1, as
well as a set of YB-1-bound mRNAs, before and after MSY3 developmental
downregulation, or in the MSY3 null background.
Identification of MSY3-bound mRNAs could provide a cue as to the function of MSY3.
Since MSY3 can be efficiently co-immunoprecipitated with RNA, determination of bound
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transcripts by microarray analysis, or UV-cross link and immunoprecipitation (CLIP) (Ule et
al., 2003), followed by cloning of bound messages, are experimentally feasible. It might also
be valuable to compare the set of messages bound by MSY3 to that associated with YB-1.
In germ cells, MSY3 contributes to packaging and silencing of mRNA, with minor
fraction associated with polysomes (Davies et al., 2000), whereas in the embryo most of the
MSY3 protein is associated with translating polysomes. A dual role in translation regulation
has been assigned to YB-1, which at high molar ratios represses translation, whereas low
levels of YB-1 are indispensable for translation initiation (Evdokimova et al., 1998). By
analogy, it is plausible that stoichiometry of MSY3 to mRNA determines whether the
protein supports or represses translation. Nonetheless, the polysomal association of MSY3
does not ultimately indicate that it is complexed with non-repressed messages. Inhibition of
translation after the initiation step was observed in a variety of systems in which 3’ UTRs
regulate translation. These include silencing of the IL-1  mRNA in human monocytes
(Kaspar and Gehrke, 1994) and the brain creatine kinase (CKB) mRNA in the rat (Shen et
al., 2003), whereas in the Drosophila the unlocalised nanos and oskar mRNAs are regulated at
a step after translation initiation (Braat et al., 2004; Clark et al., 2000). The mechanisms
employing postinitiation repression might be common, since miRNAs cosediment with
polysomes in worms and mammalian cells (Kim et al., 2004; Nelson et al., 2004; Olsen and
Ambros, 1999). In C. elegans, the lin-14 and lin-28 mRNAs are repressed at a postinitiation
stage by the lin-4 miRNA (Olsen and Ambros, 1999; Seggerson et al., 2002). Also,
imperfectly complementary short RNAs, which mimic miRNAs, repress translation after
the initiation in mammalian cells (Petersen et al., 2006). Importantly, repressed mRNAs
show the polysomal sedimentation profile and are engaged in translational elongation, as
shown by puromycin sensitivity. Furthermore, FMRP protein, which has been shown to
repress translation (Laggerbauer et al., 2001; Li et al., 2001; Mazroui et al., 2002), is present
in polysomes, which are sensitive to puromycin (Corbin et al., 1997; Khandjian et al., 2004;
Stefani et al., 2004). FMRP is also part of the RISC complex in Drosophila (Caudy et al.,
2002), and in mammalian cells (Jin et al., 2004).
Given that YB-1 can interact with FMRP (Ceman et al., 2000), it would be important to
check whether the FMRP protein or members of the Argonaute family, key molecules in
miRNA- and RNAi-mediated silencing (Carmell et al., 2002), co-immunoprecipitate with
MSY3. It should also be noted that miRNA pathway and Argonaute proteins are recently
emerging as determinants for the developmental control and stem cell decisions (Carmell et
al., 2002; Cheng et al., 2005).
3.3.4 How could translation affect neurogenesis?
Availability of eIF4E is believed to be critical for translational activation of
non-competitive mRNAs, which encode growth-related or anti-apoptotic proteins (Graff
and Zimmer, 2003). Consistently, overexpression of eIF4E induces transformation
(Avdulov et al., 2004; De Benedetti and Rhoads, 1990; Lazaris-Karatzas et al., 1990) and
parallels enhanced translation of the reporter and endogenous messages with highly
structured 5’ UTRs, such as those encoding Myc, FGF, ornithine decarboxylase (ODC),
cyclin D1, VEGF and yes src-like kinase (Defatta and De Benedetti, 2003; Graff and
Zimmer, 2003). These effects can be counteracted by elevating the levels of inhibitory
eIF4E binding proteins (4E-BPs) (Avdulov et al., 2004), which either sequester eIF4E from
mRNAs or disrupt its binding to eIF4G (Richter and Sonenberg, 2005). In patients,
upregulation of translation initiation factors and disregulation of ribosome biogenesis
coincides with malignancy (Rosenwald, 2004; Ruggero and Pandolfi, 2003). Growth factors,
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hormones and mitogen stimuli potently activate mRNA translation, largely through
activation of the phosphatidylinositol 3-kinase (PI3K) pathway (Ruggero and Sonenberg,
2005). Thus, translational regulation is linked to cell growth and may represent one of the
mechanisms by which proliferative divisions and fast cell cycle of progenitor cells are
controlled.
Of importance is that the developmental profile of MSY3 expression seems not to
reflect downregulation of the general translation apparatus, including another Y-box protein
YB-1. These preliminary findings, however, require validation. Since not only does the
activity of the translation machinery relay on the total amount of initiation factors, but also
on their phosphorylation state and availability, levels of phosphorylated eIF4E and the
ribosomal protein S6, as well as expression profile and phosphorylation of 4E-BPs, should
be monitored.
Given that MSY3 developmental expression coincides with expansion of neuroepithelial
cells, it is suggestive that MSY3 promotes proliferation and/or inhibits differentiation of
progenitors by regulating translation. If so, several mechanisms could be envisaged. First,
MSY3 might repress translation of mRNAs encoding differentiation factors. In the second
scenario, MSY3 facilitates translation of growth- and cell division-associated mRNAs.
Third, it should not be ignored that the short cell cycle of neuroepithelial cells prior to
neurogenesis, i.e. of approximately 8 h, requires rapid growth, hence efficient synthesis of
structural proteins. Although overexpression of MSY3 in the cell line did not affect general
translation, it is not excluded that MSY3 in neuroepithelial cells non-selectively enhances
global translation. Discovery of MSY3-bound messages and, possibly, its role in translation,
might provide a clue as to which of these scenarios could apply during central nervous
system development.
3.4 Concluding remarks
This work identified the murine MSY3 protein as a “pan-proliferative” marker of neural
progenitor cells in the embryonic and adult brain. Expression of MSY3 relates to the fast
cell cycle progression rather than being a stem cell feature. The presented data provide a
suggestion that MSY3 and, by analogy, human dbpA could be used to identify proliferating
cell populations throughout the nervous system also in regeneration and cancer. In this
regard, it is interesting that MSY3 has common molecular characteristics in the developing
embryo and the neuroblastoma cell line. Although multiple proteins involved in translation
are elevated during cell proliferation, MSY3 is distinct as it is not present in differentiated
neurons, which are also characterised by high metabolism and expression of YB-1.
Therefore, despite the lack of an evident phenotype in MSY3-deficient progenitors and
embryos, revealing molecular interactors of MSY3 in neuroepithelial cells could provide a
specific link between translational machinery and cell cycle progression in development and
pathology.
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4 MATERIALS AND METHODS
4.1 Standard materials
4.1.1 Technical equipment
centrifuges Beckman Coulter, Avanti J-25
Beckman Coulter, Optima MAX Ultracentrifuge
Beckman Coulter, Optima LE-80K Ultracentrifuge
Heraeus, Megafuge 1.0R
Eppendorf, centrifuge 5415R
balances Sartorius, BL 3100
Sartorius, BP 121S
water bath GFL
gradient maker Labconco, with SG-30 Hoefer unit
DNA gel chamber EMBL
protein gel chamber Sigma, E5889
Sigma, Z37
semi-dry transfer system CTI, Idstein, Germany, 11SD-1 with glass electrodes
power supply Amersham Pharmacia Biotech, EPS 301
Hoefer, EPS 2A2000
speedvac Jouan, RC10.22/RCT60
gel dryer Heto, GD-2
vacuum pumps Vacumbrand GmbH
sonicator Bandelin Electronic, Berlin, UW200
homogeniser Eurostar Digital, IKA-WERKE
film developer Kodak
cell culture hood The Baker Company, SterilGARD III Advance
cell culture incubator Heraeus, HeraCell (copper)
whole embryo culture
incubator
R.K.I. Ikemoto, Tokyo, 10-0310
anaesthesia system VetEquip, Pleasanton, California
needle puller Sutter Instrument Co., USA, P-97
pneumatic pico pump World Precision Instruments, PV 820
electro square porator BTX Genetronics, Inc., San Diego, ECM 830
cell electroporator Biorad, GenePulser II
cryostat Microtome
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ultra-cryostat Leica, ultracut UCT/FCS
light microscopes Olympus, SZX12 (dissection)
Olympus, BX61 (epifluorescence; bright field)
Zeiss LSM, Axiovert 200, LSM 510 AIM
electron microscope Morgagni, FEI, The Nederlands
pipettes Gilson
4.1.2 Chemicals
All standard chemicals were purchased from Invitrogen, Merck (Darmstadt), Roth
(Karlsruhe) or Sigma, at analysis (p.a.) quality.
DNA standards Invitrogen
MBI Fermentas
Enzymes
(molecular biology)
MBI Fermentas
New England Biolabs
Promega (Liga Fast)
Roche
Trizol LS Invitrogen
Glycogen Q-Biogene
RNase A Qiagen
GST-RNase III MPI-CBG Protein Facility
RNase Inhibitors Invitrogen
Promega
Puromycin Sigma
Pre-stained protein
standards
Invitrogen
Sigma
Protease inhibitor cocktail
(for mammalian tissue)
Sigma
Glutathione sepharose Amersham Biosciences
Protein A sepharose Amersham Biosciecnes
Protein G sepharose Amersham Biosciences
ECL detection solutions Amersham Biosciences
Pierce
Cell culture media and
supplements
Gibco Invitrogen
Trypsin Gibco Invitrogen
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Accutase PAA laboratories
DNase I type IV Roche
hrEGF Sigma
R&D
Laminin Sigma
Poly-L-lysine Sigma
Lipofectamine 2000 Invitrogen
Salmon sperm DNA Invitrogen
L-[35S]methionine, L-
[35S]cysteine mix
PerkinElmer
Rat serum
(whole embryo culture)
Charles River (Japan)
4.1.3 Kits
BCA Protein Assay Kit Pierce
EndoFree Plasmid Maxi Kit Qiagen
MEGAscript T7 Kit Ambion
Plasmid Maxi Kit Qiagen
QIAprep Spin Miniprep Kit Qiagen
QIAquick Gel Extraction
Kit
Qiagen
TOPO-cloning Kit Invitrogen
4.1.4 Gradient SDS-PAGE protein gels
NuPage 4-12% Bis-Tris Gel Invitrogen
NuPage Running Buffer Invitrogen
4.1.5 Membranes
Nitrocellulose Protan BA
pore size 0.45 m
Schleicher & Schuell
PVDF Immobilion-P
pore size 0.45 m
Milipore
4.1.6 Films
ECL Hyperfilm
Hyperfilm
Amersham Bioscience
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4.1.7 Bacterial strains
DH5 : F-, 80dlacZ M15, (lacZYA-argF)U169, deoR, recA1, endA1, hsdR17(rk-, mk+),
phoA, supE44, -, thi-1, gyrA96, relA1
BL21: F-, ompT, gal, dcm, lon, hsdSB( rB-mB-) (DE3)
HB101 (Promega): F-, thi-1, hsdS20 (rB-, mB-), supE44, recA13, ara-14, leuB6, proA2, lacY1,
galK2, rpsL20 (strr), xyl-5, mtl-1
TOP10 (Invitrogen):F-, mcrA (mrr-hsdRMS-mcrBC), 80lacZ M15, lacX74, recA1,
araD139, galU, galK, (ara-leu)7697, rpsL (StrR), endA1, nupG
DH10b pir116 (Open Biosystems):F-, endA1, recA1, galU, galK, deoR, nupG, rpsL, lacX74,
80lacZ M15, araD139, (ara,leu)7697, mcrA, (mrr-hsdRMS-mcrBC), UmcC::pir116-Frt, -
4.1.8 Cell lines
COS7:Adherent fibroblast-like cell line derived from the kidney of an African green
monkey. This line was constructed from the CV-1 cell line by transformation with the origin
defective mutant of SV40 encoding for the wild type T antigen. Contains T antigen, retains
complete permissiveness for lytic growth of SV40, supports the replication from SV40 ori.
HeLa:The adherent epitheloid cell line derived from cervical cancer cells taken from
Henrietta Lacks, who died from her cancer in 1951.
Neuro-2A: The adherent neuroblastoma clone established by R. J. Klebe and F. H. Ruddle
from a spontaneous brain tumour of a strain A albino mouse.
NIH-3T3: The adherent fibroblast cell line of highly contact-inhibited cells was established
from the NIH Swiss mouse embryo cultures. The established NIH-3T3 line was subjected
to more than 5 serial cycles of subcloning in order to develop a subclone with morphologic
characteristics best suited for transformation assays.
4.1.9 Animals
For this work following mouse strains were used:
NMRI wild type mice were purchased from Harlan and used for biochemical analyses,
cryosections and whole embryo cultures.
C57BL6 wild type mice were used for in utero electroporations and neurosphere preparation.
Tis21-EGFP mice strain in C57BL6 background, in which the protein-encoding portion of
the exon 1 of the Tis21 gene was replaced by EGFP carrying nuclear localisation signal
(Haubensak et al., 2004). In this study heterozygous embryos were used for cryosections
and whole embryo culture.
Hes5-EGFP transgenic mice strain in C57BL6 background was obtained from Verdon
Taylor and Onur Basak (Freiburg). This line was established by genomic insertion of the
construct, in which EGFP is driven from the 1.6 kb promoter region of the Hes5 gene. The
RBP-J proximal site in the promoter and the Hes5 3’UTR confer activation by Notch-1 and
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a proper expression pattern that corresponds to the Hes5 mRNA (Verdon Taylor,
unpublished data).
En2-Cre x Floxed Notch1 Notch1 cerebellar knock-out embryos were kindly provided by
Verdon Taylor (Lütolf et al., 2002). The first coding exon of the Notch1 gene was flanked by
LoxP sequences to generate the Floxed Notch1 allele and the Notch1 null allele after
Cre-induced recombination (Radtke et al., 1999). This line was crossed to the En2-Cre
transgenic line, in which the Cre recombinase is expressed from the engrailed-2 promoter
enhancer and therefore is restricted to the neuroepithelium of the midbrain-hindbrain
boundary. For cell fate tracing, the ROSA26-R Cre-reporter line (R26R) was used in a
combination with the En2-Cre transgene and Floxed Notch1 alleles. The R26R comprises the
Floxed PGK prmoter driving a neomycin cassette containing three polyadenylation
sequences and the lacZ gene with polyadenylation site introduced into the ROSA26 locus by
homologous recombination. Cre-mediated recombination deletes the PGK neo cassette and
results in constitutive expression of -galactosidase (Soriano, 1999).
All mice were maintained on a 12 h light/dark cycle. Time pregnant females were obtained
by overnight mating and the noon of a day when a vaginal plug was designated embryonic
day 0.5 (E0.5).
4.1.10 Vectors
pAAV-hrGFP
(Stratagene)
Adeno-associated viral vector expressing from the CMV
promoter the hrGFP low-toxicity green fluorescent protein
derived originally from from Renilla and codon optimised
for mammalian cells.
left ITR; CMV promoter fused with -globin intron;
hrGFP; hGH polyA; right ITR; f1 ori; ampiciline resistance
gene; pUC ori
pCAGGS2
(Christio Goridis, Paris)
Mammalian expression vector based on the hybrid chicken
-actin/rabbit -globin promoter fused to the CMV-IE
enhancer sequence.
CMV-IE, chicken -actin promoter and exon I, rabbit
-globin intron II/exon III splice acceptor site; MCS;
rabbit -globin polyA; SV40 ori; pUC13 ori; ampiciline
resistance gene
pCAGGS2-EGFP
(Christo Goridis, Paris)
pCAGGS2 vector that drives expression of EGFP.
pCAGGS2-mRFP pCAGGS2 vector that drives expression of mRFP
(monomeric red fluorescent protein).
pGEX-M7 Procaryotic chemically inducible expression vector for
construction of fusion proteins with the GST (glutathione
S-transferase) moiety at the amino-terminus.
tac promoter; GST gene; PreScission and TEV proteases
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sites; MCS; ampiciline resistance gene; origin of replication;
lac Iq repressor
pGL2
(Promega)
Mammalian expression vector that drives expression of
Photinus pyralis luciferase gene from the SV40
promoter/enhancer.
ampicilin resistance gene; fi ori; SV40 promoter; luciferase
gene; SV40 small t antigen intron; SV40 polyA; SV40
enhancer; ori ColE1
pJ4
(J.P. Magaud and
J.P. Rouault, Lyon)
Mammalian expression vector containing the 1.8-kb SmaI-
AccI fragment of the mouse Tis21 gene in the backbone of
the pME18S vector under the control of the SRa promoter.
pSM2
(Open Biosystems)
Retroviral replication defective mammalian vector for
efficient expression of shRNA-mirs in the backbone of
primary mir30 mi-RNA. Provides also puromycine
resistance for selection.
LTR; U6 promoter; mir5’; shRNA cloning site; mir3’; U6
terminator; chloramphenicol resistance gene;
phosphoglycerate-kinase-1 (PGK) promoter, puromycine
resistance gene; sinLTR; RK6 ori; f1 ori T; kanamycin
resistance gene
pSM2-luc
(Open Biosystems)
pSM2 vector that drives expression of shRNA against
luciferase
4.1.11 Clones
IRAK p961D1855Q2
(RZPD)
MSY3 N-truncated long splice variant; in the pCMV-
SPORT6 backbone
IMAG p998F169447Q3
(RZPD)
MSY3 short splice variant with the deletion of
nucleotide 810 of the open reading frame; in the pCMV-
SPORT6 backbone
4.1.12 Oligonucleotides
Sequencing primers
Sequence (5’ – 3’) Name
P1 GCC CAG ATG GAG TTC CTG TAG YB3 (469-489) F
P2 GGT CCA CGG CGC CTG CCA TAG YB3 (536-556) R
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P3 TCG GCT TCT GGC GTG TGA C pCAGGS 5’ 1
(1597-1615)
P4 CTC TAG AGC CTC TGC TAA C pCAGGS 5’ 2
(1622-1640)
P5 TTA GCC AGA AGT CAG ATG CTC pCAGGS 3’
(1880-1860)
P6 GTT ATG TAA CGC GGA ACT CC CMV-R 83
P7 GGA CGA AAC ACC GTG CTC GC pSM2-F (2476)
P8 TTC TGC GAA GTG ATC TTC CG pSM2-R (2808)
Cloning primers
Sequence (5’ – 3’) Name
P9 GGA TCC GGC TTG AGC GAG GCG GGC GA 5’YB3-N-Bam
P10 CTC GAG CTA CGC GTC CTC GCC GCC CG 3’YB3-N-Xho
P11 GGA TCC ATT GGG GAG ATG AAG GA 5’YB3-C-Bam
P12 CTC GAG CCA GGG TCA CTC GGC ACT 3’YB3-C-Xho
P13 GGC CGC AAC TGG ATC CGA CTA AAV-
NotBamMlu 5’
P14 CGC GTA GTC GGA TCC AGT TGC AAV-
NotBamMlu 5’
P15 TCG AGC TGT TGA CAG TGA GCG ACC AGA TGG A
GT TCC TGT AGA ATA GTG AAG CCA CAG ATG TAT
TCT ACA GGA ACT CCA TCT GGG TGC CTA CTG CC
T CGG
hp 647-F
P16 AAT TCC GAG GCA GTA GGC ACC CAG ATG GAG T
TC CTG TAG AAT ACA TCT GTG GCT TCA CTA TTC
TAC AGG AAC TCC ATC TGG TCG CTC ACT GTC AA
C AGC
hp 647-R
P17 TCG AGC TGT TGA CAG TGA GCG AGA GAG GCT G
AA GAC AAA GAA ATA GTG AAG CCA CAG ATG TA
T TTC TTT GTC TTC AGC CTC TCC TGC CTA CTG CC
T CGG
hp 1077-F
P18 AAT TCC GAG GCA GTA GGC AGG AGA GGC TGA A
GA CAA AGA AAT ACA TCT GTG GCT TCA CTA TTT
CTT TGT CTT CAG CCT CTC TCG CTC ACT GTC AAC
AGC
hp 1077-R
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P19 TCG AGC TGT TGA CAG TGA GCG ACA CGA CCT TA
C CAA CAC CAA ATA GTG AAG CCA CAG ATG TAT T
TG GTG TTG GTA AGG TCG TGG TGC CTA CTG CC
T CGG
hp 1363-F
P20 AAT TCC GAG GCA GTA GGC ACC ACG ACC TTA CC
A ACA CCA AAT ACA TCT GTG GCT TCA CTA TTT G
GT GTT GGT AAG GTC GTG TCG CTC ACT GTC AAC
AGC
hp 1363-R
esiRNA primers
Sequence (5’ – 3’) Name
P21 TAA TAC GAC TCA CTA TAG GGT GTA GTT GAA
GGA GAA AAG GGT GC
T7-5’-YB3_bis
P22 AAT TAA CCC TCA CTA AAG GGT TGC CAT CTT
GTG AAA CAG CG
T3-3’-YB3_bis
P23 TAA TAC GAC TCA CTA TAG GGC CTC AAC GCT
GTT TCA CAA GAT G
T7 5’ YB3_ter
P24 TAA TAC GAC TCA CTA TAG GGT TTG GTG TTG
GTA AGG TCG TGG
T7 3’YB3_ter
P25 TAA TAC GAC TCA CTA TAG GGA GAG CAA CTG
CAT AAG G
Fluc-T7 F
P26 TAA TAC GAC TCA CTA TAG GGA GAA TCT GAC
GGC AGG CAG T
Fluc-T7 R
P27 CGT AAT ACG ACT CAC TAT AGG GTG AGC AAG
GGC GAG GA
T7 EGFP F
P28 CGT AAT ACG ACT CAC TAT AGG GTA CAG CTC
GTC CAT GCC GA
T7 EGFP R
4.1.13 Antibodies
Primary antibodies
Antigen Description Dilution Supplier/
Reference
actin mouse mAb
clone AC-40
1:5000 (IB) Sigma
III-tubulin mouse mAb
clone SDL.3D10
1:500 – 1:800 (IF) Sigma
cadherin, pan- mouse mAb
clone CH-19
1:300 (IF) Sigma
Dcx goat polyclonal 1:100 (IF) Santa Cruz
Biotechnology
eIF4E rabbit polyclonal 1:1000 (IB) Cell Signaling
FMRP mouse mAb 1.7 g/ml (IB) Developmental
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clone 7G1-1 Studies Hybridoma
Bank
GFAP mouse mAb
G-A-5
1:300 (IF) Sigma
GFP rabbit polyclonal 1:500 (IF)
1:5000 (IB)
Transduction
Laboratories
GFP rabbit polyclonal 1:500 (IF) Molecular Probes
GLAST guinea pig antiserum 1:2000 – 1:4000 (IF) Chemicon
MSY3 AP4912
rabbit polyclonal, aff. pur.
1:5000 (IF, IB) Karl Matter
MSY3 AP0182
rabbit polyclonal, aff. pur.
1:1000 (IB) see below and
Results
MSY3 guinea pig antiserum
GP2
1:10,000 (IF, IB)
1:50 (EM)
1:1000 (IP)
see below and
Results
nestin mouse mAb
clone Rat-401
hybridoma supernatant
1:10 (IF)
Developmental
Studies Hybidoma
Bank
nestin rabbit polyclonal, aff. pur. 1:1000 (IF)
1:5000 (IB)
Eva Aaku-Saraste
neurofilament 160 mouse mAb
clone RMO044
1:50 (IF) Sigma
phospho-histone 3 rabbit polyclonal 1:300 (IF) Upstate
RC2 mouse mAb 1:200 – 1:300 (IF) Developmental
Studies Hybridoma
Bank
ribosomal protein
S6
rabbit mAb 1:1000 (IB) Cell Signalling
Tis21/BTG2 K4
rabbit polyclonal, aff. pur.
1:4000 (IF)
1:1000 (IB)
(Iacopetti et al.,
1999)
Tis21/BTG2 1511
rabbit polyclonal, aff. pur.
1:10,000 (IB) (Iacopetti et al.,
1999)
YB-1 rabbit polyclonal 1:500 (IB)
5 g/ml = 1:100 (IP)
Abcam
YB-1 rabbit polyclonal 1:200 (IB) Cell Signalling
ZO-1 mouse mAb
clone ZO1-1A12
1:500 (IF)
1:2000 – 1:5000 (IB)
Zymed
ZO-1 rabbit polyclonal 1:2000 (IB) Zymed
-mannopyranosyl
-glucopyranosyl
Concanavalin A
Lectin
Alexa 649 conjugate
50 g/ml Molecular Probes
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Secondary antibodies
Description Conjugate Dilution Supplier
Goat  guinea pig IgG HRP 1:5000 – 1:20,000 (IB) Jackson
ImmunoResearch
Goat  guinea pig IgG Alexa 488 1:1000 – 1:1400 (IF) Molecular Probes
Goat  guinea pig IgG Alexa 594 1:1000 – 1:1400 (IF) Molecular Probes
Goat  guinea pig IgG Alexa 649 1:1000 – 1:1400 (IF) Molecular Probes
Donkey  guinea pig IgG Cy3 1:2000 (IF) Jackson
ImmunoResearch
Goat  mouse IgG HRP 1:5000 – 1:20,000 (IB) Jackson
ImmunoResearch
Donkey  mouse IgG Alexa 594 1:1000 – 1:1400 (IF) Molecular Probes
 mouse IgM Cy2 1:2000 (IF) Jackson
ImmunoResearch
Goat  mouse IgG Cy2 1:2000 (IF) Jackson
ImmunoResearch
Goat  mouse IgG Cy3 1:2000 (IF) Jackson
ImmunoResearch
Goat  mouse IgG Cy5 1:2000 (IF) Jackson
ImmunoResearch
Goat  mouse IgG Cy5.5 1:1000 (IF) Biotrend
Chemikalien
Donkey  rabbit IgG
(min. cross-reaction)
HRP 1:5000 – 1:20,000 (IB) Jackson
ImmunoResearch
Goat  rabbit IgG HRP 1:5000 – 1:20,000 (IB) Jackson
ImmunoResearch
Donkey  rabbit IgG Alexa 594 1:1000 (IF) Molecular Probes
Goat  rabbit IgG Cy2 1:2000 (IF) Jackson
ImmunoResearch
Goat  rabbit IgG Cy3 1:2000 (IF) Jackson
ImmunoResearch
Goat  rabbit IgG Cy5 1:2000 (IF) Jackson
ImmunoResearch
Donkey  rat IgG HRP 1:5000 (IB) Jackson
ImmunoResearch
Protein A 10 nm gold J. Slot, Utrecht
University, The
Netherlands
EM: electron microscopy; IF: immunofluorescence; IP: immunoprecipitation; IB:
immunoblot. All secondary antibodies used for immunofluorescence are minimal cross-
reaction to other species.
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4.1.14 Buffers, stock solutions and media
Buffers and solutions for bacterial cultures
LB-medium 10g/L Bacto-Trypton
5g/L Bacto-Yeast-Extract
10g/L NaCl
pH 7.0
LB-agar 15g/L Bacto-Agar
in LB-medium
Ampicilin (100x) 100 mg/ml
in H2O
Chloramphenicol (100x) 40 mg/ml
in ethanol
Kanamycin (300x) 100 mg/ml
in H2O
Buffers and media for cell culture
10x PBS 13.7 M NaCl (80 g)
27 mM KCl (2 g)
14 mM KH2PO4 (2.4 g)
0.1 M Na2HPO4 (14.4 g)
H2O to 1l
adjust pH to 7.4 with HCl
Complete medium I
(COS7, HeLa, primary
neuroepithelial culture)
Dulbecco’s Modified Eagle Medium
4.5 g/l glucose
2 mM L-glutamine,
1 mM sodium pyruvate
100 U/ml penicillin (1x)
100 g/ml streptomycin (1x)
10% FCS
Complete medium II
(NIH3T3 and Neuro-2A)
Dulbecco’s Modified Eagle Medium
1 g/l glucose
2 mM L-glutamine,
1 mM sodium pyruvate
100 U/ml penicillin (1x)
100 g/ml streptomycin (1x)
10% FCS
Neurosphere  cu l tu re
medium
Dulbecco’s Modified Eagle Medium:Nutrient Mix F-12
(1:1)
2 mM dipeptid L-alanyl-L-glutamine (GlutaMAX I)
1x B27 (1:50)
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10 ng/ml hrEGF
do not sterile filter after addition of B27
Trypsin-versene 0.25% trypsin w/o EDTA
diluted in 1x versene salt solution
Papain-mix 30 U/ml papain
0.24 mg/ml cysteine
40 g/ml DNase I type IV
in Leibovitz L-15 Medium
sterile filter
Trypsin inhibitor-mix 45 mg Ovomucoid trypsine inhibitor
21 mg BSA
390 l DNase I type IV (40 mg/ml stock)
39 ml Leibovitz L-15 Medium
sterile filter, can be stored for 1 week
Freezing medium 10% DMSO
in FCS
Buffers and media for whole embryo culture
PB1 (dissection medium) Dulbecco’s PBS
100 U/ml penicillin (1x)
100 g/ml streptomycin (1x)
10% FCS
WEC (culture medium) 10 ml rat serum
2 mg/ml glucose
1 mM sodium pyruvate (1x)
100 U/ml penicillin (1x)
100 g/ml streptomycin (1x)
sterile filter
Buffers and solutions for immunostaining
Tissue cryo-solution 250 ml glycerol
250 ml ethylene glycol
500 ml 0.2 M phosphate buffer, pH 7.4
Blocking buffer I
(cryosections)
10% FCS
in PBS
Blocking buffer II
(cells)
5% FCS
1% BSA
in PBS
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Blocking buffer III 10% donkey serum
0.15% Triton X-100
in PBS
Incubation buffer III 3% donkey serum
0.15% Triton X-100
in PBS
DAPI (2000x) 1 mg/ml
in H2O
Moviol mounting medium 6 g Moviol 4-88 (Calbiochem)
15 g of glycerol (microscopy grade)
stir to mix
add 15 ml of H2O, incubate overnight
add 30 ml of 0.2 M Tris-Cl pH8.5
heat to 50ºC for 10 min
clarify by centrifugation at 5000 xg for 15 min
Buffers and solutions for electron microscopy
Fixation buffer 4% paraformaldehyde
0.1% glutaraldehyde
in 100 mM phosphate buffer, pH 7.4
Infiltration buffer 2.3 M sucrose
in phosphate buffer, pH 7.4
Cryosection buffer 1.3 M sucrose
1% methylcellulose
in phosphate buffer, pH 7.4
Contrasting solution 1% glutaraldehyde
0.3% uranylacetate
1.8% methylcellulose
Buffers and solutions for -galactosidase s taining
-galactosidase staining
buffer
Mix before use:
10 mM K3Fe(CN)6 (from 100 mM stock)
10 mM K4Fe(CN)6x3H2O (from 100 mM stock)
2 mM Mg
0.5% Triton X-100
in H2O
X-gal stock 40 mg/ml
5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside
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in DMSO (keep at –20ºC)
Buffers and solutions for DNA agarose gel electrophoresis
10x TBE 0.89 M Tris
0.89 M boric acid
20 mM EDTA
pH 8.0
50x TAE 2 M Tris
1 M acetic acid
100 mM EDTA
pH 8.5
ethidium bromide (20,000x) 5 mg/ml
in H2O
Buffers and solutions for RNA agarose gel electrophoresis
10x MOPS 200 mM MOPS
50 mM sodium acetate
10 mM EDTA
pH 7.0
1.2% RNA agarose gel 1.2 g agarose
72 ml H2O
boil until agarose dissolves, cool to 60ºC
10 ml 10x MOPS
18 ml formaldehyde (37%)
5 l ethidium bromide (5 mg/ml stock)
5x sample buffer 4 ml 10x MOPS
3084 l formamide
720 l formaldehyde (37%)
2 ml glycerol
80 l EDTA (0.5 M)
bromophenol blue
Buffers and solutions for protein  SDS-polyacrylamide gel electrophoresis
10x SDS-PAGE running
buffer
250 mM Tris-HCl
1.9 M glicine
1% SDS
pH 8.8
30.25 g/l
143.25 g/l
20 g/l
4x resolving gel buffer 1.5 M Tris-HCl
0.4% SDS
pH 8.8
18.17 g/100 ml
0.4 g/100 ml
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4x stacking gel buffer 0.5 M Tris-HCl
0.4% SDS
pH 6.8
6.05 g/100 ml
0.4 g/100 ml
6x Laemmli sample buffer 0.35 M Tris-HCl
10% SDS
30% glycerol
9.3% DTT
bromophenol blue
pH 6.8
7 ml 0.5 M Tris-HCl/10
ml
1 g/10 ml
3 ml/10 ml
0.93 g/ml
1.2 mg
AMBA 30% acrilamide
0.8% bisacrilamide
Coomassie super-stain 10% acetic acid
50% methanol
0.1% Coomassie blue
100 ml/l
500 ml/l
1 g/l
Destain 10% acetic acid
25% isopropanol
100 ml/l
25 ml/l
Buffers and solutions for immunoblotting
Anode buffer I 0.3 M Tris
20% methanol
pH 10.4
36.3 g/l
200 ml/l
Anode buffer II 25 mM Tris
20% methanol
pH 10.4
3 g/l
200 ml/l
Cathode buffer 25 mM Tris
40 mM 6-amino-n-caproic acid
20% methanol
pH 9.4
3 g/l
5.24 g/l
200 ml/l
Blocking solution 5% skimmed milk
0.2% Tween-20
in PBS
Washing solution 0.2% Tween-20
in PBS
Buffers and solutions for protein  isolation and immunoprecipitation
Homogenisation buffer I
(TKM)
50 mM triethanolamine-HCl pH 7.8
0.25 M sucrose
50 mM KCl
5 mM MgCl2
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1 mM DTT (add before use from 100 mM stock)
Homogenisation buffer II
(NIM)
20 mM Tris-HCl pH 7.5
0.25 M sucrose
50 mM KCl
5 mM MgCl2
1 mM DTT (add before use from 100 mM stock)
Homogenisation buffer III
(polysomal analysis)
20 mM Tris-HCl pH 7.5
100 mM KCl
5 mM MgCl2
Polysomal sucrose buffer I 20 mM Tris-HCl pH 7.5
15% sucrose
100 mM KCl
5 mM MgCl2
Polysomal sucrose buffer II 20 mM Tris-HCl pH 7.5
50% sucrose
100 mM KCl
5 mM MgCl2
Sucrose density barrier 20 mM Tris-HCl pH 7.5
2.3 M sucrose
50 mM KCl
5 mM MgCl2
RIPA lysis buffer 50 mM Tris-HCl pH 8.0
150 mM NaCl
1.0% NP-40
0.5% deoxycholic acid (DOC)
0.1% SDS
NP-40 lysis buffer 50 mM Tris-HCl pH 7.8
1.0% NP-40
150 mM KCl
5 mM MgCl2
NP-40 hypotonic lysis
buffer
50 mM Tris-HCl pH 7.8
1.0% NP-40
10 mM KCl
5 mM MgCl2
Wash buffer A 10 mM Tris-HCl pH 7.5
0.2 % NP-40
150 mM KCl
5 mM MgCl2
Wash buffer C 10 mM Tris-HCl pH 7.5
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5 mM MgCl2
Buffers and solutions for GST-fus ion protein purification
Elution buffer 50 mM HEPES pH 8.0
300 mM NaCl
10 mM glutathione
Buffers and solutions for endonuclease-prepared small interfering RNAs
preparation
Digestion buffer 20 mM Tris-HCl pH 7.9
5% glycerol
140 mM NaCl
2.7 mM KCl
5 mM MgCl2
0.5 mM EDTA
1 mM DTT (add before use from 100 mM stock)
Equilibration buffer 20 mM Tris-HCl pH 8.0
300 mM NaCl
1 mM EDTA
Wash buffer 20 mM Tris-HCl pH 8.0
400 mM NaCl
1 mM EDTA
Elution buffer 20 mM Tris-HCl pH 8.0
520 mM NaCl
1 mM EDTA
4.2 Methods
4.2.1 Preparation and purification of plasmid DNA
DNA was prepared and purified in a small (mini-prep) or large (maxi-prep) scale using
kits from Qiagen, following the manufacturer’s instructions. For embryo injection or cell
transfection, the EndoFree plasmid maxi kit was used, followed by additional step of
purification by ethanol precipitation in a presence of 2.5 M ammonium acetate.
4.2.2 Plasmid construction
MSY3 cDNAs
Two EST clones IMAG p988F169447Q3 and IRAK p961D1855Q2, containing part of
the long and short splice variants of mouse MSY3, were combined to generate by restriction
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digestion the full-length cDNA of both variants. To obtain the long splice variant, the
EcoRI-EcoNI fragment of the IRAK p961D1855Q2 clone was ligated into the EcoRI-EcoNI
digested IMAG p988F169447Q3. The short splice variant was obtained by subcloning the
PpuMI-NheI fragment from IMAGE p988F169447Q3 into the PpuMI-NheI digested
IRAK p961D1855Q2. The resulting cDNA clones were completely sequenced and named
pCMV-SPORT6-MSY3-L and pCMV-SPORT6-MSY3-S.
MSY3 expression vectors
The eukaryotic expression plasmids pCAGGS2-MSY3-L and pCAGGS2-MSY3-S
containing the entire CDS of the long and short YB3 splice variant, respectively, were
obtained by subcloning of the X h oI/XbaI cDNA fragments released from either
pCMV-SPORT6-MSY3-L or pCMV-SPORT6-MSY3-S plasmids into the modified
pCAGGS2 expression vector opened with XhoI and NheI. In pCAGGS2-MSY3-L-UTR
and pCAGGS2-MSY3-S-UTR vectors, the 3’UTR of MSY3 was excised by NotI and BstEII
restriction enzymes, cohesive ends were blunted with Klenow exo_ fragment and ligated.
GST-MSY3 fusion proteins vectors
The bacterial expression plasmids pGEX-MSY3-N and pGEX-MSY3-C containing
cDNA fragments of MSY3, corresponding to amino acids 2S-74A and 261I-361E, fused in-
frame to the glutathione S-transferase (GST) were constructed by PCR amplification using
Herculase DNA polymarase (Roche) from the IRAK p961D1855Q2 and
IMAG p988F169447Q3 clones using P9/P10 and P11/P12 oligonucleotides, respectively.
The thermal cycle profile employed 2 min denaturation step at 95ºC followed by
30 amplification cycles (1 min of denaturation at 95ºC, 30 s of annealing at 60ºC and x s of
extension at 68 ºC). The resulting PCR products were digested with BamHI-XhoI restriction
enzymes, whose sites were introduced in the oligonucleotides, and cloned into the
corresponding sites of the pGEX-7M vector.
Small interfering RNA vectors
Hairpin constructs containing small interfering RNAs directed against the MSY3 mRNA
at positions 647, 1077 and 1363 (the MSY3 5’UTR extends 194 bp before the ATG codon
and was here included for numbering) were obtained by insertion of annealed
oligonucleotide pairs P15/P16, P17/P18 and P19/P20, respectively, into the XhoI-EcoRI
digested pSM2 vector. The hairpin expression cassette, consisting of the U6 promoter,
mir30 sequences with a hairpin and the U6 terminator, was then inserted upstream of the
CMV promoter in the pAAV-hrGFP vector. First, a BamHI restriction site was introduced
into the pAAV-hrGFP vector opened with NotI and MluI by insertion of annealed
oligonucleotides P13/P14, generating the pAAV-hrGFP-B vector. Subsequently, the
BamHI-MluI restriction fragments from the pSM2-hp1077, pSM2-hp1363, and control
pSM2-luc plasmids were ligated into the corresponding sites of the pAAV-hrGFP-B vector.
All constructs were confirmed by sequencing.
4.2.3 GST-fusion proteins production
BL21 bacteria carrying the pGEX-MSY3-N plasmid, encoding for glutathione
S-transferase (GST) fused in frame to the N-terminal domain of MSY3 protein, were grown
in 800 ml LB until OD600=0.5. Fusion protein expression was induced with 0.2 mM
isopropyl-1-thio- -D-galactopyranoside (IPTG) for 2 h and bacteria collected by
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centrifugation for 10 min at 6,000 x g. The pellet was resuspended in a total volume of
40 ml of PBS and frozen in liquid nitrogen. The cell suspension was thawed, the protease
inhibitor cocktail added (Sigma; 1:500), and treated with 0.1 mg/ml of lysosyme for 30 min
on ice, then bacteria were disrupted by sonication at 4ºC. The lysate was cleared by
centrifugation at 112,000 x g for 1 h. GST-fusion proteins were precipitated with 500 l of
glutathione sepharose (Amersham), beads were washed 3 times in 10 ml of PBS, and loaded
on a MicroSpin column (Biorad), GST-fusion proteins were eluted with 500 l aliquots of
the elution buffer containing 10 mM glutathione. Total of 4.4 mg of protein in 2 ml of the
eluate was recovered.
Fusion of the C-terminal portion of the MSY3 protein to the GST protein, encoded in
the pGEX-MSY3-C plasmid, was recovered in the pellet upon ultracentrifugation, due to
precipitation in the inclusion bodies. Therefore this construct was not further used.
4.2.4 Generation of antibodies
Three rabbit polyclonal antisera, named 0181, 0182 and 0183, were raised against the
peptide CGGTTLPQAAADAPA (with C added for the conjugation) corresponding to the
amino acid residues 10 to 23 of the MSY3 protein; the 0182 antiserum was further affinity
purified. Independently, the affinity purified rabbit antiserum against the identical peptide,
and named AP4912, was obtained from Karl Matter (UCL, United Kingdom). Antisera GP1,
GP2 and GP3 directed against the N-terminal domain of MSY3 (amino acids S2–A74)
fused to the GST protein were raised in guinea pigs.
4.2.5 Whole embryo culture and electroporation
Preparation of embryos for the whole embryo culture was carried out at room
temperature in pre-warmed PB1. Time-pregnant females were killed via cervical
translocation, the uterus was removed and placed in PB1. E9.5 or E10.5 embryos were
dissected under a dissection microscope free of decidua and Reichert’s membrane, and yolk
sac and amnion were opened exposing the embryo to the culture medium. Embryos were
placed in 1.5-2 ml of WEC medium per embryo and cultured at 30 rpm in a continuous-
flow atmosphere of 5% CO2, in N2, with O2 in a proportion listed below.
time of culture 0 h 8 h 20 h 25 h 32 h 44 h
O2 20% 20% 60% 60% 95% (or 60%) 95%
flow (ml/min) 50 75 50 75 50 (or 100 for 60%) 50
Before injection of nucleic acid and electroporation, embryos were allowed to recover in
culture for 1-2 h. Embryos were immobilised in an agarose mold immersed in PB1 or
Dulbecco’s PBS and telencephalic vesicles were filled with PBS containing 0.01% fast green,
0.3 g/ l plasmid DNA encoding for marker fluorescent protein, and 1.8 g/ l of
pCAGGS-MSY3-L or 1 g/ l esiRNAs using a glass capillary controlled by a standard
micromanipulator and connected to a pneumatic PicoPump. Immediately after injection, 5
square electric pulses of 25 V, 50 ms each, at 1 s intervals were delivered through tweezers-
like electrodes placed at 1 cm distance. After electroporation, embryos were returned into
culture and allowed to develop for 36 (E10.5) or 48 h (E9.5). At the end of this period,
extraembryonic membranes and placenta were removed and embryos which expressed a
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fluorescent marker were washed briefly with PBS and processed for immunohistochemistry
as described below.
4.2.6 In utero electroporation
E12.5 pregnant mice were anaesthetised with isofluorane and injected sub-cutaneously
with 0.03 mg/ml aqueous solution of buprenorfin (25 l per 10 g body weight). Pregnant
mouse was placed on a warmed stage and anasthaesia was sustained by constant delivery of
isofluorane atmosphere through a nose cone. In order to access the embryos, the pregnant
female was shaved and a 1.5-2 cm ventral midline incision was made through the skin and
peritoneal muscle, through which the uterine horns were gently pulled out. The uterus was
kept wet with pre-warmed Dulbecco’s PBS during the operation time. The telencephalic
vesicles of embryos were visualised by transillumination and approximately 2 l of PBS
containing 0.02% Fast Green, 0.3 g/ l of pCAGGS-mRFP plasmid DNA, and 1.8 g/ l
of pCAGGS-MSY3-L or 1.4 g/ l of pCAGGS-MSY3-L-UTR plasmid DNA was injected
into the lateral ventricle through the uterus using a glass capillary connected to a pneumatic
PicoPump. Immediately after injection, six square electric pulses of 30 V, 50 ms each at 1 s
intervals were delivered using 1 mm diameter tweezers electrodes. After electroporation, the
uterus was placed back in the abdomen, the mouse was sutured and allowed to recover on a
warm platform. After 2 days, the animals were sacrificed and embryos which expressed a
fluorescent marker were processed for immunohistochemistry as described below.
4.2.7 Preparation of embryos for cryosectioning
Time pregnant females were sacrificed via cervical translocation, and the uterus was
removed. Embryos were dissected in chilled PBS free of diciduae and extraembryonic
membranes, except for E8 embryos, which were only removed from the uterus. For E12.5
embryos, heads were cut off at the level of the otic pit/mandibular arch to allow better
penetrance of solutions to the brain ventricles. For later stages of development, the brains
were excised, leaving meaninges. Whole embryos, heads and brains were fixed over night at
4ºC in 2-4% paraformaldehyde in a phosphate buffer, pH 7.4, by immersion, with constant
agitation. For -galactosidase staining, embryos were fixed for 2 h in 0.2% glutaraldehyde
and 2% paraformaldehyde. For electron microscopy, embryos were fixed in 0.1% GA and
4% PFA in a phosphate buffer, pH7.4. Except for electron microscopy, the tissue was then
infiltrated with 30% sucrose in PBS for 24-48 h and frozen in Tissue-Tek O.C.T compound
(Sakura Finetek). Embryos were cut on a cryostat (Microtome) to 14-20 m sections.
4.2.8 Preparation of postnatal brains for cryosectioning
For brain collection, the pups until the third postnatal week (P3W) were sacrificed by
cutting off the heads, brains removed and fixed for 24 h in 4% paraformaldehyde. Adult
mice were anaesthetised with an intraperitoneal injection of a mixture of Ketamine and
Xylazine and then intracardially perfused with 0.9% NaCl, followed by freshly prepared cold
4% paraformaldehyde in a phospate buffer, pH 7.4. The brains were removed and
post-fixed overnight in 4% paraformaldehyde. All brains were infiltrated with 30% sucrose
in PBS for 24 h. Sections were cut frozen using a sliding microtome to 40 m thick sections,
which were stored in the tissue cryo-solution at –20ºC.
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4.2.9 Cell culture and transfection
Neuroepithelial  cluster culture
Neuroepithelial clusters and dissociated cells were cultured in the Complete medium I
(Dulbecco’s Modified Eagle Medium with 4.5 g/l glucose, supplemented with 10% FCS,
100 U/ml penicillin and 100 g/ml streptomycin) in a humidified incubator at 37°C under a
5% CO2 atmosphere in 24-well plates.
Pregnant NMRI mice were sacrificed on gestational day 10 or 11 and embryos were
harvested. The forebrains of embryos were dissected free of meaninges in ice-cold Leibovitz
L-15 medium, washed with 10 ml of L-15 medium and trypsinised in 1 ml
trypsin-EDTA 0.25% at 37ºC for 3-5 min with gentle agitation. To block the trypsin, 1 ml
of complete medium containing 10% FCS was added. Cells were mechanically dissociated
with fire-polished Pasteur pipette to yield suspensions of single cells or small clusters of 10-
30 cells, as microscopically monitored. After trituration, cells were washed with 8 ml of the
complete medium and collected by centrifugation for 3 min at 1000 rpm. Clusters and cells
were diluted with the culture medium and plated at density 104-105 clusters or cells per well
of 24-well plates on coverslips coated with 0.01% poly-L-lysine (Sigma) and 10 g/ml
laminin. Clusters and dissociated cells were processed for immunostaining after 24 and 8 h,
respectively.
Neural stem cel l (neurospheres) culture
Neural stem cells were grown as free-floating aggregates (neurospheres) in a humidified
incubator at 37ºC under 6% CO2 atmosphere in Dulbecco’s Modified Eagle
Medium/Nutrient Mix F-12 (1:1), containing 1:50 B27 supplement and 10 ng/ml human
recombinant EGF. Each second day of culture, 1/4 - 1/3 volume of fresh medium was
added. Neurospheres were dissociated every 3-5 days, with sub-culture ratio of 1:3-1:5.
Preparation of neural stem cells was performed at room temperature under sterile
conditions. P1-P9 animals were sacrificed by cutting off the heads, brains were removed and
placed in the Leibovitz L-15 medium. Hemispheres were dissected free of meaninges,
choroids plexus and olfactory bulb; placed in 300 l of papain-mix : trypsin inhibitor-mix
(1:1), minced with tweezers and incubated at 37ºC for 30-45 min. The cells were dissociated
with a fire-polished Pasteur pipette in a presence of an additional 1 volume of the trypsin
inhibitor. The cell suspension was then transferred to 9 ml of DMEM/F12 medium and
spun for 5 min at 80 x g. After decanting the supernatant, cells were resuspended gently in
1 ml of culture medium and transferred to 3 ml of medium in a 25 ml flask.
For propagation, neurospheres were collected by centrifugation for 5 min at 80 x g, and
incubated in 500 l of trypsin-versene 0.25% for 6 min at 37ºC. To block the trypsin,
1 volume of trypsin inhibitor was added and cells were dissociated by trituration for 5 min
through 1 ml pipette tip. Cells were washed with 8 ml of DMEM/F-12, spun for 5 min at
80 x g, resuspended in 1 ml of culture medium, and transferred to flasks at a 1:3-1:5 ratio.
Cos7 and HeLa cell lines
Cos7 cells were maintained in a humidified incubator at 37°C under a 5% CO2
atmosphere in the Complete medium I.
Neuro-2A and NIH-3T3 cell lines
Neuro-2A cells were maintained in a humidified incubator at 37°C under a 5% CO2
atmosphere in the Complete medium II.
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Transfect ions
Transient transfections were achieved by electroporation or lipofection.
For electroporation, cells were trypsinised and 5x105 cells were resuspended in 200 l of
complete medium with 15 mM HEPES pH 7.5. 50 l of transfection mixture
containing 210 mM NaCl, 30 g of salmon sperm DNA and 5 g of pCAGGS2,
pCAGGS2-MSY3-L or pCAGGS2-MSY3-S plasmids was added to the cell suspension.
Cells were electroporated at 950 μFD, 240 V using BioRad Gene Pulser II. After
electroporation, cells were washed with complete medium containing 15 mM HEPES
pH 7.5 and plated on 100-mm Petri-dishes. Cells were analysed by immunoblotting 36 h
after transfection.
For lipofection, Lipofectamine 2000 reagent (Invitrogen) was used, according to the
manufacturer’s instructions. Briefly, 106 cells were plated on a 60-mm Petri dish the day
before transfection in the complete medium without antibiotics. Before the transfection,
medium was replaced by 2 ml serum-free OPTI-MEM I (Invitrogen). For each transfection,
5 g of plasmid DNA and 2-3 g of esiRNA was used, combined with 10-20 l of
lipofectamine.
4.2.10 Protein extract preparation
Tissue protein extracts
Tissue protein extracts were prepared from mouse embryos or adult brain. All steps
were performed at 4°C. For the time-course analysis of YB3 expression, telencephali and
hindbrains were dissected from embryonic brains in ice-cold PBS. Tissues were
homogenized in RIPA buffer containing the protease inhibitor cocktail (Sigma; 1:500), lysed
for 30 min, centrifuged at 10,000 x g for 10 min, and the supernatant collected.
Alternatively, whole embryos (E9.5), heads (E10.5-12.5) or brains (E14.5) were
solubilised in 5 volumes of 1.2x Laemmli sample buffer containing the protease inhibitor
cocktail (Sigma; 1:500) without DTT and bromophenol blue, which were added after
protein quantification. Tissue was triturated with plastic pestle or 1 ml pipet tip, and the
sample boiled for 15 min.
Protein concentration was determined using BCA Protein Assay Kit (Pierce Chemical
Company) following the manufacturer’s instructions, and 40 g of each sample was analysed
by SDS-PAGE and immunoblotting.
Cell protein extracts
HeLa cells grown on 100-mm Petri dishes were washed with ice-cold PBS, scraped from
the dish in ice-cold PBS and centrifuged at 900 x g for 5 min. The cell pellets were lysed in
200 μl of RIPA buffer containing protease inhibitor cocktail (Sigma; 1:500) for 30 min at
4°C and detergent extracts obtained after centrifugation (10,000 x g for 10 min) were
subjected to SDS-PAGE and immunoblotting.
Neuro-2A cells grown on 60-mm Petri dishes were washed twice with ice-cold PBS and
solubilised directly in 500 l of 1.2x Laemmli sample buffer containing protease inhibitor
cocktail (Sigma; 1:1000), scraped and boiled for 15 min. 20-40 l was analysed by
SDS-PAGE and immunoblotting.
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4.2.11 Differential centrifugation
The subcellular fractionation was performed at 4°C. Around 30 E10 – E11 mouse
embryos (two to three litters) were dissected in ice-cold PBS and homogenised in a glass-
Teflon Potter homogeniser  (10 strokes at 1200 rpm) in the Homogenisation buffer I or II
with addition of 40 U/ml ribonuclease inhibitor (Promega) and the protease inhibitor
cocktail (Sigma; 1:200). The homogenate was centrifuged at 900 x g for 10 min resulting in
the crude nuclei pellet and the supernatant, which was further centrifuged at 15,000 x g for
10 min to obtain the mitochondria-enriched fraction (P15) and the post-mitochondria
supernatant (PMS). The PMS was divided in aliquots, and incubated at 37°C for 45 min
without any additions or with 1 mg/ml RNase A (Qiagen), 25 mM EDTA, or 1 mg/ml
RNase A and 25 mM EDTA; or alternatively at 4°C for 45 min in absence or presence of
0.5 M NaCl, 2% Triton X-100, or 25 mM EDTA. The reaction mixtures were than
centrifuged at 100,000 x g for 2 h resulting in the P100 pellet and the S100 supernatant.
Supernatants were subjected to methanol/chloroform precipitation and resuspended in SDS
Laemmli sample buffer. The crude nuclei pellet was resuspended in the homogenisation
buffer II, filtered by centrifugation through 35 μm mesh in a cell strainer cup tube (Falcon,
BD Biosciences) at 1000 x g. The resulting pellet was resuspended in the Homogenisation
buffer II containing 1.8 M sucrose, overlaid on a 2.3 M sucrose cushion in the same buffer,
and centrifuged at 100,000 x g for 1 h. The supernatant and interphase were discarded and
the nuclear pellet was resuspended in the homogenisation buffer. Equal proportions of each
fraction were analysed by SDS-PAGE and immunoblotting.
4.2.12 Polyribosomal analysis
All steps were performed at 4°C. Around 40 E10.5 embryos were homogenised as
described above in the Homogenisation buffer III with addition of 100 U/ml ribonuclease
inhibitor (Invitrogen or Promega) and the protease inhibitor cocktail (Sigma; 1:300). The
homogenate was centrifuged at 800 x g for 10 min and the supernatant was centrifuged
further at 15,000 x g for 10 min. NP-40 was added to the supernatant to a final
concentration of 1% to release ribosomes/polyribosomes from membranes. The
supernatant was incubated for 2 h on ice without any additions, or with 25 mM EDTA or 1
mg/ml RNase A. The samples were overlaid on 11 ml of a 15-50% linear sucrose gradient
prepared in the homogenisation buffer, and centrifuged at 100,000 x g for 2 h. 1 ml
fractions were collected manually from the top of the gradient and the pellet was
resuspended in 1 ml of the homogenisation buffer. 500 μl of each fraction was subjected to
the methanol/chloroform precipitation in a presence of the haemoglobin carrier. 15% of
each fraction was then analysed by SDS-PAGE and immunoblotting analysis. RNA was
isolated from 100 μl of each fraction.
4.2.13 Immunoprecipitation
Immunoprecipitation was performed from an embryo tissue homogenate or Neuro-2A
cells. All steps were carried out at 4ºC.
Around 40 E9.5 – E10 embryos were homogenised in the NP-40 lysis buffer containing
100 U/ml ribonuclease inhibitor (Invitrogen or Promega) and protease inhibitor cocktail
(Sigma; 1:300). Alternatively 6-7 100-mm dishes of Neuro-2A cells at 60% confluency were
washed twice with PBS and cells were scraped in 200 l/dish of the NP-40 hypotonic lysis
Materials and Methods
114
buffer containing 100 U/ml ribonuclease inhibitor (Invitrogen or Promega) and the
protease inhibitor cocktail (Sigma; 1:300). Salt was adjusted to 150 mM KCl and the cell
suspension was passed 3 times through a 22 G needle. The homogenate, both from
embryos and cells, was then incubated on ice for 30 min and cleared by centrifugation at
15,000 x g for 10 min. 5 l of guinea pig GP2 anti MSY3 antiserum or control guinea pig
serum, or 2.5 g anti YB1 antibody (Abcam) or control rabbit IgG were added to 500 l of
homogenate and incubated with end-over-end agitation for 4 h. The immune complexes
were incubated with 35 l of Protein G Sepharose 4 Fast Flow (Amersham Biosciences) for
2 h with end-over-end agitation. The beads were collected by centrifugation at 3000 rpm
and washed 3 times with NP-40 buffer, 3 times with washing buffer A and 2 times with
washing buffer C. At last washing step, samples were divided in two and processed for
protein extraction or RNA isolation. Proteins were extracted from beads by boiling for
5 min in Laemmli sample buffer. 1/4 of the sample was then analysed by immunoblotting.
4.2.14 Metabolic labelling
Neuro-2A cells were transfected on 60-mm Petri dishes with pCAGGS-GFP,
pCAGGS-MSY3-L-UTR or esiRNAs directed against YB3 48 h before. 45 min prior
labelling, complete medium was replaced by Dulbecco’s Modified Eagle Medium without
methionine and cysteine (Invitrogen) supplemented with 2 mM glutamine, 100 U/ml
penicillin and 100 g/ml streptomycin. Labelling was performed in 2 ml of the same
medium containing 86 Ci/ml [35S] methionine/cysteine (Perkin Elmer). After 10, 20, or 30
min cells were washed with ice-cold PBS and labelling was stopped by addition of 500 l of
1.2x Laemmli sample buffer containing the protease inhibitor cocktail (Sigma; 1:1000). 20 l
of each sample was resolved by 12% SDS-PAGE followed by radiography.
4.2.15 Immunoblotting
Proteins were analysed by SDS-PAGE (typically 9% for MSY3) or for time-course
analysis of MSY3 expression by gradient 4-12% NuPage gels (Invitrogen), and transferred
to PVDF membranes using a semi-dry blotting system. After transfer, membranes were
incubated over night at 4ºC in the blocking buffer. Proteins of interest were then detected
by incubation with appropriate primary antibodies for 1.5 h at room temperature followed
by horseradish peroxidase-conjugated secondary antibodies. All antibodies were diluted in
the blocking buffer. Washing steps were performed for 1 h with several changes of the
washing buffer. Immune complexes were visualised with extended duration
chemiluminescence developing reagents (Pierce Chemical Company) on ECL films
(Amersham Biosciences).
4.2.16 RNA isolation
After sucrose gradient analysis, RNA was isolated from 100 l of each fraction. After
immunoprecipitation, beads with immunocomplexes, 25 l of total homogenate,
homogenate with immune complexes (pre-IP) and unbound fractions were adjusted to
100 l with wash buffer C. All samples were mixed with 3 volumes of Trizol LS
(Invitrogen), frozen in liquid nitrogen and stored at -20°C until further processed.
To isolate RNA from cells, NIH3T3 cells were grown on 100-mm Petri dishes to
50-70% confluency. Cells were washed twice with ice-cold PBS, scraped in 1500 l of PBS
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and collected by centrifugation for 3 min at 2000 x g. Cells were resuspended in 200 l of
PBS, mixed with 3 volumes of Trizol LS and frozen in liquid nitrogen.
The RNA isolation was performed according to the manufacturer’s instructions in
presence of the glycogen carrier (1-2 g/sample), and analysed by electrophoresis in 1.2%
denaturing agarose gel.
4.2.17 Endonuclase preparation of small interfering RNAs (esiRNAs)
Fragments of MSY3, luciferase, and EGFP cDNAs were amplified by PCR using
oligonucleotides P21/P22, P23/P24 (MSY3), P25/P26 (luciferase) and P27/P28 (EGFP).
Transcription was performed from 16 l of PCR product with MEGAScript T7 Kit
(Ambion) following manufacturer’s instructions, and RNA was annealed in thermal cycler
as follows: 90ºC for 3 min, ramp to 70ºC with 0.1ºC/sec, 70ºC for 3 min, ramp to 50ºC
with 0.1ºC/sec, 50ºC for 3 min, ramp to 25ºC with 0.1ºC/sec. dsRNA was partially digested
to esiRNAs with length of about 18 to 25 bp with RNase III in the 200 l of the digestion
buffer at 37ºC for 2-4 h. esiRNAs were purified in two aliquots on 200 l of Q-Sepharose
(Amersham) equilibrated with Equilibration buffer, washed with 500 l of the Wash buffer
and eluted twice with 300 l of the Elution buffer. esiRNAs were precipitated with
isopropanol, washed with 70% ethanol and resuspended in PBS.
4.2.18 Immunohistochemistry and light microscopy
Immunofluorescence of fixed cells
Cells grown on coverslips were fixed for 15 min in 4% paraformaldehyde, washed with
PBS, permeabilised with 0.3% Triton X-100 in PBS for 15 min or acetone for 3 min at
–20ºC, quenched with 50 mM NH4Cl in PBS, and incubated for 1 h in Blocking buffer I.
Cells were incubated sequentially with primary and secondary antibodies for 3 and 1 h at
room temperature, respectively. All antibodies were diluted in blocking buffer, and washing
steps were performed in PBS. Coverslips were rinsed with water and mounted onto glass
slides using Moviol solution.
Immunofluorescence of neurospheres
Neurospheres were fixed and stained in suspension, being collected by centrifugation for
5 min at 100 x g after each step. Neurospheres were fixed with 4% paraformaldehyde for
20 min, washed 3 times with PBS, permeabilised for 30 min with 0.3% Triton X-100 or
0.2% saponin, and free aldehyde groups were quenched for 30 min with 50 mM NH4Cl in
1 ml of PBS. Neurospheres were then incubated with the Blocking buffer I for 1 h at room
temperature. Incubation with primary and secondary antibodies was performed in 100 l of
blocking buffer, overnight at 4ºC and for 1.5 h at room temperature, respectively. DNA was
labelled with DAPI (5 μg/ml). Neurospheres were washed with PBS and water, and
mounted onto glass slides using Moviol solution.
Immunofluorescence of cryosections
Cryosections were rehydrated in PBS, permeabilised with 0.3% Triton X-100 in PBS for
15 min, quenched with 50 mM NH4Cl in PBS, and incubated for 1 h in the Blocking
buffer II. Optionally for this step, 0.3% Triton X-100 was added. Incubation with primary
antibodies diluted in the blocking solution was performed overnight at 4°C. Sections were
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washed with excess of PBS with agitation and incubated with the appropriate fluorochrome-
conjugated secondary antibodies diluted in blocking buffer for 1 h at 37°C. DNA was
labelled with DAPI (5 μg/ml) present together with secondary antibodies. Sections were
rinsed with water and mounted using Moviol solution.
Sections derived from postnatal brains were stained free-floating. Sections were washed
twice with Tris-buffered saline, pH 7.4 (TBS), permeabilised and blocked directly in the
Blocking buffer III, followed by overnight incubation at 4ºC with primary antibodies diluted
in the Incubation buffer III. Sections were washed three times in TBS, incubated with
secondary antibodies for 4 h at room temperature, followed by staining with DAPI for
5 min. Sections were wet-mounted on glass sl ides using DABCO
(1,4-diazabicyclo[2.2.2]octan) mounting medium.
-galactos idase staining
Cryosections from embryos fixed with 2% paraformaldehyde and 0.2% glutaraldehyde
were washed 3x for 15 min with pre-warmed at 37ºC -galactosidase buffer followed by
incubation with 1 mg/ml X-gal diluted in -galactosidase buffer at 37ºC in a dark chamber.
The chromogenic reaction was monitored under a microscope and stoped by washing with
PBS. Sections were then rinsed with water and mounted using Moviol solution.
Microscopy
Labelled sections and cells were observed using a Zeiss Axiovert 200 M confocal laser
scanning microscope or Olympus BX61 epifluorescent microscope. Zeiss LSM 510 AIM
software, Adobe Photoshop and Adobe Illustrator (Adobe Systems, San Jose, CA) were
used for data analysis and image processing.
For analysis of the MSY3 expression in various mice lines, as well as after
overexpression and downregulation experiments, single optical slices of 2-4 m were
acquired in the middle of a tissue section using the same settings. A minimum of 3 embryos
at each age or at each experimental condition was analysed. For analysis of the MSY3
subcellular and cellular distribution, in particular for comparison with Tis21-EGFP
expression, Z-stacks of 1 m slices at 0.5 m intervals spanning the tissue section were
acquired. Analysed were slices at 3 to 7 m depth with respect to the tissue section surface.
4.2.19 Electron microscopy
Embryos fixed in 4% paraformaldehyde and 0.1% glutaraldehyde were cut into pieces,
which were infiltrated with 10% gelatine at 37ºC, and embedded in 10% gelatine, followed
by infiltration with 2.3 M sucrose at 4ºC. Specimens were quickly frozen in liquid N2 and
sectioned to 80 nm cryosections, which were collected in the Cryosection buffer. The
gelatine was removed by incubation on a drop of PBS at 37ºC, and sections were subjected
to immunolabelling with primary antibody, followed by protein A coupled to 10 nm gold
particles. Sections were then treated for 10 min with the Contrasting solution and viewed in
a Morganini electron microscope.
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 ABBREVIATIONS
4E-BP eIF4E binding protein
AP affinity purified
ARE AU-rich element
bHLH basic helix-loop-helix transcription factor
BLBP brain lipid binding protein
BMP bone morphogenic protein
BTG2 B-cell translocation gene 2
CA Cornu Ammonis (Ammon’s horn) field
Cdk cyclin dependent kinase
CMV Cytomegalievirus
CNS central nervous system
Con A Concanavalin A
CP cortical plate
CRS cytoplasmic retention signal
CSD cold shock domain
CTD C-terminal domain
DG dentate gyrus
dienc diencephalon
DMEM Dulbecco’s modified essential medium
DTT dithithreitol
E embryonic day post-conception
ECL enhanced chemoluminescence
EDTA ethylendiamintetraacetic acid disodium salt
eIF eukaryotic initiation factor
ER endoplasmic reticulum
ETV6 ets variant gene 6, Tel oncogene
FACS fluorescence activated cell sorting
FCS foetal calf serum
FMRP fragile X mental retardation protein
GE ganglionic eminence
GFP green fluorescent protein
GFAP the glia-fibrillary acidic protein
GLAST astrocyte-specific glutamate transporter
GST glutathione S-transferase
Hes homologue of hairy and Enhancer of split
Id Inhibitor of DNA binding
IL-2 interleukin 2
IPTG isopropyl-1-thio- -D-galactopyranoside
IRES internal ribosomal entry sequence
IP immunoprecipitation
IZ intermediate zone
kb kilobases
kDa kilo-Dalton
K-Ras Kirsten rat sarcoma viral oncogene encoding p21 protein
LV lateral ventricle
mAb monoclonal antibody
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mb midbrain
mRFP monomeric red fluorescent protein
mRNP messenger ribonucleoprotein particle
NE2 neuroepithelial cell
NE nuclear extact
NIM nuclei isolation medium
NL neuronal layer
NLS nuclear localisation signal
NTRK3 neurotrophic tyrosine kinase receptor type 3
OD optical density
P pellet
P 2 postnatal day
PAGE polyacrylamide gel electrophoresis
PBS phosphate buffered saline
PCR polymerase chain reaction
PI pre-immune
PMS postmitochondrial supernatant
polyA polyadenylation signal
PTB polypyrimidine tract binding protein
PW postnatal week
S supernatant
SDS sodium dodecyl sulphate
SGL subgranular layer (of hippocampus)
SVZ subventricular zone
tel telencephalon
Tis21 TPA inducible sequences 21
UTR untranslated region
VEGF vascular endothelial growth factor
VZ ventricular zone
YB Y-box binding protein
YRS Y-box recognition sequence
ZO-1 zonula occludens-1
ZONAB ZO-1 associated nucleic acid binding protein

